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1 Summary 
The first section of this work comprises investigations concerning the initial steps in 
rifamycin biosynthesis. The amino sugar kanosamine was described to represent the most 
likely source of the nitrogen atom in the aminoshikimate pathway and is putatively 
synthesised by the catalytic activity of the enzymes RifL, RifK and RifM. Furthermore, in 
earlier studies kanosamine was even converted to kanosamine 6-phosphate by the rifamycin 
biosynthetic enzyme RifN. Therefore, evidence but no proof for the occurrence of 
kanosamine at an early stage in rifamycin biosynthesis was provided before the beginning of 
the present work. In this work functional studies of the gene products of rifL, rifK and rifM 
from the rifamycin producer Amycolatopsis mediterranei S699 were carried out using the 
plasmid pHGF7604 for the heterologous expression of the rifG-N genes in Streptomyces 
lividans TK24. Kanosamine was supposed to be synthesised by RifL, RifK and RifM during 
the RifL assay, employing a cell-free extract of Streptomyces lividans pHGF7604. These 
studies were based on former results concerning the RifL assay and aimed at the analytical 
detection of the putatively synthesised intermediate kanosamine en route to the known 
ansamycin precursor AHBA. Therefore, the RifL assay system was optimised, protein 
purification of cell-free extracts from Streptomyces lividans pHGF7604 was performed and 
analytical methods for kanosamine detection were developed within the scope of this study. 
The amino sugar was not detected in any RifL incubation sample, whereas concurrently no 
RT-PCR product of RifL could be verified. However, actual proof for an involvement of rifL, 
rifK and rifM in the postulated biosynthetic pathway of rifamycin could not be demonstrated 
under the terms of this study.  
 
The second section of this work is directed towards the characterisation of the gene cluster 
encoding the biosynthesis of the polycyclic xanthone IB-00208 in Streptomyces sp. 
GW2/5831. As polyketides represent an important source of nature-derived pharmaceuticals, 
their exploration provides promising opportunities for the discovery of new biogenic agents. 
Moreover, the acquirement of insights on the genetic level provides important information for 
genetic engineering that can lead to novel hybrid compounds with improved therapeutic 
values. In polyketide gene clusters “core” polyketide synthase (PKS) genes are encountered 
along with “post” PKS genes encoding modifying enzymes like oxygenases, methyl- and 
glycosyltransferases. In particular, glycosylation reactions that take place during post-PKS 
tailoring processes are relevant for genetic engineering. Especially genes encoding 
glycosyltransferases that catalyse (deoxy-) sugar attachments to the matured molecule are 
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focussed on. The information obtained in this part of the work should provide a prerequisite 
for a prospective genetic engineering of the IB-00208 and griseorhodin A biosynthetic 
pathways. A glycosylated griseorhodin A molecule is expected to feature improved 
pharmacokinetic properties. As both compounds share the same polyaromatic core skeleton, it 
can be envisioned that griseorhodin A will be accepted as an aglycon-substrate by the 
glycosylating enzyme from the IB-00208 cluster. To isolate the IB-00208 cluster, a genomic 
library was established from DNA of Streptomyces sp. GW2/5831, and screening was 
performed employing ketosynthase (KS) primers. Sequencing of the positive cosmid clones 
and subsequent BLAST search allowed the deduction of a putative cluster fragment 
containing protein coding regions characteristic of this kind of PKS clusters, and genes 
possibly involved in the biosynthesis of IB-00208 were identified. The library was 
constructed using a shuttle vector that enabled the heterologous expression of the cosmid 
sequences in Streptomyces albus. This study sets the stage for further investigations of the IB-
00208 biosynthetic gene cluster from Streptomyces sp. GW2/5831. 
 
Both parts of the study are in the field of actinomycete genetics in drug development, 
representing different types of PKS systems. The genetics of streptomycetes is of particular 
importance, as it opens up many possibilities in the fields of biotechnology and pharmacy. 
Therefore many sequencing projects contribute to an enlarged knowledge on biosynthetic 
gene clusters of therapeutic agents that are of substantial interest.  
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2 Introduction 
Secondary metabolites are natural products originating from micro- and macroorganisms. 
They are widespread in nature and often exhibit potent physiological activities. The 
pharmacological properties of biogenic agents are beneficial for example in the treatment of 
infectious diseases or cancer.1 Natural products are generally employed as putative drug 
candidates themselves or serve as drug leads in pharmaceutical research.2 In contrast to the 
basic primary metabolism, the secondary metabolism is not absolutely essential for the 
survival of organisms. These compounds are more likely to inherit ecological functions 
regarding defence against predators or diseases, reproductive advantages, improved 
intraspecies communication or interspecies competition.3 The secondary metabolism is 
usually induced at a certain developmental stage of an organism or by environmental 
conditions. Mediation of mutualistic interactions between higher organisms and producing 
microorganisms is frequently encountered (e.g., the pederin-producing bacterium, related to 
Pseudomonas aeruginosa, that is associated with the beetle Paederus fuscipes4). Natural 
products occur in a wide spectrum of chemical product classes (families) including alkaloids, 
glycosides, polyketides, terpenoids among others. Polyketides represent a prominent group of 
nature-derived drugs, prevalently antibiotics that are mainly produced by actinomycetes, in 
particular Streptomyces strains.  
 
2.1 Streptomycetes as polyketide factories  
The genus Streptomyces comprises Gram-positive, obligate aerobic bacteria exhibiting a high 
content of cytosine and guanine in their DNA.5 Taxonomically, Streptomyces species reside in 
the diverse group of actinomycetes. Due to their growth as a vegetative hyphal mass that 
creates a filamentous mycelium, enabling them to easily spread through soil, they were 
formerly designated as “ray fungi”. Streptomycetes are ubiquitous soil bacteria, likely to be 
present in aquatic habitats as well,6 and many of them are able to colonise plant rhizospheres.7 
They are important decomposers utilising extracellular hydrolytic enzymes. Their 
morphological differentiation is characterised by a life cycle consisting of the germination of 
vegetative mycelium from a single spore, followed by growth of aerial hyphae. Septation of 
these hyphae then produces unigenomic spore compartments that can commence a new cycle. 
The conidiospores represent a semi-dormant stage in the life cycle that can hold on for 
decades. It is reported by Morita that viable Streptomyces cultures were recovered from 70 
year old soil samples.8 Streptomycetes are still an outstanding source of therapeutically 
important agents, even though they have been known for a long time. As a consequence, they 
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are invaluable in the medical field, providing approximately half of all known antibiotics.5 
Many drugs for the treatment of cancer are Streptomyces-derived as well.9 Furthermore, these 
compounds are utilised in agriculture as growth promoters, agents for crop protection, 
antiparasitic agents and herbicides.10  
 
The aromatic polyketide actinorhodin 1 (figure 2.1), produced by Streptomyces coelicolor, 
provides one of the most thoroughly studied examples of all Streptomyces antibiotics.11 The 
production of antibiotics in Streptomycetes is generally growth phase-dependent. The onset of 
growth in liquid cultures takes place at the beginning of the stationary phase, whereas on solid 
media it coincides with morphological differentiation.  
 
O O
OH OH
OHOH
O
O
O
O COOHHOOC
 
 
 
Figure 2.1: Chemical structure of actinorhodin 1 from Streptomyces coelicolor with 
antibacterial activity. 
 
As microorganisms developed resistance against antibiotics, and multidrug-resistant 
pathogens like methicillin-resistant Staphylococcus aureus (MRSA) appeared, the search of 
new agents and modified compounds was greatly enforced. Therefore the development of 
analytical methods in chemistry and molecular biology led to improved screening techniques 
(counter screening), optimised fermentation procedures and target-based modifications on 
producing strains. For example, Lang et al. described a dereplication methodology for rapid 
small-scale investigation of natural products extracts.12 
 
Many important Streptomyces-derived antibiotics belong to the functionally and structurally 
diverse group of polyketides sharing considerable pharmaceutical properties. They especially 
serve as lead structures for the synthesis of improved pharmacological compounds. A small 
selection of polyketide structures and their natural producers is displayed in figure 2.2. 
Polyketides inherit a wide spectrum of pharmaceutically relevant activities, including 
antibacterial (monensin 2, tetracycline 6, rifamycin 14), antifungal (amphotericin 9), 
antiparasitic (avermectin 3), antitumour (doxorubicin 4, rubromycin 5, hedamycin 8, 
bleomycin 10) and immunosuppressant (tacrolimus 7, rapamycin 11) agents. Polyketides are a 
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prominent class of natural products often synthesised by soil bacteria like Streptomyces 
species, but also by other bacteria, fungi, marine organisms or plants.  
 
The mode of action of a polyketide can, for example, be due to the inhibition of bacterial 
protein biosynthesis by disruption of  t-RNA binding to the ribosome 30S subunit 
(tetracycline 6).13, 14 Furthermore, the reaction can be based on a DNA alkylation process 
(hedamycin 8)15 that causes the inhibition of tissue growth, or nuclear or mitochondrial DNA 
strands can be ruptured by DNA intercalating agents like doxorubicin 4, resulting in a 
cytostatic effect.16  
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Doxorubicin 4 from Streptomyces peucetius 
Antitumour activity 
 
 
γ-rubromycin 5 from Streptomyces collinus 
Antitumour activity 
Figure 2.2: Chemical structures of a small selection of polyketides, their natural producers and 
pharmaceutical properties. 
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Figure 2.2 continued: Chemical structures of a small selection of polyketides, their natural 
producers and pharmaceutical properties. 
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2.2 Biosynthesis of polyketides  
Polyketide core structures are synthesised by polyketide synthases (PKSs) that are enzymes 
related to fatty acid synthases (FASs).17 A wide variety of post-PKS tailoring enzymes act on 
the polyketide backbone, yielding structural diversity of the compounds (2.2.2). The 
abundance of polyketides can even be further enlarged by genetic engineering of different 
biosynthetic pathways (2.2.3).  
2.2.1 Polyketide synthases  
Different types of polyketides show different architectures of their biosynthetic enzymes, 
accompanied by distinct PKS programming. Based on their architecture, PKSs were initially 
classified into three families (type I, type II, type III PKS).18 Type I PKSs were described to 
work in a modular way, whereas type II PKSs were reported to act in an iterative fashion and 
exclusively in bacteria. Ketosynthases (KSs) of type III were classified as iterative chalcone 
synthases from plants. However, increasing evidence shows that there are many exceptions to 
the original classification. Iterative usage of a type I PKS was reported by a number of 
groups, e.g. Bechthold and coworkers.19 Furthermore, the iterative usage of single modules 
within a modular type I PKS was discovered (“stuttering”).20-22 Moreover, iteratively acting 
distant acyltransferases (ATs) were described that load the extender units in trans to AT-less 
type I PKSs, the so-called trans-AT PKSs.23, 24 Later works showed that trans-AT PKSs 
evolved in a completely different way than cis-AT systems.25 In the work of Kwon et al. a 
novel type II PKS is described that works non-iteratively and lacks an ACP.26 The presence of 
(plant-like) PKSs of type III in Streptomyces strains was also discovered. For example, a 
bioinformatic approach revealed the presence of three type III PKSs in Streptomyces 
coelicolor.27 It has thus become evident that transitional stages between all of the PKS classes 
can occur.28 Even a type I/type III polyketide synthase hybrid pathway is described for the 
biosynthesis of the structurally diverse ansa compound kendomycin produced by 
Streptomyces violaceoruber.29 However, despite the unambiguous occurrence of exceptions, 
the type I, II and III paradigms are well appreciated as a rough basis in polyketide 
biosynthesis research.18 Therefore, I will now describe the general modes of operation of 
different PKS systems to this classification. All types of PKSs share sequential 
decarboxylative condensation of the acyl CoA precursors and C-C bond formation catalysed 
by the ketoacyl synthase (KS) domains (in type I PKSs) or -subunits (in type II and III PKSs). 
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Type I PKSs are multifunctional enzymes that are organised in modules, each harbouring a set 
of different domains that mostly work non-iteratively. Each domain catalyses a different step 
in the biosynthesis of the polyketide, whereas one cycle of polyketide chain elongation is 
catalysed by one module. The giant PKS protein consists of a certain number of chain-
building modules that synthesise (PKS) and modify (reductive cycle, figure 2.3) the carbon 
chain. The different domains are ketosynthase- (KS), acyl carrier protein- (ACP), acyl 
transferase (AT)-, dehydratase- (DH) or ketoreductase- (KR) domains, except for the trans-
AT PKSs that lack integrated AT domains.25 The keto groups resulting from the condensation 
process may remain intact or can be modified or removed by a reductive cycle that consists of 
three steps (figure 2.3). In the first step, the keto group is reduced to a hydroxyl group by a 
KR. Adjacent dehydration is catalysed by a DH that leads to the introduction of a double bond 
in the second step. In the final ER-reaction a fully saturated carbon is generated.30 The 
operation of the reductive cycle can be stopped at any stage in PKS biosynthesis, leading to 
coexistence of keto- and hydroxyl groups as well as double or saturated C-C bonds. An N-
terminal initiation module directs the loading of the starter unit, whereas the molecule release 
is induced by an ending domain, containing a thioesterase (TE). The TE-domain catalyses the 
hydrolytic cleavage of the synthesised polyketide from the PKS. Type I PKSs are involved in 
the biosynthesis of complex polyketides such as the ansamycins (rifamycin 14), polyenes 
(amphotericin 9), macrolides (erythromycin 12) or polyethers (monensin A 2). The 
organisation of a type I PKS is displayed in figure 2.4, a. 
 
R S
O O
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enoylreductase
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Figure 2.3: Reaction steps of the reductive cycle during polyketide biosynthesis in type I PKSs.31 
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Figure 2.4: Schematic organisation of a) type I, b) type II and c) type III PKSs.18 Undefined 
number of iterative rounds is indicated by lower-case letters.  
 
Type II PKSs are multienzyme complexes carrying a single set of iteratively working proteins 
(figure 2.4, b). The enzymatic instrumentation of type II PKSs is based on a minimal PKS32 
consisting of the tandem pair termed ketosynthase (KS or KSα) / chain length factor (CLF or 
KSβ), that are both beta-ketoacyl synthases, and an acyl carrier protein (ACP). The KSβ 
subunit is closely associated with the KSα, thus generating a channel between the two 
proteins. When amino acids at four key positions in the KSβ are changed, the channel size is 
altered. This mechanism is the controlling factor for chain length determination.33, 34 KSα and 
KSβ catalyse the concerted condensation of acyl-thioesters to form a carbon skeleton. The 
ACP shuttles acyl components between the active sites of the minimal PKS, and it stabilises 
the nascent polyketide intermediates. The ACP unit tethers the growing chain that is extended 
by two carbon atoms with any further condensation round.35, 36 The building blocks used for 
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extension are for example the activated derivatives of acetic acid and malonic acid, acetyl-
CoA and malonyl-CoA. The acetyl-CoA starter unit is not directly loaded onto the PKS. It is 
derived from a previously loaded malonyl-CoA molecule by loss of carbon dioxide.37 As only 
one KS pair is present in this type II PKSs, iterative rounds are necessary to produce a carbon 
chain. Additional PKS subunits like ketoreductases (KRs), cyclases (CYCs) and aromatases 
(AROs) direct the processes that convert the elongated poly-β-ketoacyl chain to the 
polyketide intermediate that is subsequently modified by tailoring enzymes (2.2.2). Cyclases 
and related subunits function as “chaperone-like” enzymes ensuring the proper assembly of 
one single product from the highly instable poly-β-ketoacyl chain.38 Type II PKSs are 
responsible for the biosynthesis of aromatic polyketides like actinorhodin 1 (figure 2.1), 
doxorubicin 4, rubromycin 5, tetracycline 6 (figure 2.2), tetracenomycin 13 (figure 2.6) or 
griseorhodin A 17 (figure 3.1).39 The basic mechanism of type II polyketide biosynthesis is 
displayed in figure 2.4, b. 
 
A wide variety of natural products is synthesised by type III PKSs (figure 2.4, c), especially 
pigmented compounds like flavonoids occurring in flowers or fruits. These polyketides, such 
as chalcones, stilbenes or resveratrols, exhibit biological activities. For example, chalcones act 
as free radical scavengers (antioxidants) and stilbene phytoalexins are involved in plant 
pathogen defence.40 Resveratrols, occurring for example in grapes, are described to show 
cancer chemopreventive properties.41 Chalcones represent a type III polyketide scaffold, and 
the naringenin chalcone synthase (CHS) was identified as one of many enzymes that catalyse 
the flavonoid biosynthetic pathway.42 In figure 2.5 the biosynthesis of the flavonoid precursor 
naringenin chalcone is displayed. Type III PKSs represent the structurally simplest members 
of the three PKS types and, mechanistically, they do not use ACP.43 The monomer subunits of 
type III PKSs work independently, each capable of performing all reaction steps. The 
assembly of this class of natural products is governed by the simple homodimer KS (III) 
protein that performs a series of decarboxylation, condensation and cyclisation reactions. The 
active site uses free CoA-linked substrates. Type I and II PKSs use acyl carrier protein (ACP) 
for the activation of the acyl CoA substrates, and for the channelling of the growing 
polyketide intermediates. Type III PKSs are independent from an ACP function, as they 
directly act on the acyl CoA substrates. The iteratively working homodimeric KS protein is 
encoded in a single open reading frame and exhibits a small size (80-90 kDa). Therefore type 
III PKSs are ideal targets for protein engineering, and one focus in type III polyketide 
research is placed on rational engineering of their active sides by changing amino acid 
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residues to generate and modify diverse compounds. For example, three of the functionally 
divergent type III polyketide synthases, chalcone synthase43, octaketide synthase44 (OKS) and 
pentaketide chromone synthase45 (PCS), have been characterised and engineered. Products of 
type III PKSs can also be incorporated into more complex natural products like the 
glycopeptide antibiotic vancomycin.46  
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O
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O O
CoAS OH
OH
OH
OOH
+
3x
CHS
 
 
                  p-coumaroyl-CoA                  malonyl-CoA                                 naringenin chalcone 
 
Figure 2.5: Biosynthesis of the flavonoid precursor naringenin chalcone via the type III PKS 
chalcone synthase (CHS).42  
 
 
2.2.2 Post-PKS tailoring  
The nascent polyketide molecule synthesised by the PKS can be further modified due to the 
activity of tailoring enzymes like monooxygenases, methyltransferases and 
glycosyltransferases that act on the natural product.1 Thus the post-PKS tailoring processes 
have a huge impact on the overall structure of a polyketide, accompanied by biasing its 
pharmaceutical properties, for example antibiotic activity.2 Particularly, glycosyltransferases 
play a very important role providing polyketides with sugar moieties.  
 
Sugar components, especially 6-deoxyhexoses, play a major role in natural product activity by 
changing the pharmacokinetic properties of the aglycons and serve as recognition sites for 
reaction mechanisms.47 Many therapeutically important compounds like avermectin 3, 
doxorubicin 4 or erythromycin 12 contain sugar moieties attached to the aglycone core. The 
attachment is catalysed by the activity of glycosyltransferases (GTs) that are usually located 
inside the biosynthetic gene clusters of the compounds. To a certain extent, some 
glycosyltransferases exhibit a “relaxed substrate specificity”48 regarding the structure of the 
appended glycosyl unit of the aglycone target and the attachment site on the target core.49, 50 
These facts are of avail in genetic engineering (2.2.3). A brief insight into the results of 
tailoring enzyme activity on a polyketide core is shown in figure 2.6 instancing erythromycin 
A 12 and tetracenomycin 13 biosynthesis.  
 
 Introduction 
 12 
 
a) 
SCoA
O O O
SCoA
OH
OH
OH
O
O
O
OH MeO
NMe2OH
Me
C2H5 Me
Me
O
O
Me
OH
OH
MeMe
O
O
O
O
OH
OMe
+
DEBS
- CoA (7x)
- CO2 (6x)  (10x)
tailoring
enzymes
O-
 
                                                                                                                  
                                                              Erythromycin A 12 
 
 
b) 
CoAS O
O O
O O O
Me
OO
OOO
SEnz
O
OH
OH OH OH
OH
OH
OMe
OH
OH
OH
OH Me OO O
O
OMe
OMe
MeO
(10x)
TcmKLM
- CoA
- CO2
(10x)
- CO2
- H2O
  (4x)
tailoring 
     enzymes
aldol addition
 
 
                                                                                                                Tetracenomycin 13 
 
Figure 2.6: Summarised biosynthetic scheme of a) erythromycin A, involving 6-
deoxyerythronolide B synthase (DEBS) and b) tetracenomycin.18, 51 
 
2.2.3 Engineered biosynthesis of “unnatural natural products”  
In the past, therapeutic agents were solely produced by the isolation of natural products from 
different environmental niches, by chemical synthesis or semi synthesis. Since the mid-
eighties a novel technique, engineered biosynthesis, opened up many possibilities in 
generating new pharmaceuticals.  
 
Engineered biosynthesis utilises nature’s machinery for the genetic manipulation and 
combination of biosynthetic pathways. This technique was first demonstrated by Hopwood52 
and coworkers who successfully introduced actinorhodin genes from Streptomyces coelicolor 
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into the medermycin producer Streptomyces sp. AM-7161, yielding the new compound 
mederrhodin A that carried an additional OH-group as compared to actinorhodin. This 
combination of genes from two or more pathways is called combinatorial biosynthesis. 
Genetic engineering has become a powerful tool in recent years, leading to the construction of 
hybrid compounds that feature improved drug actions.53 Moreover, by generating new 
effective agents, genetic engineering might represent an answer to overcoming the resistance 
of microorganisms against antibiotics. Due to the fact that sugars are crucial for the effectivity 
of many pharmaceutical agents they represent an interesting target for genetic engineering 
that is aimed at the biosynthesis of new glycosylated natural products. As a precondition, the 
corresponding gene clusters and their functionalities must be investigated and described. 
Genes encoding GTs and deoxysugar biosynthesis represent an important biotechnological 
tool for altering glycosylation reactions in combinatorial biosyntheses of medically important 
compounds. Natural products are of high complexity, making chemical modifications as well 
as their total synthesis difficult and non-economic. Therefore the biological approach lends 
itself to generating new versions of therapeutical agents. The key benefit of known natural 
core skeletons is their validation by evolution. One approach to genetic engineering can be the 
modification of the glycosylation pattern. The first recombination experiment involving a GT 
was reported by Solenberg et al. where a hybrid glycopeptide was synthesised by using a 
cloned GT from the vancomycin producer Amycolatopsis orientalis expressed in 
Streptomyces toyocaensis.54 A further study describes the production of several novel 
glycosylated tetracenomycins. The hybrid compounds were synthesised by engineered 
biosynthesis of the elm gene encoding a GT from the elloramycin producer Streptomyces 
olivaceus Tü2352 that was transformed into the urdamycin producer Streptomyces fradiae 
Tü2717 and the mithramycin producing strain Streptomyces argillaceus ATCC12956.55  
 
2.3 Sugar moieties in early and late polyketide biosynthesis 
2.3.1 Rifamycins 
Rifamycins were first isolated from the actinomycete Amycolatopsis mediterranei by Sensi 
and coworkers.56, 57 The compounds of this family are potent antibacterial agents, inhibiting 
RNA polymerase and thus DNA transcription.58 Rifamycin B 14 (figure 2.7) and derivatives 
like rifampicin represent the most important drugs in the treatment of tuberculosis and 
leprosy. Rifamycins (A, B, C, D, E, S, SV, W) belong to the family of ansamycins that are 
macro cyclic lactam antibiotics.59 Their characteristic structure consists of an aromatic (or 
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quinoid) core bridged by an aliphatic lactam handle (handle = ansa, lat.). All ansamycins, 
including rifamycins, share the same core structure that is introduced by the key intermediate 
3-amino-5-hydroxybenzoic acid (AHBA, figure 2.8) of their amino shikimate biosynthetic 
pathway.60, 61 The core skeleton of rifamycin is synthesized by a type I PKS, whereas AHBA 
represents the starter unit.62  
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Figure 2.7: Chemical structure of rifamycin B 14, from Amycolatopsis mediterranei S699 with 
antibacterial activity.  
 
2.3.2 Functional studies of rifL, rifK and rifM in early rifamycin biosynthesis 
As described by Guo and Frost63, the origin of the amino shikimate pathways nitrogen atom in 
rifamycin biosynthesis is most likely represented by the amino sugar kanosamine (3-amino-3-
desoxy-D-glucose). For this reason, the biosynthesis of kanosamine was then focussed on. 
Guo and Frost postulated that the introductory step in AHBA biosynthesis is the conversion of 
the substrate UDP-glucose to 3-keto-UDP-glucose by means of rifL, which codes for the 
oxidoreductase (UDP-3-keto-D-glucose dehydrogenase) RifL.64 A subsequent RifK (UDP-3-
keto-D-glucose transaminase)-catalysed amino transferase reaction in the presence of L-
glutamine was supposed to yield UDP-kanosamine, which would be finally released as 
kanosamine after separation from uridine diphosphate by RifM (UDP-kanosamine 
phosphatase). There are indications that RifK may have two enzymatic activities: The 
dehydratase activity involved in aromatisation of 5-deoxy-5-amino-3-dehydroshikimate65 and 
an aminotransferase activity introducing the nitrogen into a carbohydrate precursor of 
aminoDAHP.66 The presence of two rifK homologues in the asm gene cluster is consistent 
with this notion.67 The reaction scheme is displayed in figure 2.8.  
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Figure 2.8: Proposed introductory steps in AHBA biosynthetic pathway yielding the intermediate 
kanosamine.63  
 
Guo and Frost detected kanosamine by electrospray mass spectrometry under reaction 
conditions including UDP-6,6-[2H2]-glucose, NAD+, glutamine, a cell-free extract from 
Amycolatopsis mediterranei and pH 6.8.63 Interestingly, in their study no additional 
supplements like PLP or magnesium were required for kanosamine formation. Their work 
was inspired by experiments carried out by Umezawa68, where a cell-free extract of the 
natural kanosamine producer Bacillus pumilus69 (formerly known as Bacillus 
aminoglucosidicus) was incubated with UDP-14C-D-glucose, NAD+ and glutamine yielding 3-
amino-3-deoxy-D-glucose (kanosamine). Furthermore, it was shown by Arakawa et al.70 that 
the RifN protein (kanosamine kinase) specifically converts kanosamine into kanosamine-6-
phosphate. In the work of Guo, Frost and Arakawa a cell-free extract of the natural rifamycin 
producer Amycolatopsis mediterranei was used. 
 
The gene cluster encoding zwittermicin A biosynthesis in Bacillus cereus UW85 was isolated 
in a study by Thomas and coworkers.71 Interestingly, it was proposed that this cluster also 
includes genes encoding enzymes involved in kanosamine biosynthesis. The deduction from 
the gene sequences led to a putative kanosamine biosynthetic pathway that is analogous to the 
mechanism proposed by Guo and Frost.63 
 
A preliminary work by Boettcher72 showed that the RifL oxidoreductase activity was 
detectable in cell-free extracts of Streptomyces lividans TK24 pHGF7604. Furthermore, RifL 
oxidoreductase activity was not present in cell-free extracts of Streptomyces lividans TK24 
 Introduction 
 16 
 
that contained the plasmid pHGF7607 (carrying a mutated rifL gene) or pHGF7608 (carrying 
a mutated rifM gene), respectively. Therefore, a specific RifL reaction as well as a co-
operative mechanism among the gene products of at least rifL and rifM could be assumed. 
These findings formed the basis of the first section of this work. The putative multienzyme 
complex formed by RifL, RifK and RifM could be further investigated by utilisation of 
mutants harbouring either a point mutated rifK* gene or a rifK deletion mutant, respectively. 
 
Functional proof of rifL, rifK and rifM in kanosamine biosynthesis is still missing. Although 
several indications for the involvement of kanosamine in AHBA formation existed, the amino 
sugar had not been verified as an intermediate (formed by RifL, RifK and RifM) of the 
rifamycin pathway before the beginning of this work.  
2.3.3 Pentangular aromatic polyketides  
Pentangular aromatic polyketides are a group of biosynthetically related, albeit structurally 
diverse compounds from actinomycetes. Members of this group are the benastatins (apoptosis 
inducing), pradimicins (antifungal), fredericamycins (topoisomerase inhibitor) and members 
of the griseorhodin/ rubromycin (human telomerase inhibitor, HIV reverse transcriptase 
inhibitor) family (figure 2.9). Different pentangular polyketides are naturally synthesised from 
the shared precursor collinone by utilisation of different post-PKS tailoring enzymes. Another 
compound that is structurally related to collinone is the polycyclic xanthone IB-00208 (2.3.4, 
figure 2.9). The biosynthetic family was termed “pentangular polyketides” by Piel and 
Hertweck.73 They identified an unusual type of C-19 ketoreductase (BenL in the benastatin 
cluster) that occurs in all pentangular polyketide pathways. Furthermore, gene inactivation 
experiments revealed collinone as common intermediate of the rubromycin and griseorhodin 
pathways.74 The members of the griseorhodin/ rubromycin family are extensively modified 
aromatic polyketides that possess a unique spiroketal pharmacophore crucial for the 
antitumour (telomerase inhibition) activity.75 The spiroketal moiety is generated in a highly 
complex oxidative tailoring process.76 This includes the cleavage of four carbon-carbon bonds 
in a pentangular polyketide precursor followed by an epoxidation event. Concurrent, a large 
number of oxidoreductases is encoded in the griseorhodin A PKS system.  
 
2.3.4 IB-00208 and post-PKS tailoring in late polyketide biosynthesis  
The polycyclic xanthone IB-00208 displays antibiotic activity against Gram-positive 
organisms and antitumour activity against mouse leukaemia, human lung and colon 
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carcinoma and human melanoma cell lines.77 Another member of the family of polycyclic 
xanthones is the aromatic polyketide lysolipin that is a potent antimicrobial and antitumour 
agent that was characterised on the genetic level.78 Other kinds of antibacterial and antitumour 
compounds structurally related to IB-00208 are cervinomycins and citreamicins.79, 80 IB-
00208 was first isolated from a marine-derived Actinomadura sp. strain by Malet-Cascon and 
co-workers.81 The polycyclic xanthone structure is glycosylated. The appended sugar is a 
trimethyldeoxypyranose hexose introduced by a GT during post-PKS tailoring processes. 
Moreover, IB-00208 exhibits oxygen units at positions C-2 and C-9. This represents another 
similarity to the highly oxidised griseorhodin A and other members of the rubromycin family 
(besides the similar intermediate), albeit a spiroketal part is not present in IB-00208. 
 
Genetic engineering between different pentangular post-PKS biosynthetic routes seems to be 
a promising method for generating pharmaceuticals tailored to particular needs. 
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Figure 2.9: Abundance of pentangular aromatic polyketides due to diverse tailoring processes of  
a common pathway intermediate.  
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3 Goals of the present study  
The present study comprises two parts that display sugars involved in early and late 
polyketide biosynthesis. 
 
Goal of the work presented in chapter 4.1 was to provide a better understanding of the 
introductory steps in rifamycin biosynthesis, specifically concerning the formation of the 
amino sugar intermediate kanosamine that is putatively encoded by the genes rifL, rifK and 
rifM.64 Functional studies of rifL, rifK and rifM from rifamycin B (14) producer 
Amycolatopsis mediterranei S699 in a heterologous host should verify their involvement in 
kanosamine formation. The analytical detection of kanosamine should be carried out after an 
enzymatic catalysis by means of RifL, RifK and RifM from a cell-free extract of Streptomyces 
lividans pHGF7604 in the RifL assay system. The enzyme assay should be performed by the 
use of a cell-free extract from Streptomyces lividans pHGF7604, harbouring all genes 
required for AHBA biosynthesis, the starter unit UDP-glucose and all necessary cofactors 
(5.6.6). The RifL assay was previously described to monitor the oxidoreductase reaction 
catalysed by RifL.72 Moreover, the existence of a multienzyme complex putatively formed by 
RifL, RifK and RifM should be verified. Therefore, cell-free extracts of the rifK mutants 
Streptomyces lividans pHGFrifL, K*, M and Streptomyces lividans pHGFrifL, M should be 
applied to the assay system. As a consequence, kanosamine should not be formed due to the 
pathway interruption caused by a non-functional or lacking rifK gene. The oxidoreductase 
RifL was supposed to show activity when associated with inactive RifK*, whereas the 
absence of RifK would inhibit RifL activity.  
 
Focus of the second part of this work is the isolation of the polyketide gene cluster encoding 
the biosynthesis of IB-00208 15 in Streptomyces sp. GW2/5831 (4.2). The strain Streptomyces 
sp. GW2/5831 was isolated from a soil sample by co-workers of Prof. Laatsch.82 The bacterial 
cells exhibit a red colour when cultivated on solid medium and in liquid culture due to the 
presence of the polyketide. Other compounds produced by Streptomyces sp. GW2/5831 are 
not known. The structure of IB-00208 contains a deoxysugar moiety putatively introduced to 
the polyketide core structure by a glycosyltransferase during the tailoring processes in late 
polyketide biosynthesis. IB-00208 is reminiscent of the polyaromatic tridecaketide collinone 
16, a precursor of pentangular polyketides like, for example, griseorhodin A 17 (figure 3.1).83 
It was therefore assumed that IB-00208 might be synthesised by a type II PKS as well. 
Griseorhodin A (a member of the rubromycin family) is a telomerase inhibitor and therefore a 
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potential anti tumour agent. Due to its insolubility in most solvents, severe restrictions exist 
on the utilisation as a drug, whereas structure modification could lead to improved 
pharmacokinetics. A promising approach could be the introduction of a deoxysugar moiety 
into griseorhodin A structure. The tailoring steps in griseorhodin biosynthesis could thus be 
modified by adding the glycosyltransferase gene from Streptomyces sp. GW2/5831. A hybrid 
biosynthetic pathway could therefore lead to a glycosylated griseorhodin A compound, 
exhibiting improved pharmacokinetic properties. These properties comprise the liberation, 
absorption (resorption), distribution, metabolism and excretion of therapeutic agents 
(LADME principle).  
 
In Streptomycetes all genes required for the biosynthesis of a particular antibiotic usually 
occur in a single cluster accompanied by one or more antibiotic self-resistance genes.84 Type 
II PKS biosynthetic gene clusters generally consist of 15 to 40 open reading frames, holding 
coding capacities between 20 to 60 kb. Therefore it is promising to establish a genomic 
library of a producing organism using lambda phage particles that can be packaged with 40 kb 
DNA strands as the maximum size. As the average insert size of the cosmids in the library is 
35 kb (4.2), it might be possible to encounter a large portion or even the complete IB-00208 
cluster located on one of the positive cosmids. The strategy for detecting the IB-00208 cluster 
from Streptomyces sp. GW2/5831 relied on earlier work on griseorhodin A biosynthesis, in 
which degenerate PKS primers (deduced from highly conserved motifs of ketosynthase 
domains) were utilised as probes to identify the PKS genes encoding griseorhodin A 
biosynthesis.83 Therefore a genomic cosmid library should be established and screened for the 
ketosynthase domain. Sequence alignments of the positive cosmid clones should reveal 
similarities to other type II PKS systems in the data base, and a putative genetic organisation 
of the cluster should be deduced. Another goal was the heterologous expression of genomic 
fragments from the IB-00208 cluster, harbouring the ketosynthase domain, in Streptomyces 
albus that should help to verify the cluster by functional proof.  
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Figure 3.1: Chemical structures of IB-00208, collinone and griseorhodin A. 
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4 Results and discussion 
 
4.1 Investigating the initial steps in rifamycin biosynthesis  
The initial steps in rifamycin biosynthesis were proposed to be catalysed by the enzymes 
RifL, RifK and RifM yielding the amino sugar kanosamine (figure 2.8).63 In this study, it was 
intended to reveal their biosynthetic function in precursor supply by detecting kanosamine 
synthesised in a cell-free system (RifL assay, 5.6.6). 
 
The procedure to assay the RifL-oxidoreductase was established in our lab by Boettcher 
within the scope of her study on AHBA biosynthesis.72 In the former study, the over-
expression of the relevant enzymes RifL, RifK and RifM in E. coli was not successful as it 
resulted in inactive protein. In general, the expression of Streptomyces genes in E. coli can be 
difficult because of different codon usage in these strains. Furthermore, incorrect protein 
folding or the formation of insoluble inclusion bodies can result in inactive proteins. As 
attempts to perform an over-expression of RifL, RifK and RifM in Streptomyces lividans had 
been unsuccessful in the study of Boettcher, the rif genes could only be constitutively 
expressed. Therefore, Streptomyces lividans TK24 was used by Boettcher as a heterologous 
host to the shuttle vector pHGF7604 (figure 4.1) harbouring all eight rifamycin biosynthetic 
genes rifG-N required for AHBA biosynthesis.66  
 
In the present study, analytical experiments were developed and carried out in order to detect 
the early stage intermediate kanosamine in RifL incubations. The assays were performed 
employing cell-free extracts from Streptomyces lividans (TK24) pHGF7604 that was kindly 
provided by Boettcher. The assays described in 4.1.9 were carried out using cell-free extracts 
from Streptomyces lividans TK23 harbouring different plasmids respectively (figure 4.16, 
table 5.8). These experiments were performed in order to access only the relevant genes for 
kanosamine formation instead of the complete equipment for AHBA biosynthesis. The 
plasmids and recombinant strains employed in 4.1.9 were kindly constructed by Kaulard.85 
 
In this study, the RifL assay was reproduced and carried out using minimal and standard 
conditions (4.1.1), different nitrogen sources (4.1.2), different hydride acceptors (4.1.3) and 
different purification grades of the cell-free extracts respectively (4.1.4). Protein analysis of 
the cell-free extracts was performed using SDS-PAGE and MALDI-TOF-MS (4.1.5). Means 
to detect kanosamine comprised TLC, HPLC and GC-MS measurements (4.1.6). Furthermore, 
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the RifL reaction was monitored via 1H-NMR (4.1.7). RT-PCR was carried out in order to 
verify the presence of the required gene products (4.1.8). A putative enzyme complex 
between RifL, RifK and RifM was studied (4.1.9) and the RifK and RifM reactions were 
investigated separately (4.1.10).  
 
 
 
Figure 4.1: Plasmid pHGF7604, map taken from Yu et al. (2001). Shuttle vector, ColE1-origin, 
Ampr (selection in E. coli); SCP2*-origin, Thior (selection in Streptomyces), genes rifG-N from the 
rifamycin biosynthetic gene cluster of Amycolatopsis mediterranei S699, under control of the 
actII-orf4 promoter. 
 
4.1.1 The RifL-oxidoreductase assay 
 
Reproduction of previous experiments 
Preliminary studies concerning the NAD+-dependent oxidoreductase RifL were described to 
result in the specific conversion of UDP-glucose by RifL in the presence of the hydride 
acceptor NAD+.72 At first the earlier assays were reproduced as a precondition to the 
analytical detection of the putative assay product kanosamine. The RifL oxidoreductase 
enzyme assay was conducted as described in 5.6.6. Initially, no RifL enzyme activity was 
encountered. This was overcome by verification of the procedure with regard to all assay 
parameters that were double checked. To verify the cultivation period of seven days for 
Streptomyces lividans pHGF7604, a growth kinetics was conducted as described in 5.4.7. The 
corresponding culture mycelia were harvested after different cultivation periods between one 
day to seven days. Each cell pellet was subjected to the production of a cell-free extract that 
was applied to the RifL assay. This experiment was the crucial step, revealing NAD+ 
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consumption in a cell-free extract obtained after a five-days cultivation (table 4.1, figure 4.3) 
instead of after a seven-days cultivation that had been recommended before. All other assay 
conditions were applied as described before, and it was then possible to carry out the assay, 
yielding reproducible data relating to NADH accumulation.  
 
Table 4.1 Growth kinetics of Streptomyces lividans (TK24) pHGF7604 and RifL 
assay results of the corresponding cell-free extracts prepared from mycelia cultivated 
between one and seven days 
Cultivation time [h] Weight [g] Colour of mycelium 
and R5-medium 
UV signal (340 nm) in 
RifL assay 
24 1,6 Yellow - 
48 1,9 Yellow - 
72 3,3 Yellow - 
96 3,9 Yellow - 
120 4,2 Blue + 
144 4,8 Blue - 
168 4,8 Blue - 
 
 
 
 
Figure 4.2: Liquid culture of  Streptomyces lividans pHGF7604 in R5 medium, showing blue 
colour after 120 h cultivation time (table 4.1). 
 
 
The emerging blue colour of the cultivation medium was attributed to the actII-orf4 promoter 
activity located on plasmid pHGF7604 to control gene transcription (figure 4.2). The actII-
orf4 regulatory gene originates from the gene cluster of Streptomyces coelicolor encoding the 
biosynthesis of the red-blue coloured antibiotic actinorhodin.5 The formation of this antibiotic, 
that is physiologically produced at very low amounts in Streptomyces lividans, can be highly 
increased if actinorhodin activation genes are cloned into Streptomyces lividans. This 
indicates that ActII-ORF4 should also regulate the downstream genes on pHGF7604 
properly.72  
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Negative control reactions 
To provide the test system with a negative control, the unmodified Streptomyces lividans TK 
24 strain was utilised and the corresponding preparation of a cell-free extract was performed 
as described before. In RifL assay measurements that were carried out employing the 
unmodified Streptomyces lividans TK 24 cell-free extract no UV signal at 340 nm occurred 
and therefore it was assumed that no NADH production took place (figure 4.3). This was 
considered to putatively correlate with the absence of RifL in the cell-free extract of the 
unmodified strain. Further control reactions were carried out omitting UDP-glucose, NAD+ or 
the cell-free enzyme solution, respectively (figure 4.3). Furthermore, denatured enzyme that 
was obtained after heating at 95 °C for 10 min was used as negative control (figure 4.3). All 
of these control measurements showed no deviation from a negative reaction. These 
observations formed the new basis of RifL enzyme assay, providing evidence that the 
predicted RifL-catalysed oxidoreductase reaction takes place.  
 
Standard assay conditions 
In order to provide all cofactors and reaction conditions required for kanosamine biosynthesis, 
the following substances were included in the standard RifL enzyme essay (5.6.6): 
pyridoxalphosphate (PLP) serves as cosubstrate for the RifK aminotransferase. In crystal 
structure experiments RifK was shown to be tightly bound to its cofactor PLP.86 The gene 
product RifK is known to belong to a family of PLP-dependent aminotransferases 
preferentially used by streptomycetes in secondary metabolic pathways for the formation of 
amino sugars, aminocyclitols and other amino compounds.87 Due to a typical PLP-binding 
motif with a conserved aspartate (Asp-159) and the active site lysine (Lys-188) it is presumed 
that the cofactor binds as a Schiff’s base.65 As RifM has considerable similarity to the CBBY 
family of phosphoglycolate phosphatases, the RifM-catalysed reaction was supposed to 
require magnesium chloride as reported for other CBBY phosphatases.66, 88 Moreover, 
magnesium chloride was found to enhance RifL activity (Arakawa, personal communication). 
The incubation also required the supply of a nitrogen source for the introduction into the 
kanosamine ring (figure 2.8). As reported by Guo and Frost, glutamine was supposed to be 
the appropriate nitrogen donor.63  
 
Minimal assay conditions 
As described above, the standard enzyme assay included components required for RifL 
activity and additionally contained putative supplements for RifK and RifM reactions. In 
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order to determine the RifL-catalysed reaction only in the presence of its substrate and 
cofactor, a minimal assay was carried out containing cell-free extract of Streptomyces lividans 
pHGF7604, UDP-glucose and NAD+. The final absorbance rate was almost identical after 20 
min regardless of whether a minimal or a complete assay was performed (figure 4.3) showing 
that glutamine, magnesium chloride and pyridoxal phosphate do not show a visual influence 
on the measurement. In later experiments it was observed that the UV signal was slightly 
higher when any nitrogen source was omitted in the assay system (figure 4.5).  
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Figure 4.3: RifL assay utilising a cell-free extract from Streptomyces lividans pHGF7604. 
 
The RifL assay results of positive reactions and negative controls are displayed in figure 4.3. 
The RifL reaction is dependent on a native cell-free extract, UDP-glucose and NAD+. The 
minimal assay was required to determine the influence of the RifK and RifM cofactors on the 
RifL reaction (4.1.2). The minimal assay showed no difference from a standard assay 
assuming no adverse effect on RifL reaction. Compared to the minimal and standard assays, 
all negative controls do not exhibit any activities related to NADH accumulation in the RifL 
assay. The negative control employing the unmodified strain verifies that the reaction is 
putatively due to the activity of a recombinant enzyme originating from the plasmid 
pHGF7604. The only NAD+ consuming enzyme expressed from genes encoded on the 
plasmid is the oxidoreductase RifL.  
 
Reaction time 
It was discovered by Umezawa et al. that kanosamine was formed within 30 min when UDP-
glucose was incubated with a cell-free extract of Bacillus pumilus (formerly: Bacillus 
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aminoglucosidicus), glutamine and NAD+ in phosphate buffer.68 In a study by Lee it was 
reported that UDP-kanosamine can be detected via HPLC after the incubation of NapL 
(homologous to RifL) and NapK (homologous to RifK) with 4 mM UDP-glucose, 4 mM 
NADP and 3 mM glutamine for 12 hours at 37 °C and pH 7.4.89 Lee observed that NapL 
activity (absorbance rate) was ten-fold higher when NapL was incubated together with NapK. 
NapL and NapK are enzymes from the geldanamycin producer Streptomyces hygroscopicus 
that correspond to RifL and RifK from the rifamycin producer Amycolatopsis mediterranei. 
On the one hand, the first two biosynthetic steps catalysed by RifL and RifK can be assumed 
to take place within 12 hours as well, because the absorbance rate of NapL (0.03) was 
comparable to RifL (0.05) in this study both determined after 20 min incubation time. On the 
other hand, although the Rif and Nap proteins are homologous enzymes, they are functionally 
not completely identical. For example, NADP serves as hydride acceptor in NapL/ NapK 
incubation as described above, whereas it is not accepted in the RifL reaction (4.1.3.2). 
Moreover, there was no PLP needed to accomplish UDP-kanosamine formation, although 
RifK is described to be a PLP-dependent aminotransferase.65  
 
The RifL assays were directly subjected to HPLC, and additional assay duplicates were 
prepared and were stored at 37 °C for 1, 2, 5, 12 and 24 h for kanosamine formation before 
they were proceeded to analysis.  
4.1.2 Impact of different nitrogen sources on the RifL assay 
For the introduction of the nitrogen atom into the amino sugar ring, glutamine was supposed 
to be the appropriate source (figure 2.8).63, 68 To test the influence of different nitrogen 
sources on NADH accumulation during the UV assay, glutamine, glutamic acid, asparagine, 
aspartic acid and ammonium chloride were tested separately. As reported by Arakawa et al., 
the rate of NADH formation increases when glutamine is added to the RifL assay as nitrogen 
source. Asparagine and ammonia were less effective in his study, whereas glutamate and 
aspartate were inactive.70 Lee reported that NapL activity was increased in the presence of 
glutamine. In this study, all tested nitrogen sources yielded the same absorption rate for 
NADH production (figure 4.4).  
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Figure 4.4: Different nitrogen sources applied to the RifL standard assay. 
 
In another UV incubation series, any nitrogen source was omitted from the assay system in 
order to determine the influence of nitrogen absence on the RifL reaction. The RifL assays 
without a nitrogen source were carried out employing crude cell-free extract or 60% 
ammonium sulfate-precipitated cell-free extract from Streptomyces lividans pHGF7604 
respectively. In comparison to standard assays using crude or precipitated cell-free extract, the 
absorption rate was increased if any nitrogen source was omitted in the incubation reaction 
(figure 4.5). 
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Figure 4.5: The effect of nitrogen absence in the RifL assay. 
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4.1.3 Application of different hydride acceptors in the RifL assay 
4.1.3.1 Acetylpyridine adenine dinucleotide (APAD) 
Acetylpyridine adenine dinucleotide (figure 4.6) is a NAD+ analogue with higher oxidation 
potential than NAD+. It can substitute for NAD+ as a hydrogen-accepting cofactor in 
dehydrogenase reactions.90 APAD is known to shift the equilibrium of enzymatic reactions. It 
was therefore used to enhance RifL catalytic activity. In fact, APAD yielded a higher 
conversion rate compared to NAD+ in the RifL assay (figure 4.7). A prominent increase of the 
absorption rate occurred when using FPLC-purified protein solution (4.1.4) which showed a 
16-fold higher absorption rate than previously obtained with the crude cell-free extract 
employing NAD+ (figure 4.9). This experiment was carried out in order to increase substrate 
conversion accompanied by a putatively higher product yield in the RifL assay. 
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Figure 4.6: Chemical structure of acetylpyridine adenine dinucleotide (APAD). 
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Figure 4.7: RifL assay utilising APAD as a hydride acceptor instead of NAD+. 
 
4.1.3.2 Nicotine amide adenine dinucleotide phosphate (NADP) 
NADP was applied to the RifL assay instead of NAD+ and compared to a standard assay 
using NAD+ (figure 4.8). In the incubation including NADP as a hydride acceptor no increase 
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in absorbance rate was monitored, and the standard assay exhibited the NAD+ consumption as 
described before (4.1.1). This experiment revealed that NADP is not involved in the RifL 
reaction, whereas Lee reported that NADP was required for UDP-kanosamine formation.89 In 
contrary to Lee’s observation that absorbance rate doubled when using NADP instead of 
NAD+, in the RifL assay NADP did not function as hydride acceptor.  
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Figure 4.8: RifL assay utilising NADP as a hydride acceptor instead of NAD+. 
 
4.1.4 Purification of cell-free extracts from Streptomyces lividans pHGF7604 
In the experiments conducted so far, the rif genes were constitutively expressed in the 
heterologous host, and therefore expected to be present in very low amounts in the cell-free 
extracts. Therefore protein purification was performed by means of ammonium sulfate 
precipitation (4.1.4.1) and FPLC (4.1.4.2 and 4.1.4.3) in order to increase the protein content 
in the cell-free extract.  
 
4.1.4.1 Ammonium sulfate precipitation for the purification of RifL 
Purification of the crude cell-free extract of Streptomyces lividans pHGF7604 was 
accomplished by ammonium sulfate precipitation followed by using Sephadex® columns for 
desalting procedure. From 8 g of wet cell mass, 8 mg total protein were obtained by 60% 
ammonium sulfate precipitation. The active protein, detected by the UV assay indicating RifL 
oxidoreductase reaction, was located in the 60% ammonium sulfate fraction. All other 
fractions tested between 10 and 90% ammonium sulfate did not exhibit activity. A 
spectrophotometric enzyme assay of 100 µg enriched protein yielded a doubled absorption 
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rate for NADH production, compared with 100 µg of total protein from the crude extract 
(figure 4.9).  
 
4.1.4.2 Fast Protein Liquid Chromatography (FPLC) of precipitated extracts using 
DEAE-Sepharose 
Advanced purification of previously pre-purified extracts (4.1.4.1) was performed by means 
of FPLC using DEAE-Sepharose. The separated fractions consisting of 10 ml were 
concentrated up to 1.5 ml each by using Amicon® Ultra-15 centrifugal filter devices. The 
concentrated protein fractions were each applied to the RifL assay. One active fraction was 
detected that showed a higher absorption rate after 20 min compared to the 60% ammonium 
sulfate fraction. The active fraction comprised approximately 1.5 mg protein. The FPLC-
chromatogram is shown in the appendix (6.1). 
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Figure 4.9: RifL assay utilising different purification grades of Streptomyces lividans pHGF7604 
cell-free extracts. 
 
The use of cell-free extracts with higher purification grades resulted in higher absorption rates 
in the RifL assay compared to that with lower purity or the crude extract respectively. These 
findings are summarised in figure 4.9, where the negative control is also included. Therefore 
it was assumed that the target enzyme RifL had been purified or at least enriched. 
 
4.1.4.3 Intermediate protein purification and gel filtration of Streptomyces lividans 
pHGF7604 cell-free extract by means of FPLC 
After the protein capture step (4.1.4.2), intermediate purification of the active protein fraction 
was attempted by hydrophobic interaction chromatography (HIC). The intention of this 
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purification step was to prepare the protein for gel filtration. This procedure yielded an 
inactive protein (data not shown). The loss of enzyme activity after FPLC-HIC purification 
might be due to long room temperature exposure, since it was not possible to cool the 
equipment. This was nevertheless followed by gel filtration on a Superdex© column in order 
to at least determine the protein sizes. No proper separation could be achieved (data not 
shown). For the determination of the protein sizes SDS-PAGE (4.1.5.1) and MALDI-TOF 
analysis were therefore carried out (4.1.5.2).  
4.1.5 Size determination of proteins from Streptomyces lividans pHGF7604  
4.1.5.1 SDS-PAGE  
A protein gel (SDS-PAGE) was employed to analyse a precipitated cell-free extract of 
Streptomyces lividans pHGF7604 (4.10, lane 4) as well as three different FPLC-purified 
fractions (4.10, lanes 1-3) thereof. The extracts applied to lane 2 and lane 4 showed activity in 
the RifL assay, whereas the extracts applied to lane 1 and 3 were inactive but flanked the 
active fraction in FPLC. The following protein sizes were expected: RifL exhibits a size of 40 
kDa, RifK comprises 43 kDa in size and RifM resembles a 26 kDa protein.91 It was shown on 
the gel that a ~25 kDa protein was enriched in the active cell-free extract fraction from 
Streptomyces lividans pHGF7604 after FPLC purification (figure 4.10, lane 2). As the size 
determination is not precise, this band resides in the range of the 26 kDa RifM phosphatase. 
This was not expected, because the RifL protein (~40 kDa) was the targeted molecule as it 
was monitored with the enzyme assay system. An approximately 40 kDa protein was also 
enriched, but in much lower amounts than the ~25 kDa protein. Maybe this is evidence for the 
existence of a multi enzyme complex that was reported earlier for RifL and RifK (4.1.9).  
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Figure 4.10: SDS-PAGE, all protein solutions were obtained from a cell-free extract of 
Streptomyces lividans (TK24) pHGF7604. Lane 1: FPLC purified protein fraction 1 showing no 
RifL activity, lane 2: FPLC purified protein fraction 2 showing high RifL activity, lane 3: FPLC 
purified protein fraction 3 showing no RifL activity, lane 4: 60% ammonium sulfate fraction, lane 
5: molecular weight marker. 
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4.1.5.2 MALDI-TOF-MS  
The purified cell-free extract (4.1.4.2) from a liquid culture (5.4.2.2) of Streptomyces lividans 
pHGF7604 was prepared and applied to MALDI-TOF-MS analysis (5.7.4.3). The mass range 
comprised 0.2 to 100 kDa. The ions were detected in the range between 0.5 and 2.2 kDa, 
whereas Rif-proteins exhibit sizes of 40 kDa (RifL), 43 kDa (RifK) and 26 kDa (RifM).91 
Therefore the presence of the proteins RifL, RifK and RifM in the cell-free extract of 
Streptomyces lividans pHGF7604 could not be confirmed. For the mass spectrum see 
appendix.  
 
4.1.6 Detection of kanosamine 
RifL, RifK and RifM were supposed to catalyse the enzymatic steps that would finally release 
kanosamine. Previous experiments indicated that the RifL-catalysed reaction takes place, and 
subsequent RifK and RifM catalysis was assumed (4.1.1). It was therefore now attempted to 
provide evidence for kanosamine to be an intermediate in early stage AHBA biosynthesis. As 
the formation of kanosamine was to be elucidated in incubation samples, TLC and HPLC 
methods for the detection of the amino sugar were developed. Furthermore, mass 
spectrometry and NMR analysis were carried out to check for the presence of kanosamine.  
 
4.1.6.1 TLC for kanosamine detection 
The reference kanosamine was detected by TLC at amounts of up to 20 µg (figure 4.11). 
However this sample showed 40% impurity determined in the laboratory of H. Floss. The 
detection limit of the pure compound was assumed to be much lower. The structure isomer 2-
amino-2-desoxy-D-glucose (glucosamine) was tentatively used as reference substance 
because it was available in unlimited amounts. The detection limit of glucosamine was 
determined to be 0.2 µg, although this method is maybe still not sensitive enough for very low 
amounts of the analyte that might be encountered in the enzyme assay. Furthermore, since the 
components of the RifL assay solution interfered with the detection on a TLC, this method 
was not applicable to the samples generated in this study (data not shown). 
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Figure 4.11: TLC of kanosamine and glucosamine. Lane 1: glucosamine 1 µg, lane 2: 
glucosamine 0,5 µg, lane 3: kanosamine 20 µg, lane 4: kanosamine 50 µg. 
 
 
4.1.6.2 HPLC for kanosamine detection 
A derivatization of the kanosamine reference, and in parallel glucosamine, was attempted 
using 9-fluorenylmethoxycarbonyl chloride (Fmoc-chloride) according to the method 
described by Kirschbaum et al.92 However, no major compound was detected. Due to many 
by-products the reaction was unspecific, and the method was therefore regarded as unsuitable 
(data not shown). 
 
The kanosamine reference was successfully detected with high-performance anion-exchange 
(HPAE)- chromatography with pulsed amperometric detection (PAD) like described in 5.7.2. 
Kanosamine exhibits a retention time of 10 min (figure 4.12). Interestingly, the same method 
was recently reported to be highly recommended for sensitive and direct kanosamine 
detection within the scope of impurity control for the antibacterial agent tobramycin.93  
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Figure 4.12: HPLC chromatogram of 3.8 µg kanosamine using pulsed amperometric detection 
(PAD). 
 
The detection limit of the kanosamine reference (60%) was determined at 1.1 nM (= 0.2 µg), 
causing a PAD response of 16 nano Coulomb (nC). In HPLC experiments, the proposed 
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compound kanosamine that is putatively formed by the gene products of rifL, rifK and rifM 
could not be detected in any RifL incubation sample. However the assay components 
interfered with a proper HPLC detection showing many peaks in the chromatogram (data not 
shown). All samples were therefore subjected to GC-MS analysis (4.1.6.3), because this was 
supposed to provide more reliable results.  
 
4.1.6.3 GC-MS measurements for kanosamine detection 
Samples for GC-MS analysis were prepared according to the procedure described in 5.6.6, 
including measurement of absorbance change at 340 nm for 20 minutes. Prior to further 
analysis, the samples were stored at 37 °C for 24 hours in order to allow sufficient time for 
the formation of the putative compound. The reaction was then stopped by addition of 500 µl 
methanol. Variables in the RifL assay comprised the use of different cofactors, nitrogen 
sources and protein purification grades. For cofactor supply, either 4 mM NAD+ or 0.8 mM 
APAD was utilised. The following nitrogen sources (2 mM each) were employed individually 
to investigate kanosamine formation: glutamine, glutamic acid, asparagine, aspartic acid. The 
enzyme solution was represented by a crude cell-free extract, a fraction precipitated in 60% 
ammonium sulfate or a purified FPLC fraction. Only a single parameter was varied in each 
assay sample.  
 
It was required to stabilise the analyte using trimethylsilyl (TMS) derivatization in order to 
prevent degradation during GC-MS chromatography. The reference kanosamine was detected 
as trimethylsilyl ether exhibiting a molecular mass of 553.36 m/z (see appendix). However, in 
silylated assay samples no compound with a corresponding molecular mass was detected.  
 
4.1.7 1H-NMR experiments of RifL-incubation samples 
To gain further insights into the procedures of the RifL assay 1H-NMR measurements were 
carried out. For 1H-NMR experiments RifL incubation reactions were pipetted as listed in 
5.6.6, whereas the reagents were dissolved in deuterium oxide and immediately placed in the 
NMR tube for measurement. A duplicate sample was always measured by UV spectroscopy 
for comparison and verification of “active” protein. 
  
A signal emerging at 5.5 ppm (figure 4.13) was observed. This was attributed to a background 
epimerase reaction (figure 4.14) by G. Dräger on the basis of his earlier works. Therefore, an 
incubation was set up according to the RifL assay except for containing UDP-glucose-
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epimerase instead of a cell-free extract. In fact, the same signal at 5.5 ppm was observed as 
described before, and no signal apart from that occurred. Blank tests employing either a cell-
free extract from the unmodified strain Streptomyces lividans TK24 or omitting any protein 
showed no signal at 5.5 ppm. The cell-free extract from the unmodified strain Streptomyces 
lividans TK23 was analysed as well as a cell-free extract from Streptomyces lividans TK23 
pHGFrifK, L, M. Both exhibited the signal at 5.5 ppm. Also tested was the incubation with 
UDP-galactose instead of UDP-glucose that yielded the same signal as well.  
 
It is noted by Oguiza et al. that Streptomyces lividans harbours a galE gene encoding a protein 
that shares a high degree of identity to known UDP-galactose-4-epimerases from gram-
positive microorganisms.94 These proteins catalyse the interconversion of UDP-galactose and 
UDP-glucose.95 As the GalE protein has a size of ~34 kDa,96 it is unlikely that the enriched 
unknown ~25 kDa protein shown in SDS-PAGE (4.10) represents GalE. But there are other 
bands visible that are located within the range of 34 kDa. 
 
These results suggest that NAD+ consumption in the RifL assay was only based on this 
putative epimerase reaction. Epimerases and oxidoreductases are both NAD+- consuming 
enzymes, and in the RifL assay only NADH accumulation is monitored. Besides this fact 
there is no further indication for the proposed RifL reaction. There is no other NAD+-
consuming enzyme encoded on the plasmid pHGF7604. 
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Figure 4.13: 1H-NMR spectra of cell-free extracts from Streptomyces lividans TK24 pHGF7604 
(A) and Streptomyces lividans TK24 (B), arrows indicate the 1H chemical shift at 5.50-5.54 ppm 
(A) and the absent signal (B). 
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Figure 4.14: Epimerisation reaction of UDP-glucose via UDP-glucose-4-epimerase.  
 
 
The enzyme measurement designated as RifL assay might actually not show RifL activity. 
The reaction is probably caused by an epimerase. The use of an epimerase inhibitor, for 
example 8-anilino-1-naphthalenesulfonic acid, could therefore be applied.97 Due to the fact 
that only 15 to 30% of UDP-glucose are converted to UDP-galactose there was still a 
sufficient amount of UDP-glucose available for the actual RifL reaction (G. Dräger, personal 
communication). However, kanosamine was not detected in any incubation sample. 
Therefore, doubts concerning the presence of RifL in cell-free extracts of Streptomyces 
lividans pHGF7604 should be clarified via RT-PCR (4.1.8).  
 
4.1.8 RT-PCR of cDNA from Streptomyces lividans pHGF7604 
In order to clarify the presence of the rifL gene product (RifL) in the recombinant strain 
Streptomyces lividans pHGF7604, RT-PCR was carried out. Approximately 50 µg of total 
RNA were isolated (5.5.6.1) from 65 mg cell material of a liquid culture of Streptomyces 
lividans pHGF7604 (5.4.2.2). The remaining DNA was degraded using DNAse (RQ1DNAse, 
Promega) according to the manufacturer’s instructions. Total RNA, and in parallel a control 
RNA supplied in the cDNA synthesis Kit (Fermentas), was employed in cDNA synthesis 
(5.5.6.2). Successful synthesis of cDNA from both, sample and control, was verified on an 
agarose gel. Reverse transcriptase (RT)-PCR was performed using sample copy DNA and the 
specific primer pair “RT-PCR-Oxido”, and RT-PCR was conducted as described in 5.5.6.3. 
The plasmid rifKLM was used as a positive control, respectively, that yielded the expected 
PCR product of approximately 800 bp, whereas the cDNA from Streptomyces lividans 
pHGF7604 resulted in no PCR product (figure 4.15). Therefore, in all probability, no 
transcription of the cloned gene rifL took place under the terms of this study. 
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Figure 4.15: RT-PCR on an agarose gel. Lane 1: DNA Ladder Mix; lane 2: sample cDNA; lane 3: 
sample cDNA; lane 4: sample cDNA; lane 5: sample cDNA; lane 6: sample cDNA; lane 7: 
negative control reaction using no template DNA; lane 8: positive control reaction using rifKLM 
as template DNA. 
 
4.1.9 Studies of a putative functional interaction between RifL, RifK and RifM 
In parallel, other plasmids were constructed during the work of Kaulard85 that were intended 
for the study of a putative enzyme complex. It should be demonstrated in the present work 
that the three enzymes RifL, RifK and RifM exhibit functional interaction and therefore pass 
their products among each other. It was shown by Guo and Frost that RifL and RifK form a 
complex.63 Moreover, RifL and RifM deletion mutants show no UV reaction in RifL assay,72 
and the RifK homologue NapK is co-eluted if only the RifL homologue NapL is His-tagged.89  
 
This part of the study was carried out to access only the relevant genes for kanosamine 
formation. Therefore rifL, rifK and rifM were cloned in a Streptomyces shuttle vector, and 
transformed into Streptomyces lividans host cells.85 However, the introduction of the plasmids 
into Streptomyces lividans TK24 that was used for pHGF7604 was not possible, and therefore 
the TK23 derivative of Streptomyces lividans was used. The strains Streptomyces lividans 
TK23 and Streptomyces lividans TK24 are mutants of Streptomyces lividans 1326 that should 
only differ in their antibiotic resistance.5 For comparison with my earlier experiments the 
plasmid pHGF7604 and the empty plasmid pHGF were also transformed into Streptomyces 
lividans TK23 and were applied to the RifL assay (4.16). In parallel, two other constructs, 
pHGFrifL, K*, M and pHGFrifL, M, were cloned to analyse the putative multi enzyme 
complex formed by RifL, RifK and RifM. These constructs were designed in order to explore 
the influence of RifK aminotransferase on kanosamine production and on a functional 
interaction of rifL, rifK and rifM gene products respectively. Whereas the rifK gene carries a 
point mutation in pHGFrifL, K*, M, it is deleted on the plasmid pHGFrifL, M. In the proposed 
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pathway kanosamine will not be formed in the absence of rifK or if rifK is mutated (rifK*). 
Enzymatic activity of RifL should not be influenced by the point mutation found in 
pHGFrifL, K*, M in which RifK* is assumed to have no altered conformation, and is 
therefore available for complex formation. A conversion of 3-keto-UDP-glucose to 
kanosamine ought to be impossible, and heterologous expression of pHGFrifL, M should 
impede complex formation and thus RifL activity. Site-directed mutagenesis to construct 
pHGFrifL, K*, M was carried out by replacing the codon for lysine with the codon for aspartic 
acid at position 188 of RifK by change of two nucleotides. As all PLP-requiring enzymes 
share this conserved region as an active site for cofactor-binding, catalysis of RifK reactions 
should be blocked in the rifK* mutant. The gene products should be expressed and 
biosynthetic analysis was intended in the present work. As a precondition, a cell-free extract 
from the unmodified strain Streptomyces lividans TK23 was tested in rifL assay (figure 4.16). 
This resulted in showing a high NAD+ consumption, unlike what was observed for 
Streptomyces lividans TK24 unmodified strain. Therefore, the general expression of 
pHGF7604 and in particular in Streptomyces lividans TK23 was challenged. Nevertheless, the 
samples were checked for the presence of kanosamine via GC-MS, and kanosamine was not 
detected. Purification by means of 60% ammonium sulfate fractionation did not result in a 
higher absorption rate in the RifL assay compared to the crude cell-free extract. Both showed 
an absorption rate of 0.06 after 20 min. 
 
The rifL, rifK and rifM genes are absolutely essential for the biosynthesis of AHBA.65 
However they are not related to any shikimate pathway enzymes, whereas the other rif genes 
resemble their counterparts in shikimate pathway. Different AHBA gene clusters were 
compared, and it was observed that the arrangement of the rifG-N homologues involved in 
AHBA biosynthesis relative to rifK and its homologues is not uniform in all studied gene 
clusters. A variation of the relative arrangement of rifK (and homologues) to the other AHBA 
biosynthetic genes exists, although a conserved close association between rifK, rifL and rifM 
homologues occurs in all analyses. The linked arrangement of rifK, rifL and rifM in one 
operon is highly conserved in all analysed clusters. The rifL gene encodes a 359-amino acid 
protein (40 kDa) with its initiation codon located 73 bases downstream of the rifK gene. The 
rifM gene encodes a 232-amino acid protein (26 kDa), and is located 14 bases downstream of 
rifL. The rifK gene encodes a 388-amino acid protein (43 kDa).91 Therefore a functional 
interaction of the corresponding proteins was assumed, and the existence of a multienzyme 
complex between RifL, RifK and RifM was hypothesised.98 In an enzyme complex the 
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involved proteins exhibit coordinated catalytic activity. The channelling of substrates via 
multienzyme complexes has many advantages over the free diffusion of intermediates. For 
instance the transit time between active sites is reduced,99 and labile intermediates (like 3-
keto-UDP-glucose in this work) are protected from decomposition.100  
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Figure 4.16: RifL assay using crude cell-free extracts of Streptomyces lividans (TK23) harbouring 
different plasmids.  
 
So far the data show that Streptomyces lividans TK23 cannot be used as host strain to the 
plasmid pHGF7604 because of its residual activity.  
 
It was shown by SDS-PAGE in the work of Kaulard that even a crude cell-free extract of the 
unmodified host strain Streptomyces lividans TK23 contains a highly concentrated ~25 kDa 
protein.85 This is consistent with the finding in 4.1.5.1 where an ~25 kDa protein was enriched 
in a purified cell-free extract of Streptomyces lividans pHGF7604 that showed high activity in 
RifL assay. As displayed in figure 4.16, a crude cell-free extract of Streptomyces lividans 
TK23 exhibits a considerable activity in RifL assay. This provides evidence for the observed 
activity not being related to a recombinant gene product encoded on plasmid pHGF7604, but 
it might be due to a native protein from Streptomyces lividans that is constitutively expressed 
at a higher level in TK23 than in TK24 derivative.  
 
The outcome of the chapters 4.1.8 and 4.1.9 suggested that it would not be promising to 
proceed this topic via the current strategy. Further experiments conducted on AHBA enzymes 
are listed below despite they are of no interest after the findings reported before.  
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4.1.10 The steps catalysed by RifK and RifM 
As Streptomyces lividans pHGF7604 was assumed to be equipped with the genetic tools to 
synthesize AHBA, there was no tight control of the enzyme assay in order to stop the reaction 
at the stage of kanosamine or, on the other hand, to monitor the actual state during RifL assay. 
Therefore the remaining RifK- and RifM- catalysed reactions were originally intended to be 
investigated individually.  
 
4.1.10.1 Aminotransferase reaction putatively catalysed by RifK  
In a study by Lucher et al., the keto acid product derived from the amino donor glutamine was 
characterized as 2-oxoglutaramate, indicating that the α-amino group of glutamine 
participates in the transamination reaction.101 For this reason, 2-oxoglutaramate was 
synthesised as described in 5.8 for employment as the predicted amino acceptor deriving from 
glutamine. The unstable intermediate 3-keto-UDP-glucose was not available for an individual 
RifK reaction. Therefore the reversed reaction should have been carried out employing UDP-
kanosamine and the putative amino acceptor 2-oxoglutaramate. However, precipitation 
occurred in the UV cuvette that was attributed to 2-oxoglutaramate that would probably 
interfere with any substantial reaction.  
 
4.1.10.2 Phosphatase reaction putatively catalysed by RifM  
RifM has considerable similarity to the CBBY family of phosphatases.66 UDP-kanosamine 
was incubated with a cell-free extract of Streptomyces lividans pHGF7604 in the presence of 
magnesium chloride, but the conversion of UDP-kanosamine to kanosamine was not 
confirmed in HPLC measurements of the present work correlating with the absence of rif 
genes (4.1.8) in the cell-free extracts (data not shown).  
 
Conclusion 
In a study by Yu et al.66 the genes rifG-N were heterologous expressed in Streptomyces 
coelicolor YU105 that is unable to produce AHBA or AHBA-derived ansamycins. This 
resulted in the production of AHBA. Therefore it was assumed that AHBA biosynthesis must 
be attributed to the rifG-N genes. In the present study, however, the early stage intermediate 
kanosamine was not detected in RifL incubation samples using cell-free extracts of 
Streptomyces lividans pHGF7604 harbouring the rifG-N genes. The rifG-N genes, in 
particular rifL, were putatively not expressed under the terms of the present study. It might be 
the case that Streptomyces lividans does not provide the genetic equipment for a proper 
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expression of the rif genes. Unfortunately, no further insights into the early steps of rifamycin 
biosynthesis could be gathered during this part of the work. To date the mechanism of 
nitrogen introduction in early stage AHBA biosynthesis via kanosamine is neither verified nor 
another mechanism is proposed in further studies. Therefore this mechanism still remains 
unclear.  
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4.2 Isolation of a polyketide gene cluster from Streptomyces sp. 
GW2/5831 
 
This section of the present study was directed towards the isolation and investigation of the 
gene cluster encoding the biosynthesis of the polycyclic xanthone IB-00208 in Streptomyces 
sp. GW2/5831, a polyketide to which sugar units are attached in the post-PKS stage. The 
approach is presented in the following steps. 
4.2.1 Isolation of genomic DNA from Streptomyces sp. GW2/5831  
Genomic DNA from Streptomyces sp. GW2/5831 was isolated (5.5.1, figure 4.17) for the use 
in subsequent PCRs (5.5.5.1, 4.2.2) and for the production of a genomic library (5.5.10, 
4.2.4). 
 
 
 
 
 
Figure 4.17: Streptomyces sp. GW2/5831 on M2 agar (left) and agarose gel of isolated high 
molecular weight genomic DNA (right, lane 1: DNA ladder Mix, lane 2: genomic DNA). 
 
4.2.2 Amplification, cloning and sequencing of a gene fragment encoding a 
ketosynthase in genomic DNA of Streptomyces sp. GW2/5831 
The genomic DNA (4.2.1) was subjected to PCR employing the degenerate ketosynthase (KS) 
primers KS2F, KS2R, KS4F and KS1R (table 5.11, figure 4.20).83 These primers were 
designed from KSα motifs conserved in type II PKSs of pentangular polyketide pathways. The 
degenerate PCR primers were utilised for the amplification of the KS in the type II PKS gene 
cluster of the pentangular polyketide IB-00208. Since a ketosynthase is the most conserved 
component of a PKS, it represented the most suitable target for the detection of a previously 
not sequenced type II PKS cluster in a producing organism.102 The detection of the 
ketosynthase in the biosynthetic gene cluster of IB-00208 was used as a tool for accessing 
adjacent regions of the PKS that encode tailoring enzymes like glycosyltransferases. A 
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glycosyltransferase was expected to direct the attachment of the sugar moiety to the core 
structure of IB-00208 (figure 4.18).  
 
O
O
OMe
OMe
O O
O
O
O
OH
O
OMe
OMe
OMe
 
 
Figure 4.18: Chemical structure of the polycyclic xanthone IB-00208. 
 
        1 gtgagccgac gcgccgtcat cacggggatc ggagccgtcg ctcccggcgg catcggacgg 
       61 gacgcgtact gggacctgct cgcgcacggc cgtacggcca cccggcggat cagccggttc 
      121 gacgcgtcgg cgttccgctc gcaggtcgcc gccgaatgcg acttcgaccc ggtcgccgcg 
      181 gggctgagcc cgcaggaagt gcgccggatg gaccgggccg cccagttcgc ggtggtcgcg 
      241 gcccaggagg cgatcgagga cagcggcatc gacgtcggcg cgggcgaccc ggggcggacc 
      301 gcggtcagca tcggcagcgc ggtcggctgc accaccggcc tggaggacga gtacgcggtc 
      361 ctctcggacg gcggccggaa ctggctggtc gaccacacct acggggtccc gcacctgtac 
      421 ggctacatgg tccccagcac gctggcggcc gaagtggcct ggcgggcgcg ggcggagggc 
      481 ccggtggcac tgatctcgac cggctgcacc tccggtctcg acgcgatcgc ccacggcgtg 
      541 cagctcatcg aggagggcgc cgccgacatc gtcctggcgg gcgccaccga cgccccgctg 
      601 tcccccatca cctccgcctg cttcgacgcg atcaaggcga cgacgcccaa cgcggaccag 
      661 gacccgggca gcgcctcccg ccccttcgac ggccgccgcg acggcttcgt gctgggcgag 
      721 ggctcggcgg tcatggtgat cgaggaggcc ggggcggccc gccgccgggg ggccaccgtc 
      781 tacgccgagg tggccggttt cgccaaccgc tccaacgcct tccacatgac cgggctcaag 
      841 cccgacgggc gggagatggc cgaggccatc cgggtcgccc tggaccgcgc gcggctcgac 
      901 cccggcgcga tcgaccacgt caacgcgcac ggctccggca ccaagcagaa cgaccggcac 
      961 gagacggccg ccttcaagcg gtccctgggg cagcgcgccc acgagatccc ggtcagctcc 
     1021 atcaagtcga tgatcgggca ctccctgggg gcgatcggct ccctggaggt ggccgcctgc 
     1081 gccctggcgc tgcgccacca ggtggtgccg cccacggcga acctcacggt ccccgacccc 
     1141 cagtgcgacc tggactacgt cccggtcacc gcccgggagc accgcatgga ccacgtcctc 
     1201 agcgtcggca gcggattcgg cggcttccag agcgccatga tcctcagccg gcccggagcc 
     1261 cgtaaggagg cggtcgcgtg a 
 
Figure 4.19: Primer binding sites (bold and underlined) of the ketosynthase primer pair KS2F/ 
KS2R inside the griseorhodin A gene cluster, indicating the gene sequence encoding the KSα 
subunit (grhA) of griseorhodin A in the genome of the producing strain Streptomyces JP95.83 
 
The degenerate primer pair KS2F/ KS2R (figure 4.19) amplified a clear PCR product of 
approximately 900 bp (expected: 880 bp) in size (5.5.5.1, figure 4.20: lane 2), whereas the 
other two degenerate primer pairs KS4F/ KS1R and KS4F/ KS2R yielded several unspecific 
bands (figure 4.20, lanes 3 and 4). The PCR product (figure 4.20: lane 2) was cloned, 
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sequenced and used to design specific primers (4.2.3) to bind in a homologous fashion to the 
genomic region encoding the ketosynthase in the targeted PKS gene cluster of Streptomyces 
sp. GW2/5831. Therefore, the amplified and recovered PCR product was cloned into 
pBluescript (5.5.8), and heat shock transformation was carried out using E. coli XL1-Blue 
chemically competent cells (5.5.9.1, 5.5.9.2). Plasmid DNA was isolated (5.5.2) from 14 
clones that indicated the insertion of foreign DNA by showing a white colour in “blue-white” 
screening (5.5.9.6). Subsequent cleavage of the samples with the endonuclease RsaI (5.5.7.1) 
resulted in five different restriction patterns, and the corresponding plasmids were subjected 
to sequence analysis using the T7 standard primer-binding site of pBluescript. The obtained 
sequences were analysed by homology search using BLAST X. The results are listed in table 
4.1. 
 
 
 
 
 
 
    900 bp 
 
    500 bp 
  
 
 
 
Figure 4.20: Agarose gel of PCRs of degenerate primers with genomic DNA of Streptomyces sp. 
GW2/5831. Lane 1: DNA Ladder Mix; lane 2: KS2F/ KS2R; lane 3: KS4F/ KS1R; lane 4: KS4F/ 
KS2R. 
 
Table 4.1 Deduced functions of BLAST X data base search results 
Sample 
name 
Significant sequence alignment Identity  
(%) 
Length 
(bp) 
Protein accession 
number (GenBank) 
  origin    
pBES1 KSα subunit (RubA) Streptomyces 
collinus 
DSM2012  
70 428 AF293355 
pBES2 S-
adenosylmethionine 
synthetase (MetK) 
Thermobifida 
fusca YX 
86 397 CP000088 
pBES3 KSα subunit (RubA) Streptomyces 
collinus 
DSM2012  
70 428 AF293355 
pBES4 putative 
uncharacterised 
protein 
Streptomyces 
avermitilis MA-
4680 
57 275 BA000030 
pBES5 KSα subunit (RubA) Streptomyces 
collinus 
DSM2012 
70 428 AF293355 
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The sequence alignment of the cloned PCR product (figure 4.20, lane 2) showed a high 
similarity to the rubromycin rubA sequence, exhibiting an identity of 70% to the KSα subunit. 
This result is represented in the samples pBES1, pBES3 and pBES5. The query lengths 
comprised 701 bp (pBES1), 710 bp (pBES3) and 602 bp (pBES5), whereas the region of 
sequence homology spanned 428 bp in all of the three samples. Since the KS of a pentangular 
type II PKS system from a Streptomyces strain was the targeted sequence and the KSα subunit 
of the pentangular type II PKS rubromycin gene cluster from Streptomyces collinus exhibited 
a significant similarity, these data strongly suggest that the analysed sequence belongs to the 
IB-00208 gene cluster. The sequence of pBES2 encodes S-adenosylmethionine synthetase 
from Thermobifida fusca. Taxonomically, Thermobifida fusca and Streptomyces strains are in 
the order of Actinomycetales. The sequence encoded on pBES4 produced a significant 
alignment with a putative uncharacterised protein from Streptomyces avermitilis. As only 3 
samples out of five contained the targeted KS-fragment, it was shown that degenerate primers 
can cause false positive detections. Therefore a specific primer pair was required for the 
library screening (4.2.3). 
4.2.3 Design of specific primers 
Specific primers were designed based on the sequenced PCR product between positions 45 bp 
and 734 bp of plasmid pBES1. Thus, the specific primer pair BES1 should amplify a PCR 
product with a size of 691 bp (figure 4.21).  
 
        1 ggccccctcg aggtcgacgg tatcgataag cttgattccg atcatcgact tgatggagct 
                 61 gaccggcacc tcgtaggccc gctgcccgag gctgcgcttg aacgcggccg tctcgtgccg 
      121 gtcgttctgc ttggtgcccg acccgtgcgc gttgatgtag tcgatgtcgt ccggccccag 
      181 cctcgcctgc cgcatggcga ccgtgatggc ctcggccatc tcgcggccgt cgggcttcag 
      241 cccggtcatg tggtaggcgt tgctgcgccc ggcgaccccg gccacctcgg cgtacacgtg 
      301 ggcgtcgcgg cggcgcgccg ccgacgcctc ctccagcaca acacggccga gccctcgccg 
      361 aggacgaacc cgtcccggtc gcggtcgaac ggccgcgagg cgtgcgcggg gtcgtcgttg 
      421 ttgggggacg tcgccttgat cgcgtcgaag caggccgagg tgatcggcga gatcggcgcg 
      481 tcggtggccc cggcgatcac cacgtccgcg gcgccctccc ggatgagctg ggcgccgtgc 
      541 gcgacggcgt ccagcccgga ggtgcagccg gtggagatca gcgccaccgg cccctcggcg 
      601 ccgacccgcc aggccacctc gaccgccagc gtgctgggca ccatgtagcc gtacagctgc 
      661 ggcaccccgt actcgtggtc gaccagccac tgccggccgc cgtcgctgag gacgatgtac 
      721 tcctcctcca gccccatcgt gcagccgacc gcgctgccga ggctgacgcc gacgcggtcc 
            781 cggtcgcagc 
Figure 4.21: Primer binding sites (bold and underlined) of the specific primer pair BES1 in the 
ketosynthase region of Streptomyces sp. GW2/5831 DNA sequence. 
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The specific primer pair was used in a PCR with genomic DNA from Streptomyces sp. 
GW2/5831, yielding an amplified product of approximately 700 bp (figure 4.22). Based on 
this result, the BES1 primer pair was then used for screening a Streptomyces sp. GW2/5831 
library for the ketosynthase of interest (4.2.5).  
 
 
 
 
 
 
 
 
 
700 bp  
500 bp 
 
 
 
  
Figure 4.22: Agarose gel of PCR of specific primer pair BES1 with genomic DNA. Lane 1: DNA 
Ladder Mix; lane 2: ~700 bp PCR product. 
 
4.2.4 Production of a genomic library from Streptomyces sp. GW2/5831  
 
A genomic cosmid library was constructed as described in 5.5.10, using genomic DNA from 
Streptomyces sp. GW2/5831 (4.2.1) and the pAY1 shuttle vector. Both are displayed in figure 
4.23, visualised on agarose gels. PAY1 was constructed based on the stable integrative 
plasmid pSET152 containing the oriT region for conjugative transfer, the ФC31 attachment 
site and the cos site that was inserted from the plasmid pWEB.83 Shuttle vectors are employed 
to enable intergeneric transfer between different bacterial strains. In this case we hoped that 
this technique allows gene expression of a cosmid from the library in a heterologous host. 
 
The sheared, non blunt-ended, genomic DNA was recovered from a low-melting point 
agarose gel with the appropriate size of ~ 40 kb (figure 4.23). For the ligation into pAY1 it 
was required to be blunt-ended, because the vector was restricted with EcoRV yielding blunt 
ends. Therefore the sticky ends of the DNA fragments were filled with deoxynucleotides 
during the blunt ending reaction (5.5.10.1). The pAY1 vector DNA was prepared as described 
in 5.5.10.2. 
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Figure 4.23: Quantitative analysis of genomic DNA during library production (left), pAY1 vector 
DNA after purification (right). A: DNA before blunt ending reaction: lane 1: 0.5µl; lane 2: 1 µl; 
lane 3: 2 µl; lane 4: 20 ng of Fosmid Control DNA (~36 kb); B: Lane 1: DNA Ladder Mix, lane 2:  
0.5 µl pAY1 vector DNA (~10 kb) after purification (5.5.10.2). 
  
A ligation reaction was carried out as described in 5.5.10.3 using the blunt ended genomic 
DNA and the pAY1 vector (figure 4.23). The transfection of E. coli EPI300™ T1R plating 
strain with the plasmid-packaged lambda phages was performed according to the 
manufacturers instructions.  
 
The titer of the transfected cells comprised about 4,800 colony forming units. This was about 
3.5-fold larger than the number of clones required to cover the approximately 40 kb sequence 
of the Streptomyces sp. GW2/5831 PKS gene cluster (~ 1400). The amount was calculated 
according to the formula presented in chapter 5.5.10.4. Actually, 2016 random cosmid clones 
were preserved in 21 microtiter plates (5.5.10.5, figure 4.24) representing the genomic DNA 
library. Each cosmid harboured a ~ 40 kb genomic DNA fragment of Streptomyces sp. 
GW2/5831.  
 
A 
 
 
B 
 
Figure 4.24: Microtiter plates from the library. A: Micro titer plates containing positive clones 
(4.2.5) that are indicated by an orange dot on the corresponding row (A-H) and single well (1-12); 
B: Micro titer plate number 14, holding positive clones on locations A4, B5 and C3. 
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4.2.5 Library screening for polyketide synthase gene fragments 
To isolate the gene cluster responsible for IB-00208 biosynthesis, a PCR based screening of 
the gene library from Streptomyces sp. GW2/5831 was performed. This approach was 
conducted using the KS-specific primer pair BES1 (see also 4.2.3).  
 
To save time and minimize reagent amount, “row-pools” were established by combining 
aliquots of each well (12) in a row into one eppendorf tube (5.5.10.5). Thus eight “row pools” 
resulted from each microtiter plate. The “row-pools” were then screened for the PCR product 
(5.5.10.6). After the detection of a positive pool (figure 4.25 A), all the 12 wells of the 
corresponding row were screened individually (figure 4.25 B). The positive clones identified 
in this manner are listed in table 4.2. 
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Figure 4.25: Agarose gels of PCRs from screening procedure. A: PCR from the pooled rows A-H 
of microtiter plate four, lane 1: DNA Ladder Mix; lane 2: pool A; lane 3: pool B; lane 4: pool C; 
lane 5: pool D; lane 6: pool E; lane 7: pool F; lane 8: pool G; lane 9: pool H; lane 10: negative 
control; lane 11: positive control; lane 12: DNA Ladder Mix. B: PCR from 12 single wells in row 
G of microtiter plate four, lane 1: DNA Ladder Mix; lane 2: well 1; lane 3: well 2; lane 4: well 3; 
lane 5: well 4; lane 6: well 5; lane 7: well 6; lane 8: well 7; lane 9: well 8; lane 10: well 9; lane 11: 
well 10; lane 12: well 11; lane 13: well 12; lane 14: positive control.  
 
The screening of the genomic library from Streptomyces sp. GW2/5831 with the KS-specific 
primer pair BES1, conducted as described in 5.5.5.3, yielded 16 positive cosmid clones that 
are listed in table 4.2. The corresponding PCRs were double-checked and are shown on an 
agarose gel (figure 4.26). This confirmed the location of the sixteen positive cosmid clones in 
the library. 
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Table 4.2 Location of positive cosmid clones in the library exhibiting a BES1 PCR 
product (~700 bp) 
Cosmid number Coordinates 
 Microtiter plate Row (A-H) Number (1-12) 
1 1 C 3 
2 3 A 2 
3 3 A 3 
4 3 E 10 
5 4 G 1 
6 9 F 3 
7 9 F 7 
8 10 E 8 
9 10 G 2 
10 14 A 4 
11 14 B 5 
12 14 C 3 
13 17 G 6 
14 18 C 7 
15 19 D 1 
16 20 D 1 
 
 
 
 
Figure 4.26: Agarose gel of all positive cosmid clones after amplification of the ~700 bp PCR 
product. Lane 1: DNA Ladder Mix; lane 2: cosmid 1; lane 3: cosmid 2; lane 4: cosmid 3; lane 5: 
cosmid 4; lane 6: cosmid 5; lane 7: cosmid 6; lane 8: cosmid 7; lane 9: cosmid 8; lane 10: DNA 
Ladder Mix; lane 11: DNA Ladder Mix; lane 12: cosmid 9; lane 13: cosmid 10; lane 14: cosmid 
11; lane 15: cosmid 12; lane 16: cosmid 13; lane 17: cosmid 14; lane 18: cosmid 15; lane 19: 
cosmid 16; lane 20: negative control; lane 21: positive control; lane 22: DNA Ladder Mix.  
 
4.2.6 Restriction mapping and spot-sequencing of the positive cosmid clones  
The obtained positive cosmid clones (4.2.5) were further analysed for discovery of putative 
identical clones. Therefore cosmid DNA was isolated from an overnight culture of every 
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positive clone. Subsequent single restriction analysis was carried out using BamHI 
endonuclease. A distinct restriction pattern was obtained for each of the 16 positive clones 
that showed that the clones contained different sequences (figure 4.27).  
 
 
 
Figure 4.27: Restriction analysis of positive cosmid clones with BamHI. Lane 1: DNA Ladder 
Mix; lane 2: cosmid 1; lane 3: cosmid 2; lane 4: cosmid 3; lane 5: cosmid 4; lane 6: cosmid 5; lane 
7: cosmid 6; lane 8: cosmid 7; lane 9: cosmid 8; lane 10: cosmid 9; lane 11: cosmid 10; lane 12: 
cosmid 11; lane 13: cosmid 12; lane 14: DNA Ladder Mix; lane 15: DNA Ladder Mix; lane 16: 
cosmid 13; lane 17: cosmid 14; lane 18: cosmid 15; lane 19: cosmid 16; lane 20: DNA Ladder 
Mix. 
 
In order to gain insight into the cosmid content, spot-sequencing primers were designed 
employing the upstream and downstream parts of the EcoRV restriction site of the pAY1 
vector (figure 4.28). As the genomic DNA fragments of Streptomyces sp. GW2/5831 were 
cloned at the EcoRV restriction site of pAY1 vector, it was thus possible to end-sequence 
each positive construct. 
 
 
4100 
 
 
        4151 
 
agcacgccat agtgactggc gatgctgtcg gaatggacga ta_tcgaattc  
                                                                                       EcoRV 
 
gtaatcatgt catagctgtt tcctgtgtga aattgttatc cgctcacaat 
 
 
Figure 4.28: Section around EcoRV cleavage site (4142 bp, underlined) from pAY1 vector 
sequence (4100-4200bp), primer binding sites (AY1ES1 forward, AY1ES1 reverse) are bold and 
underlined. 
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All positive cosmids were subsequently end-sequenced to obtain insights into the outer parts 
of the cloned fragments. On the basis of these results, it was then decided which cosmids were 
of further interest. 
 
The vector primers AY1ES1 forward and AY1ES1 reverse were used for spot-sequencing of 
the 16 positive cosmids (pAYES 1-16). The sequences were then analysed by BLAST X, 
which retrieved homologies to proteins that are presented in table 4.3.  
 
Table 4.3  Sequence analysis of insert ends from all positive cosmids 
Insert 
designation 
 
Co-
ordinates1 
Sequence 
length2 
(bp) 
Homology3 
(proposed function)  
 
Gene 
region4 
(bp) 
Protein 
region 
(aa)5 
Protein 
length 
(aa) 
Identity6 
(%) 
pAYES 1 
forward 
1C3 178 ATP-binding cassette 
(ABC)-type drug   
export system 
[Streptomyces 
avermitilis]103 
ABC-type drug 
transport system  
(PdmR2, pradimicin 
cluster)[Actinomadura 
hibisca]104, 105 
40-170 
 
 
 
 
50-160 
4-49 
 
 
 
 
7-44 
258 
 
 
 
 
259 
56 
 
 
 
 
57 
pAYES 1  
reverse 
1C3 373 UDP-glucose 4-
epimerase (GalE) 
[Saccharopolyspora 
erythraea]106 
40-372 111-
221 
355 60 
pAYES 2  
forward 
3A2 103 no significant 
similarity - - - - 
pAYES 2  
reverse 
3A2 700 oxidoreductase 
[Mycobacterium 
ulcerans]107 
21-677 1-228 292 36 
 
pAYES 3  
forward 
3A3 557 putative secreted 
protein [Streptomyces 
coelicolor]108    
conserved hypo- 
thetical regulatory 
protein 
[Mycobacterium 
ulcerans]107 
5-127 
 
 
101-
184 
35-76 
 
 
267-
294 
318 
 
 
301 
45 
 
 
60 
pAYES 3  
reverse 
3A3 814 oxidoreductase, short-
chain dehydrogenase/ 
reductase (SDR) 
family [Arthrobacter 
aurescens]109 
70-807 
 
 
 
 
1-259 
 
 
 
 
264 
 
 
 
 
48 
 
 
 
 
                                                 
1
 micro titer plate (number) row (letter) column (number) 
2
 of the read from vector to insert  
3
 highest sequence homology on protein level, additional hits are only listed in case of importance or if related to 
different gene regions  
4
 first and last base pair position of insert indicating homology of fragment sequence and data base element 
5
 first and last amino acid position indicating homology of fragment sequence and homologous protein  
6
 percentage of sequence homology 
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3-oxo-acyl-reductase 
(acyl-carrier-protein) 
(FabG) 
[Saccharopolyspora 
erythraea]106  
70-813 
 
1-265 268 43 
pAYES 4  
forward 
3E10 390 no significant 
similarity - - - - 
pAYES 4  
reverse 
3E10 579 putative FAD-binding 
monooxygenase 
[Bradyrhizobium 
sp.]110 
227-
568 
4-122 562 43 
pAYES 5  
forward 
4G1 571 FAD-dependent 
oxidoreductase 
[Myxococcus 
xanthus]111 
1-180 
 
297-
356 
385 41 
 
pAYES 5  
reverse 
4G1 362 ABC-transporter 
related precursor 
[Frankia sp.]112 
44-361 753-
862 
1302 36 
pAYES 6  
forward 
 
9F3 542 sodium/hydrogen 
exchanger 
[Stigmatella 
aurantiaca]113 
162-
341 
 
16-86 677 
 
50 
pAYES 6  
reverse 
9F3 646 putative 
dehydrogenase (LlpS, 
lysolipin cluster) 
[Streptomyces 
tendae]78  
2-571 93-281 287 36 
pAYES 7  
forward 
9F7 
- poor DNA quality - - - - 
pAYES 7  
reverse  
 
9F7 1031 oriT-binding protein 
(TraJ) [uncultured 
bacterium]114 
aminoglycoside-
acetyltransferase 
(AacC4) [E. coli]115 
67-381 
 
 
818-
1030 
19-123 
 
 
188-
258 
123 
 
 
258 
75 
 
 
94 
pAYES 8  
forward  
10E8 - 
 
poor DNA quality - 
 
- 
 
- 
 
- 
 
pAYES 8 
reverse 
10E8 
- poor DNA quality - - - - 
pAYES 9  
forward 
10G2 816 hypothetical protein 
[Oryza sativa]116  
605-
796 
171-
242 
282 34 
pAYES 9  
reverse 
10G2 469 putative ATP-
dependent RNA 
helicase 
[Streptomyces 
avermitilis]117 
71-469 557-
687 
877 62 
pAYES 10 
forward 
14A4 832 putative integral 
membrane protein 
(MMPL) [Salinispora 
arenicola]118, 119  
3-359 590-
708 
714 67 
pAYES 10 
reverse 
14A4 506 no significant 
similarity - - - - 
pAYES 11 
forward 
 
14B5 810 hypothetical protein 
[Oryza sativa]120 
putative serine/ 
threonine protein 
88-513 
 
439-
786 
76-221 
 
408-
523 
339 
 
576 
30 
 
27 
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kinase [Streptomyces 
coelicolor]108 
pAYES 11 
reverse 
 
14B5 516 putative cyclase 
(PdmL, pradimicin 
cluster) 
[Actinomadura 
hibisca]104, 105 
putative polyketide 
cyclase [Streptomyces 
griseus]121 
putative cyclase 
(GrhS, griseorhodin 
cluster) [Streptomyces 
sp. JP95]83 
polyketide synthase 
[Frankia alni]112 
putative cyclase 
(RubE, similar to 
PdmL in pradimicin 
cluster) [Streptomyces 
collinus]122  
222-
515 
 
 
 
234-
515 
 
255-
515 
 
 
237-
515 
 
11-133 
2-99 
 
 
 
 
1-94 
 
 
10-96 
 
 
 
3-93 
 
 
70-110 
147 
 
 
 
 
141 
 
 
144 
 
 
 
172 
 
 
123 
69 
 
 
 
 
62 
 
 
62 
 
 
 
59 
 
 
56 
pAYES 12 
forward 
14C3 
- 
 
poor DNA quality 
 
- - - - 
pAYES 12 
reverse 
14C3 
- poor DNA quality - - - - 
pAYES 13 
forward 
17G6 471 no significant 
similarity - - - - 
pAYES 13 
reverse 
17G6 742 FAD-dependent 
oxidoreductase 
[Myxococcus 
xanthus]111 
1-699 133-
356 
385 40 
pAYES 14 
forward 
18C7 
 
 
 
 
778 oxygenase (GrhM) 
[Streptomyces sp. 
JP95]83  
putative 
monooxygenase 
(fredericamycin 
cluster) [Streptomyces 
griseus]121  
oxygenase (PdmE, 
pradimicin cluster) 
[Actinomadura 
hibisca]104, 105 
RubQ (rubromycin 
cluster, similar to 
ORF5 in pradimicin 
cluster) [Streptomyces 
collinus]122  
254-
577 
 
239-
568 
 
 
 
263-
583 
 
 
251-
577 
5-112 
 
 
2-110 
 
 
 
 
8-114 
 
 
 
3-110 
150 
 
 
149 
 
 
 
 
153 
 
 
 
148 
47 
 
 
45 
 
 
 
 
42 
 
 
 
47 
pAYES 14 
reverse 
18C7 
- poor DNA quality - - - - 
pAYES 15 
forward 
19D1 584 hemerythrin cation- 
binding domain 
protein (HHE) 
[Mycobacterium 
sp.]118  
33-584 351-
533 
747 30 
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pAYES 15 
reverse 
19D1 501 6-aminohexanoate 
cyclic dimer 
hydrolase 
[Mycobacterium 
smegmatis]123  
75-194 525-
565 
1075 39 
pAYES 16 
forward  
20D1 
- poor DNA quality - - - - 
pAYES 16 
reverse  
 
20D1 999 aminoglycoside-
acetyltransferase 
(AacC4), apramycin 
resistance gene [E. 
coli]115 
492-
998 
 
 
 
90-258 
 
 
 
 
258 
 
 
 
86 
 
 
 
Homologies to gene products from type II PKS systems occur frequently within the 
sequenced DNA fragments. Several of them (pAYES 1 forward, pAYES 11 reverse, pAYES 
14 forward) belong to the biosynthetically related pradimicin-type pentangular polyketides 
like the fredericamycins and members of the griseorhodin/ rubromycin family.73 Furthermore, 
oxidoreductases that often occur as tailoring enzymes in polyketide biosynthesis were 
discovered on the fragments pAYES 2 reverse, pAYES 3 reverse, pAYES 5 forward and 
pAYES 13 reverse. Therefore it is most likely that at least parts of the targeted IB-00208 gene 
cluster are encountered on the positive cosmid clones.  
4.2.7 Heterologous expression of the positive cosmid sequences 
To reveal the function of the positive cosmid sequences (table 4.2), heterologous expression 
was carried out using Streptomyces albus as host strain. Intergeneric transfer of the cosmid 
DNA was accomplished as described in 5.5.11. The inserted cosmids and the corresponding 
designation of the conjugated strains are listed in table 4.4.  
 
Biosynthetic gene clusters that code for aromatic polyketides usually comprise 15 to 40 open 
reading frames, holding capacities between 20 to 60 kb. For IB-00208 we expected a size of 
approximately 40 kb. Since the sizes of the inserts in the generated cosmid gene library reach 
approximately 40 kb, it is theoretically possible to encounter the whole IB-00208 gene cluster 
in one of the 16 positive clones. A heterologous expression could therefore be accomplished 
by the transfer of a single cosmid. Ideally, successful transfer of the complete gene cluster 
would be accompanied by the production of the compound. Due to the intense red colour of 
the xanthone, a producing recombinant may be identified visually after the heterologous 
expression in Streptomyces albus host strain via conjugal transfer. Therefore, any deviation 
from a white mycelium was monitored. On the other hand, it could be possible that the 
heterologous expression of only parts of the cluster, dependent on the cosmid content, yields 
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another secondary metabolite, even previously unknown. For example collinone, an 
intermediate from the griseorhodin pathway, is produced by a knockout mutant lacking the 
oxygenase GrhO5.73  
 
The transfer of genetic information between E. coli and Streptomyces can be accomplished by 
intergeneric conjugation.5 This method is advantageous because it is still easier to manipulate 
E. coli rather than Streptomyces DNA. The mating system consisted of the non-methylating/ 
mobilisation-proficient E. coli ET12567/pUZ8002 donor strain 124 and Streptomyces albus 
J1074 host strain. The donor strain was transformed with the positive pAY1 cosmid clone 
DNA. The vector pAY1 possesses an origin of transfer (oriT) sequence and contains an 
integrase function of the actinomycete phage ФC31 where the site-specific integration of the 
foreign DNA into the host genome takes place.125 A successful transfer of cosmid DNA can 
be verified by selection on the apramycin resistance gene marker (aacC4). The overlay with 
nalidixic acid inhibits the bacterial growth of the donor strain during incubation after the 
conjugation event. Streptomyces exconjugants, that usually appeared after five days of 
cultivation, were repeatedly transferred onto fresh agar plates containing different media in 
order to remove remaining E. coli cells. Use of different solid and liquid media enhanced the 
possibility of finding a putative new secondary metabolite produced by one of the 
recombinant Streptomyces albus strains SE01-SE16. This method is described as “one strain 
many compounds”- (OSMAC) principle.126 According to this, one strain is enabled to produce 
different compounds depending on the provided media components.  
 
Table 4.4 Conjugated Streptomyces albus strains carrying cloned fragments from 
Streptomyces sp. GW2/5831 (for cosmid numbers see table 4.2.) 
Strain designation Conjugated fragment 
Streptomyces albus SE01 Cosmid 01 
Streptomyces albus SE02 Cosmid 02 
Streptomyces albus SE03 Cosmid 03 
Streptomyces albus SE04 Cosmid 04 
Streptomyces albus SE05 Cosmid 05 
Streptomyces albus SE06 Cosmid 06 
Streptomyces albus SE07 Cosmid 07 
Streptomyces albus SE08 Cosmid 08 
Streptomyces albus SE09 Cosmid 09 
Streptomyces albus SE10 Cosmid 10 
Streptomyces albus SE11 Cosmid 11 
Streptomyces albus SE12 Cosmid 12 
Streptomyces albus SE13 Cosmid 13 
Streptomyces albus SE14 Cosmid 14 
Streptomyces albus SE15 Cosmid 15 
Streptomyces albus SE16 Cosmid 16 
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All sixteen conjugated Streptomyces albus strains (SE01-SE16) are represented in figure 4.29. 
They were grown on solid M2 medium which is known as the production medium for IB-
00208 in Streptomyces sp. GW2/5831.  
 
 
Figure 4.29 : Conjugated Streptomyces albus strains (SE01-SE16) on M2 medium. 
 
Fifteen of the strains show no visual deviation from the wild type of Streptomyces albus. In 
contrast, the characteristic white colour of the spores was repeatedly not exhibited by 
Streptomyces albus SE08, which might be due to the lack of sporulation. The morphology of 
all conjugated Streptomyces albus (SE01-16) strains cultured on other media did not differ 
from appearance in figure 4.29. Utilised agar plates consisted of LB- (figure 4.30), MS- and 
2CM medium (without illustration). For the cultivation in liquid media, LB-, TSB- and meat 
extract medium were employed (without illustration). Meat extract medium is known as 
production medium for IB-00208 in liquid cultures of Streptomyces sp. GW2/5831 (Prof. H. 
Laatsch, personal communication). No variation in appearance from unmodified Streptomyces 
albus was detected. The absence of any coloured compound indicated that IB-00208 is not 
produced by one or more of the conjugated strains. None of the cosmids harbours the entire 
IB-00208 biosynthetic gene cluster. To obtain verification of received apramycin resistance of 
the host strains, the conjugated strains were spread on LB medium containing apramycin 
(figure 4.30). The strains SE02, SE07, SE10, SE12 and SE16 do not grow on apramycin agar 
plates, whereas all other conjugated strains exhibit apramycin resistance. 
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Figure 4.30: Conjugated Streptomyces albus strains (SE01-SE16) on LB medium including 
apramycin. 
 
The growth of conjugated strains on and in apramycin containing media does not necessarily 
mean that the complete cosmid DNA, including apramycin resistance gene cassette, is 
integrated into the genome of the host strain. Resistance may occur spontaneously. To 
unequivocally proof the integration of the cosmid DNA into the genome of Streptomyces 
albus, genomic DNA was therefore isolated from conjugated strains and employed in a PCR 
with BES1 primer pair under the same conditions as applied in the library screening. The 
PCRs are visualised on an agarose gel (figure 4.31). Amplification of the known ~700 bp 
PCR product documents the presence of the cloned fragment in the heterologous host.  
 
 
 
 10 kb 
 
 
   1 kb 
0.5 kb 
 
 
 
 
10 kb 
 
 
1 kb 
0.5kb 
Figure 4.31: Visualised PCR of genomic DNA from conjugated Streptomyces albus strains 
(SE01-SE16) with BES1 primers. Lane 1: 1 kb ladder; lane 2: SE01; lane 3: SE02; lane 4: SE03; 
lane 5: SE04; lane 6: SE05; lane 7: SE06; lane 8: SE07; lane 9: SE08; lane 10: SE09; lane 11: 
SE10; lane 12: SE11; lane 13: SE12; lane 14: SE13; lane 15: SE14; lane 16: SE15; lane 17: SE16; 
lane 18: positive control (genomic DNA from Streptomyces sp. GW2/5831); lane 19: negative 
control (without any template DNA); lane 20: 1 kb ladder.   
 
Integration was proven for seven strains (SE01, SE04, SE05, SE11, SE13, SE14 and SE15), 
although the PCR product of SE13 is amplified to a lesser extent than all others. As no 
coloured compound was visually detected in these confirmed conjugated Streptomyces albus 
strains SE01, SE04, SE05, SE11, SE13, SE14 and SE15, the entire IB-00208 gene cluster is 
not located on one of these cosmids. The remaining nine strains had not integrated the cloned 
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fragment into their genome. Thus the colour of the mycelia is not significant, and can 
therefore not be appraised. The strains SE02, SE07, SE10, SE12 and SE16 neither grow on 
apramycin nor do they show a PCR product. The strains SE03, SE06, SE08 and SE09 grow 
on apramycin, although their genomic DNA does not contain the corresponding cosmid 
sequence. Further attempts could generate exconjugants of SE02, SE03, SE06, SE07, SE08, 
SE09, SE10, SE12 and SE16.  
 
The lack of any visible compound might be due to the heterologous expression of the 
incomplete IB-00208 biosynthetic gene cluster in the so far conjugated strains. Analytical 
investigations could lead to the detection of a putative, uncoloured pathway intermediate that 
might be produced by one of the conjugated Streptomyces albus strains containing cluster 
fragments. 
 
4.2.8 Subcloning and sequencing of selected cosmid clones 
Important sequences might be hidden in regions of the cosmids that were not sequence-
analysed so far. To gain more insight into the sequence content of the cloned fragments, 
another approach was required. Therefore, subcloning technique was performed. 
 
4.2.8.1 Subcloning of selected cosmid clones  
To obtain more sequence information about the cosmid DNA samples, two out of the sixteen 
positive cosmid clones were selected and digested into smaller fragments. Aside from the 
results of restriction analysis (4.2.6) and heterologous expression (4.2.7), the information in 
table 4.3 was consulted for sample selection. To obtain as much sequence data as possible, the 
maximum cluster coverage was aspired. It was putatively represented by the cosmids 11 and 
14. 
 
For restriction of the cosmid DNA three different type II endonucleases (table 4.5) were 
tested. NotI is an eight base cutter, whereas SacI and PstI are six base cutters. For cosmid 11, 
the NotI restriction pattern was the most suitable which exhibited the best band separation and 
yielded 12 fragments of reasonable size for cloning (table 4.6). The endonuclease SacI 
digested cosmid 14 into 14 fragments (table 4.6). PstI did not generate a useful restriction 
pattern. The fragments were recovered from the gel via gel extraction (5.5.4.2). The vector 
pBluescript was restricted with NotI for cosmid 11 and SacI for cosmid 14. After the ligation 
reaction of the recovered fragments with pBluescript, the DNA was introduced into E. coli 
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XL-1 Blue electrocompetent cells. Plasmid DNA was isolated from overnight cultures of 
white transformants (5.5.9.6), and restriction was carried out. The sizes of vector and 
fragments were verified (table 4.6, figures 4.32 and 4.33). As fragment pBSSE1105 (lane 6, 
figure 4.32) and pBluescript both exhibit a size of about 3000 bp, the plasmid DNA was 
restricted with two endonucleases. Cleavage of pBSSE1105 was therefore carried out with 
NotI and ScaI simultaneously, generating three fragments. The fragment pBSSE1105 is 
represented in the 3000 bp band, whereas pBluescript was restricted by ScaI yielding one 
band at ~1000 bp and a further band at ~ 2000 bp, respectively. A double digestion with ScaI 
was also required for fragment pBSSE1406 (lane 8, figure 4.33) that resulted in a 3000 bp 
fragment derived from pBSSE1406, and pBluescript was cleaved as described above. 
 
The subclones were subjected to sequence analysis. Sequencing of the obtained fragments, 
based on the standard T3 and T7 primers, provided more evidence for putative protein coding 
regions involved in IB-00208 biosynthesis (see table 4.7). 
 
Table 4.5 Sequences, cleavage sites and evolving overhang of utilised endonucleases 
Endonuclease Sequence (5’-3’) Cleavage site (5’-3’) Overhang  (5’-3’) 
NotI GCGGCCGC GC  GGCCGC 
CGCCGG  CG 5’- GGCC 
SacI GAGCTC GAGCT  C 
C  TCGAG AGCT-3’ 
PstI CTGCAG CTGCA G 
G ACGTC TGCA-3’ 
 
 
 
Table 4.6 Fragments and sizes of cosmids 11 and 14  
Sample designation Fragment size (bp) Sample designation Fragment size (bp) 
pBSSE1101 14.000 pBSSE1402 10.000 
pBSSE1102 10.000 pBSSE1403 8.000 
pBSSE1103 6.000 pBSSE1404 6.000 
pBSSE1104 5.000 pBSSE1405 3.800 
pBSSE1105 3.000 pBSSE1406 3.000 
pBSSE1106 1.800 pBSSE1407 2.500 
pBSSE1107 1.400 pBSSE1408 1.800 
pBSSE1108 1.100 pBSSE1409 1.600 
pBSSE1109 700 pBSSE1410 1.300 
pBSSE1110 600 pBSSE1411 1.200 
pBSSE1111 550 pBSSE1412 800 
pBSSE1112 < 500 pBSSE1413 650 
pBSSE1401 12.500 pBSSE1414 550 
 
The sizes of the large fragments were determined by means of the 1 kb extension ladder 
(figure 4.32, lane 1 and 4.33, lane 1). 
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Figure 4.32: Subclones of cosmid 11 after plasmid DNA isolation and restriction cleavage with 
NotI, the plasmid DNA in lane 6 was additionally cleaved with ScaI. Lane 1: 1 kb extension 
ladder; lane 2: fragment 1101; lane 3: fragment 1102; lane 4: fragment 1103; lane 5: fragment 
1104; lane 6: fragment 1105; lane 7: fragment 1106; lane 8: fragment 1107; lane 9: fragment 
1108; lane 10: fragment 1109; lane 11: fragment 1110; lane 12: fragment 1111; lane13: fragment 
1112; lane 14: 1 kb ladder.  
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Figure 4.33: Subclones of cosmid 14 after plasmid DNA isolation and restriction cleavage with 
SacI,  the plasmid DNA in lane 8 was additionally cleaved with ScaI. Lane 1: 1 kb extension 
ladder; lane 2: fragment 1401; lane 3: 1 kb ladder; lane 4: fragment 1402; lane 5: fragment 1403; 
lane 6: fragment 1404; lane 7: fragment 1405; lane 8: fragment 1406; lane 9: fragment 1407; lane 
10: fragment 1408; lane 11: fragment 1409; lane 12: fragment 1410; lane13: fragment 1411; lane 
14: fragment 1412; lane 15: fragment 1413; lane 16: fragment 1414; lane 17: 1 kb ladder.  
 
 
4.2.8.2 Sequence analysis of subcloned fragments 
The subclones were then subjected to DNA sequencing (5.5.12.3), and the results of the 
BLASTX queries (5.5.12.4) are listed in table 4.7.  
 
   
 
 
         Table 4.7 Results of BLAST analysis of sequenced subclone-fragments (cosmids 11, 14) 
Sample 
designation 
Sequencing 
direction 
Read 
length 
(bp) 
Proposed function 
(homolog) Origin  
Region of 
homology 
(bp) 
Identity 
(%) 
Seq.length 
(homolog) 
(aa) 
Region of 
homology 
(aa) 
Accession 
number 
pBSSE1101 T3 866 KSβ subunit (RubB) 
 
Streptomyces 
collinus 
204-4 59 422 24-90 AF293355 
   KSα subunit (RubA) Streptomyces 
collinus 
845-264 79 428 224-417 AF293355 
pBSSE1101 T7 1027 serine/threonine protein 
kinase 
Streptomyces 
coelicolor 
680-501 37 576 462-523 NP_628048 
 
pBSSE1102 T3 395 high-affinity branched-
chain amino acid 
transport protein (ABC 
superfamily, ATP-
binding) 
Frankia alni 
ACN14a 
 
77-388 51 256 75-181 YP_715216 
 
pBSSE1102 T7 703 ABC transporter, 
transmembran region, 
type 1 precursor 
Nocardioides sp. 651-
367/343-
113 
53/42 1081 434-
528/557-
633 
YP_922154 
 
pBSSE1103 T3 734 transcriptional regulator 
(repressor) TetR family 
protein 
Streptomyces 
avermitilis 
351-665 34 242 42-146 NP_822557 
 
pBSSE1103 T7 525 hypothetical protein 
 
Stigmatella 
aurantiaca 
DW4/3-1 
518-207 54 499 299-398 ZP_01460657 
 
pBSSE1104 T3 760 putative ABC 
transporter, drug export 
system 
Streptomyces 
avermitilis 
740-135 44 258 55-256 NP_827888 
 
pBSSE1104 T7 714 KSβ subunit (RubB) Streptomyces 
collinus 
86-712 67 422 88-302 AF293355 
 
pBSSE1105 T3 695 putative secreted protein 
 
Streptomyces 
coelicolor 
18-692 38 342 97-324 NP_630686 
pBSSE1105 T7 946 putative ABC 
transporter (CydCD) 
Streptomyces 
coelicolor 
145-696 49 1172 942-1139 NP_628131 
 
pBSSE1106 T3 925 sodium/hydrogen 
exchanger 
Stigmatella 
aurantiaca 
584-796 50 677 16-86 EAU68588 
 
   
 
 
DW4/3-1 
pBSSE1106 T7 945 sodium/hydrogen 
exchanger 
Stigmatella 
aurantiaca 
DW4/3- 
708-166 41 677 208-388 EAU68588 
pBSSE1107 T3 816 putative ABC 
transporter ATP-binding 
protein 
Nocardia 
farcinica 
261-815 35 926 5-184 YP_119573 
 
pBSSE1107 T7 873 putative ABC 
transporter ATP-binding 
protein 
Nocardia 
farcinica 
426-797 42 926 1-126 YP_119573 
pBSSE1108 T3 907 high-affinity branched-
chain amino acid 
transport protein (LivG) 
(ABC superfamily, 
ATP-binding)  
Frankia alni 850-563 58 272 12-107 YP_715217 
 
pBSSE1108 T7 982 high-affinity branched-
chain amino acid 
transport protein (ABC 
superfamily, ATP-
binding) 
Frankia alni 240-944 51 272 10-246 YP_715217 
pBSSE1109 T3 1036 putative branched-chain 
amino acid transport 
system 
Frankia alni 747-25 26 401 12-262 YP_713343 
 
pBSSE1109 T7 1041 putative branched-chain 
amino acid transport 
system 
Frankia alni 40-831 27 401 17-269 YP_713343 
pBSSE1110 T3 648 polyketide synthase 
modules and related 
proteins 
Burkholderia 
mallei GB8  4 
431-291 42 1516 1150-1198 ZP_00439137 
 
 
pBSSE1110 T7 804 polyketide synthase 
modules and related 
proteins 
Burkholderia 
mallei GB8  4 
238-444 41 1516 1150-1205 ZP_00439137 
pBSSE1111 T3 1005 putative ABC 
transporter ATP-binding 
protein 
Frankia alni 495-1 44 937 354-534 YP_713339 
 
   
 
 
pBSSE1111 T7 1020 putative ABC 
transporter ATP-binding 
protein 
Frankia alni 78-638 42 937 354-540 YP_713339 
pBSSE1112 T3 1065 putative ABC 
transporter ATP-binding 
protein 
Frankia alni 290-111 48 937 536-595 YP_713339 
pBSSE1112 T7 - - - - - - - - 
pBSSE1401 T3 742 SARP family pathway 
specific regulatory 
protein 
putative monooxygenase 
Streptomyces 
griseus  
 
Streptomyces 
griseus 
321-13 
 
 
731-438 
36 
 
 
46 
280 
 
 
246 
1-105 
 
 
29-127 
YP_001827897 
 
 
AAQ08922 
 
pBSSE1401 T7 595 putative O-
methyltransferase 
Streptomyces 
griseus 
98-589 52 353 157-322 AAQ08925 
 
pBSSE1402 T3 1010 conjugal transfer protein 
TraJ 
Birmingham IncP-
alpha plasmid 
763-419 98 123 9-123 YP_001687709 
 
pBSSE1402 T7 761 putative 3-oxoacyl-ACP 
reductase 
Streptomyces 
tendae 
472-86 51 245 45-173 CAM34370 
 
pBSSE1403 T3 1010 hypothetical protein E. coli 873-508 95 123 2-123 NP_040360 
pBSSE1403 T7 984 PadR-like family 
transcriptional regulator 
 
daunorubicin resistance 
ABC transporter ATPase 
subunit 
Streptomyces 
avermitilis MA-
4680 
Alkaliphilus 
metalliredigens 
QYMF 
101-667 
 
 
861-980 
44 
 
 
57 
215 
 
 
323 
26-212 
 
 
11-50 
NP_827886 
 
 
YP_001321687 
pBSSE1404 T3 983 putative 3-oxoacyl-ACP 
reductase  
Antibiotic biosynthesis 
monooxygenase (BenJ) 
Streptomyces 
tendae 
Streptomyces sp. 
A2991200 
11-199 
 
536-769 
51 
 
38 
250 
 
115 
183-248 
 
13-90 
CAM34340 
 
CAM58802 
 
pBSSE1404 T7 992 uncharacterised protein  Streptomyces 
fradiae 
989-303 36 345 115-343 P20187 
 
pBSSE1405 T3 181 no hits found - - - - - - 
pBSSE1405 T7 923 KSα subunit (RubA) 
 
putative cyclase (RubE) 
Streptomyces 
collinus 
Streptomyces 
396-922 
 
93-377 
67 
 
61 
428 
 
143 
6-181 
 
45-140 
AF293355 
 
AAG03066 
   
 
 
collinus  
pBSSE1406 T3 853 short-chain 
dehydrogenase/reductase 
(SDR) 
Frankia sp. 
EAN1pec 
 
814-752 66 312 13-33 YP_001511055 
 
pBSSE1406 T7 639 hypothetical protein 
(Pd2U) angucycline 
cluster 
Streptomyces sp. 
WP 4669 
173-550 50 311 71-195 AAO65359 
 
pBSSE1407 T3 892 FAD-dependent 
oxidoreductase 
Burkholderia sp. 
383 
830-6 40 566 257-537 YP_366401 
 
pBSSE1407 T7 953 short-chain 
dehydrogenase/reductase 
(SDR)  
Frankia sp. 
EAN1pec 
 
342-812 40 246 36-185 YP_001507428 
 
pBSSE1408 T3 931 O-methyltransferase 
 
dehydrogenase (LlpS) 
Streptomyces 
griseus  
Streptomyces 
tendae 
382-2 
 
931-551 
51 
 
47 
353 
 
293 
21-147 
 
161-287 
AAQ08925 
 
CAM34368 
 
pBSSE1408 T7 917 putative dehydrogenase 
(LlpS) 
3-oxoacyl-ACP 
reductase  
Streptomyces 
tendae 
Streptomyces 
tendae 
417-872 
 
86-307 
51 
 
58 
293 
 
245 
13-164 
 
172-245 
CAM34368 
 
CAM34370 
pBSSE1409 T3 928 putative 
methyltransferase 
(GrhL) 
Streptomyces sp. 
JP95 
77-772 42 343 65-288 AF509565 
pBSSE1409 T7 662 hypothetical protein Streptomyces 
pristinaespiralis 
ATCC 25486 
253-612 33 244 117-241 ZP_03191407 
 
pBSSE1410 T3 899 putative polyketide 
cyclase (RubE) 
putative polyketide 
cyclase (RubD) 
Streptomyces 
collinus 
Streptomyces 
collinus 
115-2 
 
545-222 
60 
 
69 
143 
 
123 
1-38 
 
1-108 
AAG03066 
 
AAG03065 
 
pBSSE1410 T7 890 flavin reductase domain-
containing protein 
Frankia sp. 
EAN1pec 
541-101 46 170 6-150 YP_001510489 
 
pBSSE1411 T3 1067 putative 3-oxoacyl-ACP 
reductase (GrhO10) 
Streptomyces sp. 
JP95 
504-4 45 249 1-167 AF509565 
pBSSE1411 T7 948 SARP-family regulatory Streptomyces 104-499 41 280 119-250 YP_001827897 
   
 
 
protein  griseus  
pBSSE1412 T3 - - - - - - - - 
pBSSE1412 T7 993 apramycin resistance 
gene 
Cloning vector 
pSET152 
 
856-98 99 258 6-258 CAC93947 
 
pBSSE1413 T3 - - - - - - - - 
pBSSE1413 T7 965 putative 
monooxygenase, 
momA-like 
Streptomyces 
cinnamonensis 
385-696 30 206 30-152 CAL34085 
 
pBSSE1414 T3 - - - - - - - - 
pBSSE1414 T7 962 LacZ alpha peptide Cloning vector 
pYESW29 
596-1066 100 191 28-184 ABI35978 
 
          The clones utilised for subcloning are located at the library coordinates 14B5 (cosmid 11) and 18C7 (cosmid 14).  
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4.2.8.3 Appraisal of subcloning results 
The obtained sequence data (table 4.7) were analysed to identify open reading frames 
(5.5.12.5). The predictions of these protein coding regions are listed in table 4.8. The putative 
organisation of the identified open reading frames (ORFs) within the genome of Streptomyces 
sp. GW2/5831 in the region of the IB-00208 biosynthetic gene cluster is presented in figure 
4.34. It was not possible to arrange all sequence information from table 4.7 inside the cluster 
scheme. In cosmid 11 the content of sequenced DNA comprises 13.6 kb, covering one third of 
the insert. Subcloning of cosmid 14 yielded 19.5 kb of sequenced DNA that corresponds to 
one half of the insert size. Sequencing of 33.1 kb of genomic DNA from Streptomyces sp. 
GW2/5831 revealed 20 open reading frames encoding PKS-, -post PKS tailoring, -regulatory, 
-resistance and transport proteins as well as proteins with unassigned functions.  
 
Table 4.8: Proposed functions of ORFs putatively involved in the biosynthesis of IB-
00208  
 
ORF 
Amino 
Acids 
Proposed Protein 
Function 
Sequence Similarity 
(Protein, Origin) 
 
Identity 
Protein Accession 
Number 
ORF01 422 KSβ RubB, Streptomyces 
collinus 
67% AAG03068 
ORF02 428 KSα RubA, Streptomyces 
collinus 
79% AAG03067 
ORF03 143 rubromycin 
biosynthesis-related 
cyclase I 
RubE, Streptomyces 
collinus 
69% AAG03065 
ORF04 143 rubromycin 
biosynthesis-related 
cyclase II 
RubD, Streptomyces 
collinus 
60% AAQ08915 
ORF05 170 Flavin reductase 
domain-containing 
protein 
Franean1_6241, Frankia 
sp. EAN1pec 
46% YP001510489 
ORF06 311 Hypothetical protein 
from angucycline type II 
cluster 
Pd2U, Streptomyces sp. 
WP 4669 
50% AAO65359 
ORF07 312 short-chain 
dehydrogenase/reductase 
(SDR) 
Franean1_6815, Frankia 
sp. EAN1pec 
66% YP001511055 
ORF08 246 short-chain 
dehydrogenase/reductase 
(SDR) 
FabG, Frankia sp. 
EAN1pec 
 
40% YP001507428 
ORF09 566 FAD-dependent 
oxidoreductase 
Bcep18194 _C6708, 
Burkholderia sp. 383 
40% YP366401 
ORF10 345 Unknown Uncharacterised protein, 
Streptomyces fradiae 
36% P20187 
ORF11 115 Antibiotic biosynthesis 
monooxygenase 
BenJ, Streptomyces sp. 
A2991200 
38% CAM58802.1 
ORF12 249 3-oxoacyl-ACP 
reductase 
GrhO10, Streptomyces sp. 
JP95 
45% AAM33668 
ORF13 280 Regulatory protein SARP family pathway 
specific regulatory 
41% YP001827897 
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protein, Streptomyces 
griseus 
ORF14 246 Monooxygenase FdmL, Streptomyces 
griseus 
46% AAQ08922 
ORF15 353 O-methyltransferase FdmN, Streptomyces 
griseus 
52% AAQ08925 
ORF16 293 Dehydrogenase LlpS, Streptomyces 
tendae 
47% CAM34368.1 
ORF17 245 3-oxoacyl-ACP 
reductase 
LlpZIII, Streptomyces 
tendae 
58% CAM34370.1 
ORF18 323 Resistance protein daunorubicin resistance 
ABC-transporter ATPase 
subunit, Alkaliphilus 
metalliredigens  
57% YP_001321687 
 
ORF19 215 Transcriptional regulator PadR, Streptomyces 
avermitilis MA-4680 
43% BAC74421 
ORF20 206 Monooxygenase MomA, Streptomyces 
cinnamonensis 
30% CAL34085 
 
 
 0.3 kb 
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Figure 4.34: Genetic organisation of ORFs in the putative IB-00208 gene cluster deduced 
from the sequences of the cosmids 11 and 14. Each arrow represents the direction of 
transcription of an ORF (1-20), proposed functions are summarized in table 4.8. 
Restriction sites (NotI/ SacI) of the cosmid DNA are indicated by black triangles (▲), 
homologous regions are labelled by a black dashed line (----), gaps are marked with (//), 
fragment numbers are shown in bold, and the border between cosmids 11 and 14 is 
indicated by (/...). 
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Polyketide core genes 
The backbone of the polyketide structure is synthesised due to catalytic activity of a minimal 
PKS (KSα, KSβ, ACP). Genes belonging to the minimal PKS of the putative IB-00208 gene 
cluster are encountered within the sequenced fragments of the subclones. Parts of the KSα 
subunit are encoded on the fragments “pBSSE1405 T7” (6-156 aa) and “pBSSE1101 T3” 
(224-417 aa) that together represent ORF02. The query sequence of ORF02 shows a high 
identity (79%) to KSα subunits of other type II PKS systems from pentangular73 polyketides 
like rubromycin from Streptomyces collinus (RubA). The fragment “pBSSE1101 T3” contains 
an acyltransferase GHSxG motif around Ser350 that is typical for a KSα. Furthermore, 
“pBSSE1104 T7” and “pBSSE1110 T3” cover homologies to polyketide synthases and 
related proteins. The sequence on “pBSSE1104 T7”, designated as ORF01, encodes a part of 
the KSβ subunit similar to RubB (88-302 aa) in the rubromycin biosynthetic gene cluster. The 
sequence on “pBSSE1110 T3” is similar to polyketide modules and related proteins. 
Therefore it may harbour the so far undetected ACP component of the minimal PKS. The  
KSβ-encoding fragment “pBSSE1104” exhibits a size of approximately 5 kb, whereas the 
fragment “pBSSE1101 T3”, that is connected to “pBSSE1104” in the upstream direction, 
comprises approximately 14 kb. The resulting distance between the KS subunits and ACP 
would suggest a disconnected minimal PKS like described before for the griseorhodin and 
daunorubicin clusters (see regulatory and resistance genes). On the other hand it could also be 
the case that the ACP component follows downstream the KSβ on the unsequenced region of 
“pBSSE1104 T7”. The formation of a polyketide ring system is referred to catalytic activity 
of at least two cyclases.83 Two cyclases were identified on the subcloned fragments 
“pBSSE1410 T3” and “pBSSE1405 T7” holding sequence homologies to genes involved in 
the biosynthesis of pentangular polyketides. The sequence encoded on “pBSSE1410 T3” 
shows a high identity to the RubD (60%) and RubE (69%) putative polyketide cyclases 
(ORF04, ORF03) from the rubromycin cluster. A part of ORF3 (RubE, 45-140) is located on 
“pBSSE1405 T7”.  
 
PKS tailoring genes 
The tailoring genes that are detected inside the analysed sequences encode proteins involved 
in electron transfer reactions, except for one that putatively directs a methyltransferase 
reaction. As IB-00208 contains many oxygenated residues, enzymes that catalyse redox 
processes are expected. Parts of the fragments “pBSSE1411 T3” (1-167 aa) and “pBSSE1404 
T3” (183-249 aa) contain a sequence homologous to GrhO10 that has the proposed function 
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of a 3-oxoacyl-ACP reductase (ORF12). Interestingly, GrhO10 is described to code for an 
unusual type of ketoreductase of the SDR family that is found in gene clusters of pentangular 
polyketide pathways.73 The ORF17 that is spread between “pBSSE1402 T7” (38-172 aa) and 
“pBSSE1408 T7” (173-245 aa) exhibits similarity to the lysolipin LlpZIII 3-oxoacyl-ACP 
reductase from Streptomyces tendae. Another similarity to the lysolipin cluster is detected in 
ORF16 that is functionally related to the dehydrogenase LlpS on the protein level. The 
sequences on “pBSSE1406 T3” and “pBSSE1407 T7” produce alignments to proteins of the 
family of short-chain dehydrogenases/ reductases (SDRs) and are not further characterised 
(ORF07, ORF08). As monooxygenases transfer oxygen atoms to a substrate they are expected 
in the biosynthetic pathway of IB-00208. The ORF14 encodes a putative monooxygenase 
from Streptomyces griseus known as the producer of fredericamycin. Two other 
monooxygenases from Streptomyces strains are detected in ORF11 (“pBSSE1404 T3”) and 
ORF20 (“pBSSE1413”). ORF11 is similar to the BenJ antibiotic biosynthesis monooxygenase 
from the benastatin cluster, whereas ORF20 represents a MomA-like monooxygenase that is 
not further characterised. These oxygenases may play roles in common post-PKS tailoring 
steps.121 The transfer of methyl groups from the ubiquitous S-adenosyl-L-methionine (SAM) 
to nitrogen, oxygen or carbon atoms is frequently employed in bacteria, and is well known in 
Streptomycetes. As IB-00208 contains five methoxy groups, the presence of O-
methyltransferases was expected. The sequences “pBSSE1401 T7” (157-329 aa) and 
“pBSSE1408 T3” (21-147 aa) feature homology to the FdmN O-methyltransferase (ORF15) 
from the fredericamycin cluster.  
 
Regulatory and resistance genes 
The sequence of “pBSSE1403 T7” is similar to a PadR transcriptional regulator (ORF19). 
The sequence encoded in ORF13 belongs to the Streptomyces antibiotic regulatory protein 
(SARP) family.127 Proteins of this family bind to promoter regions to activate the transcription 
of downstream genes. They are part of many PKS systems, and they often contain a TTA 
codon involved in regulation. A TTA codon is present in the sequence of “pBSSE1411 T7” 
(ORF13). The gene encoded in ORF18 belongs to the branched-chain amino acid transport 
protein family within the large super family of ATP-binding cassette (ABC) transporter 
proteins.112 They are known to be responsible for the translocation of a variety of compounds 
across biological membranes. ABC transporters are involved in the extrusion of noxious 
substances, ranging from small ions to macromolecules. They therefore may be responsible 
for antibiotic resistance (drug transporter) or fulfil functions in primary metabolism. The 
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protein function of the sequence encoded on “pBSSE1403 T7” (ORF18) is annotated as a 
daunorubicin resistance ABC transporter ATPase component in the database. Many ABC 
transporters are detected on cosmid 11 that might contain mainly DNA beyond the cluster.  
 
Proteins with unknown functions 
Proteins with unknown functions (ORF06, ORF10) are similar to uncharacterised proteins 
from Streptomycetes.  
 
Outlook and prospects for future research  
The sequencing results of the cosmid DNA fragments from two of the positive clones from 
the library strongly suggest an involvement of the corresponding gene products in the 
biosynthesis of IB-00208. Although the presence of polyketide core genes, tailoring genes, 
regulation and resistance genes provides an indication of finding the demanded cluster, one 
must keep in mind that further experiments, like gene inactivation, are still necessary for 
proof of the actual function of the isolated DNA fragments.  
 
As no genes coding for sugar biosynthesis or sugar attachment were identified so far, the 
remaining DNA regions of the subclones should be analysed. Furthermore, screening of the 
cosmids should be attempted by chromosome walking.  
 
Another approach for generating a glycosylated compound could be the usage of biosynthetic 
gene cassettes for the heterologous production of several deoxyhexoses.128 Their transfer to 
polyketide aglycones could then be accomplished by utilising glycosylation engineering to 
replace the natural substituents.129-131  
 
A new candidate, IB-00208, is here described that belongs to the rare and barely investigated 
class of pentangular polyketides. IB-00208 carries an unusually high number of methyl 
groups. This class of pentangular polyketides includes compounds that exhibit unusual 
spiroketal moieties resulting from the cleavage of C-C bonds, like, for example, the heavily 
oxidised griseorhodin A.76 Members of this class share the pathway precursor collinone. 
Therefore it can be envisioned that either griseorhodin A can be glycosylated by a GT from 
the IB-00208 cluster or it can be considered possible that the griseorhodin tailoring genes76 
can be used to convert IB-00208 into a hybrid polyketide carrying the spiroketal 
pharmacophore.  
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In conclusion, the findings on the genetic level in this work so far correlate very well with the 
chemical structure of the molecule, and represent a basis for further investigations and 
modifications of the IB-00208 biosynthetic gene cluster from Streptomyces sp. GW2/5831. 
These insights contribute to polyketide research, and can be applied to tailored biosynthesis. 
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5 Materials and methods (experimental procedures) 
 
5.1 Chemicals, laboratory equipment and other materials 
5.1.1 Chemicals  
Table 5.1 Chemicals utilised in experiments of the present work   
Chemical Source 
Acetonitrile SDS GmbH, 76437 Rastatt 
Acetylpyridine adenine dinucleotide (APAD) Sigma-Aldrich, 82024 Taufkirchen 
Acrylamide   Carl Roth GmbH, 76185 Karlsruhe 
Agar Merck-Eurolab, 64295 Darmstadt 
Agarose, NEEO ultra Carl Roth GmbH, 76185 Karlsruhe 
Agarose, low melt Carl Roth GmbH, 76185 Karlsruhe 
L-Amino acid oxidase  Sigma-Aldrich, 82024 Taufkirchen 
Ammonia, liquid Merck-Eurolab, 64295 Darmstadt 
Ammonium chloride Merck-Eurolab, 64295 Darmstadt 
Ammonium molybdate heptahydrate  Merck-Eurolab, 64295 Darmstadt 
Ammonium peroxodisulfate (APS) Merck-Eurolab, 64295 Darmstadt 
Ammonium sulfate Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
Ampicillin Merck-Eurolab, 64295 Darmstadt 
Apramycin Sigma-Aldrich, 82024 Taufkirchen 
Asparagine   Merck-Eurolab, 64295 Darmstadt 
Aspartic acid Merck-Eurolab, 64295 Darmstadt 
Boric acid Merck-Eurolab, 64295 Darmstadt 
Bradford Reagent Sigma-Aldrich, 82024 Taufkirchen 
Bromophenol Blue Sigma-Aldrich, 82024 Taufkirchen 
Calcium chloride dihydrate Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
Calcium carbonate Merck-Eurolab, 64295 Darmstadt 
Casaminoacids  Life Technologies (Gibco BRL), 76131 Karlsruhe 
Catalase Sigma-Aldrich, 82024 Taufkirchen 
Chloramphenicol Sigma-Aldrich, 82024 Taufkirchen 
Chloroform SDS GmbH, 76437 Rastatt 
Coomassie® Brilliant Blue G250 Sigma-Aldrich, 82024 Taufkirchen 
Copper(II) chloride dihydrate Sigma-Aldrich, 82024 Taufkirchen 
Deoxynucleoside triphosphates (dNTP’s) 10 mM 
set of dATP, dCTP, dGTP, dTTP 
Invitrogen GmbH, 76131 Karlsruhe 
Deuterium oxide Deutero, 56288 Kastellaun 
Diethylaminoethyl-Sepharose® FF (DEAE)            GE Healthcare Bio-Sciences AB Uppsala, Sweden 
Dimethyl sulfoxide (DMSO) Carl Roth GmbH, 76185 Karlsruhe 
Dithiothreitol (DTT) Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
Ethanol SDS GmbH, 76437 Rastatt 
Ethidium bromide   Carl Roth GmbH, 76185 Karlsruhe 
Ethidium bromide solution (1%) Merck-Eurolab, 64295 Darmstadt 
Ethyl acetate  SDS GmbH, 76437 Rastatt 
Ethylenediamine-tetraacetic acid (EDTA) Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
Glacial acetic acid (99%) Merck-Eurolab, 64295 Darmstadt 
Glucose Merck-Eurolab, 64295 Darmstadt 
Glutamic acid  Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
Glutamine Sigma-Aldrich, 82024 Taufkirchen 
Glycerol Merck-Eurolab, 64295 Darmstadt 
Glycine  Carl Roth GmbH, 76185 Karlsruhe 
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Hydrazine  Merck-Eurolab, 64295 Darmstadt 
Instant Ocean® Aquarium Systems, 57400 Sarrebourg, France 
IPTG (Isopropyl-ß-D-thiogalactopyranoside) Carl Roth GmbH, 76185 Karlsruhe 
Iron(III) chloride hexahydrate Merck-Eurolab, 64295 Darmstadt 
Iron(II) sulfate heptahydrate Sigma-Aldrich, 82024 Taufkirchen 
Kanamycin Sigma-Aldrich, 82024 Taufkirchen 
Kanosamine Prof. Floss, Seattle, WA 98195, USA 
LMW-SDS Marker Kit GE Healthcare Bio-Sciences, 80807 München 
Lysozyme  Merck-Eurolab, 64295 Darmstadt 
Magnesium chloride hexahydrate Merck-Eurolab, 64295 Darmstadt 
Magnesium sulfate heptahydrate Merck-Eurolab, 64295 Darmstadt 
Malt extract Merck-Eurolab, 64295 Darmstadt 
Manganese chloride tetrahydrate  Merck-Eurolab, 64295 Darmstadt 
Mannitol Sigma-Aldrich, 82024 Taufkirchen 
Meat extract Carl Roth GmbH, 76185 Karlsruhe 
Mercaptoethanol Serva, 69115 Heidelberg 
Methanol SDS GmbH, 76437 Rastatt 
MOPS (3-morpholinopropanesulfonic acid) Sigma-Aldrich, 82024 Taufkirchen 
Nalidixic acid Sigma-Aldrich, 82024 Taufkirchen 
Nicotinamide adenine dinucleotide (ß- NAD+) Sigma-Aldrich, 82024 Taufkirchen 
Ninhydrine Merck-Eurolab, 64295 Darmstadt 
Nitrogen  Praxair Industriegase, 56659 Burgbrohl 
Nitrogen, liquid Institut für Strahlen- und Kernphysik, 53115 Bonn 
Orange G Sigma-Aldrich, 82024 Taufkirchen 
Orcinol Sigma-Aldrich, 82024 Taufkirchen 
Oxygen (99,5%) Praxair Industriegase, 56659 Burgbrohl 
Peptone  Carl Roth GmbH, 76185 Karlsruhe 
Phenol-chloroform-isoamyl alcohol mixture 
(25:24:1) 
Carl Roth GmbH, 76185 Karlsruhe 
Phenylmethanesulfonyl fluoride (PMSF) Sigma-Aldrich, 82024 Taufkirchen 
Potassium acetate (KOAc) Carl Roth GmbH, 76185 Karlsruhe 
Potassium chloride Carl Roth GmbH, 76185 Karlsruhe 
Potassium dihydrogen phosphate Merck-Eurolab, 64295 Darmstadt 
di-Potassium hydrogen phosphate Merck-Eurolab, 64295 Darmstadt 
Potassium sulfate Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
L-Proline Merck-Eurolab, 64295 Darmstadt 
2-Propanol Merck-Eurolab, 64295 Darmstadt 
Pyridine Merck-Eurolab, 64295 Darmstadt 
Pyridoxal 5`-phosphat (PLP) Sigma-Aldrich, 82024 Taufkirchen 
Sodium acetate Carl Roth GmbH, 76185 Karlsruhe 
Sodium chloride Merck-Eurolab, 64295 Darmstadt 
Sodium dodecyl sulfate (SDS) Carl Roth GmbH, 76185 Karlsruhe 
Sodium hydroxide Merck-Eurolab, 64295 Darmstadt 
Sodium hydroxide solution 50% Sigma-Aldrich, 82024 Taufkirchen 
Sodium tetraborate  Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
Soytone    Difco Laboratories, Detroit, MI 48288, USA 
Starch from potato, soluble Sigma-Aldrich, 82024 Taufkirchen 
Sucrose  Merck-Eurolab, 64295 Darmstadt 
TES-buffer (N-[Tris(hydroxymethyl)methyl]-2-
aminoethanesulfonic acid) 
Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
Tetramethylethylenediamine (TEMED) Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
Thiostrepton Sigma-Aldrich, 82024 Taufkirchen 
Trifluoroacetic acid (TFA) Merck-Eurolab, 64295 Darmstadt 
Tris-Base (Tris-[hydroxymethyl]-aminomethane) Merck-Eurolab, 64295 Darmstadt 
Tryptone Carl Roth GmbH, 76185 Karlsruhe 
UDP-galactose Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
 Materials and methods 
  75 
 
UDP-glucose Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
UDP-glucose epimerase Calbiochem (Merck KgaA), 64293 Darmstadt 
UDP-kanosamine Prof. Floss, Seattle, WA 98195, USA 
X-gal (5-bromo-4-chloro-3-indolyl-ß-D-
galactopyranoside) 
Life Technologies (Gibco BRL), 76131 Karlsruhe 
Xylene Cyanol FF Sigma-Aldrich, 82024 Taufkirchen 
Yeast Extract (Select®) Life Technologies (Gibco BRL), 76131 Karlsruhe 
Zinc(II) chloride Fluka/ Sigma-Aldrich, 82024 Taufkirchen 
Zinc(II) sulfate heptahydrate Sigma-Aldrich, 82024 Taufkirchen 
 
5.1.2 Molecular biological kits, enzymes and molecular weight markers 
Table 5.2 Reagent sets used in the present work  
Name Manufacturer 
Epicentre® CopyControl™ Fosmid Library 
Production Kit CCFOS110 
Epicentre Biotechnologies, Madison, WI 53713, 
USA 
First Strand cDNA Synthesis Kit Fermentas GmbH, 68789 St. Leon-Roth 
QIAquick Gel Extraction Kit Qiagen GmbH, 40724 Hilden 
RNeasy® Mini Kit Qiagen GmbH, 40724 Hilden 
 
Table 5.3 Enzymes employed in molecular biological experiments 
Enzyme Manufacturer 
Antarctic phosphatase New England Biolabs, 65926 Frankfurt  
Bovine serum albumin (BSA) New England Biolabs, 65926 Frankfurt  
DNase (RNase-free) Promega, 68199 Mannheim 
GoTaq® DNA Polymerase (5u/µl) Promega, 68199 Mannheim 
RNAse A Invitrogen GmbH, 76131 Karlsruhe 
T4 DNA Ligase New England Biolabs, 65926 Frankfurt 
Restriction endonucleases 
BamHI New England Biolabs, 65926 Frankfurt 
EcoRV New England Biolabs, 65926 Frankfurt 
NotI New England Biolabs, 65926 Frankfurt 
RsaI Jena Bioscience GmbH, 07749 Jena 
SacI New England Biolabs, 65926 Frankfurt 
ScaI Jena Bioscience GmbH, 07749 Jena 
Enzymes included in molecular biological kits (5.1.2) are not listed here. 
 
 
 
Table 5.4 Molecular weight markers for gel electrophoresis 
Name Source 
1 Kb DNA Ladder Invitrogen GmbH, 76131 Karlsruhe 
1 Kb DNA Extension Ladder  Invitrogen GmbH, 76131 Karlsruhe 
GeneRuler™ DNA Ladder Mix Fermentas, 68789 St-Leon-Rot 
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5.1.3 Laboratory equipment and other materials 
Table 5.5 Laboratory equipment 
Facility Manufacturer 
Analytical balances Mettler, 35353 Gießen; Sartorius, 37075 
Göttingen 
Analytical column Carbopac™ PA-10 Dionex, Sunnyvale, CA 94085, USA 
Centrifuges 5804R, 5417R Eppendorf, 22339 Hamburg 
Centrifuge Rotina 35R Hettich, 78532 Tuttlingen 
Clean bench Laminar Airflow BSB 4A Gelaire Flow Laboratories, 53340 Meckenheim 
Clean bench Kojair Biowizard Class II Kojair, 35700 Vilppula, Finland 
Digital camera DC 90 Kodak, 70327 Stuttgart 
FPLC fraction collector Frac-900 GE Healthcare Bio-Sciences AB Uppsala, Sweden 
FPLC pump Äkta™ P-920 GE Healthcare Bio-Sciences AB Uppsala, Sweden 
FPLC UV monitor UPC-900 GE Healthcare Bio-Sciences AB Uppsala, Sweden 
Gel documentation Syngene gene genius Bio 
imaging system 3088S Imager 
Frederick, MD 21704, USA 
Gel electrophoresis systems Biometra, 37079 Göttingen; Bio-Rad, Hercules, 
CA 94547, USA 
HPLC detector (ED-40) Dionex, Sunnyvale, CA 94085, USA 
HPLC pump (GP-40) Dionex, Sunnyvale, CA 94085, USA 
Microbiological incubators WTB Binder GmbH, 78532 Tuttlingen; Heraeus 
63450 Hanau 
Microbiological incubator shaker Certomat BS-1 Sartorius, 37075 Göttingen 
Microbiological incubator shaker HT Infors Infors AG, CH-4103 Bottmingen, Schweiz 
MicroPulser™ Electroporator Bio-Rad, Hercules, CA 94547, USA 
Milli-Q® Water System Millipore, 65760 Eschborn 
Mixer uzusio VTX-3000L LMS Laboratory and Medical Supplies, 78086 
Brigachtal 
NMR Bruker Avance 300 DPX Bruker, 76287 Rheinstetten 
NMR Bruker DPX 500 Bruker, 76287 Rheinstetten 
PCR thermo cycler T3  Biometra, 37079 Göttingen 
PCR thermo cycler TGradient Biometra, 37079 Göttingen 
PH meter 766 Calimatic Knick GmbH, 14163 Berlin 
Polyacrylamide gel electrophoresis Maxigel 
system  
Biometra, 37079 Göttingen 
Spectral photometer Biomate3 Thermo Electron/ Thermo Fisher Scientific, 
Waltham, MA 02454, USA 
Spectral photometer Uvikon 860 Kontron, 85386 Eching- München 
Steam autoclave V65 Systec GmbH, 35435 Wettenberg 
Steam autoclave Varioklav  H+P, 85764 Oberschleißheim 
Thermomix comfort Eppendorf, 22339 Hamburg 
Ultra-low temperature freezer VIP series –86 °C Sanyo, Bensenville, IL 60106, USA 
Ultrasonic disintegrator Sonifier model 250 Branson, Danbury, Connecticut, USA 
Ultraviolet crosslinker CL-1000 UVP UVP Inc., Upland, CA 91786, USA 
Vacuum concentrator Speed Vac Plus SC110A Thermo Electron/ Savant 
Waltham, MA 02454, USA 
Vacuum concentrator 5301 Eppendorf, 22339 Hamburg 
Water bath GFL 1083 GmbH für Labortechnik, 30938 Burgwedel 
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Table 5.6 Expendable items and other materials  
Material Vendor 
Amicon Ultra 15 centrifugal filter units Millipore, Bedford, MA 01730, USA 
Amprep Octa decyl mini columns GE Healthcare Bio-Sciences AB Uppsala, Sweden 
Falcon™  tubes for centrifugation BD Biosciences, Fa. Faust, 53340 Meckenheim 
Membrane filters 0,2 µm Schleicher und Schüll, 37586 Dassel 
Nalgene® cryogenic vials  via Fa. Faust, 53340 Meckenheim 
Parafilm® (American National Can) via Fa. Brand  
46562 Voerde-Friedrichsfeld 
Petri dishes Greiner Bio-One GmbH, 45326 Essen 
Pipet tips Sarstedt, 51582 Nümbrecht 
Reaction vessels (0,2 ml, 0,5 ml, 1,5 ml, 2,0 ml)  Fa. Eppendorf, 22339 Hamburg 
Sephadex™ G-25 solid phase extraction columns 
(PD-10) 
GE Healthcare Bio-Sciences AB Uppsala, Sweden 
TLC silica gel (Merck 60 F254) Merck, 64295 Darmstadt 
UV cuvettes   Ratiolab GmbH, 63303 Dreieich-Buchschlag 
 
5.1.4 Sterilisation of solutions and equipment 
Sterilisation of media, buffers and glassware was carried out using a steam autoclave 
(normally at 121 °C, 20 min). Temperature-sensitive solutions were sterilised with Millipore 
filters exhibiting a pore size of 0.22 µm.  
5.1.5 Preparation of Millipore® water 
Deionised water obtained from a Milli-Q Water System was used for all applications. For 
molecular biology techniques this water was additionally autoclaved.  
5.1.6 Clean room conditions 
Tasks that required clean room conditions were conducted under a class II laminar airflow 
cabinet. 
 
5.2 Biological material, plasmids and oligonucleotides 
 
Table 5.7 Bacterial strains used in biosynthetic studies 
Name Genotype Function Source 
Streptomyces lividans 
TK24 
str-6, SLP2-, SLP3- Host strain for 
heterologous expression 
or negative control 
HKI Jena 
Streptomyces lividans 
TK23 
spc-1, SLP2-, SLP3- Host strain for 
heterologous expression 
or negative control 
HKI Jena 
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Table 5.8 Recombinant strains for biosynthetic studies 
Host strain Inserted plasmid 
Streptomyces lividans TK24 pHGF7604  
Streptomyces lividans TK23 pHGF7604  
Streptomyces lividans TK23 pHGF/pNEB rifK, L, M 
Streptomyces lividans TK23 pHGF/pNEB rifK*, L, M 
Streptomyces lividans TK23 pHGF/pNEB rifL, M 
Streptomyces lividans TK23 pHGF empty plasmid (1,48 kb), without rif- 
genes, as a negative control 
 
Table 5.9 Bacterial strains used in PKS project 
Name Genotype Function Reference or source 
Streptomyces sp. 
GW2/5831 
 - Donor strain for gene 
library 
Prof. Laatsch, 
Göttingen 
Streptomyces albus 
J1074 
- Host strain for 
heterologous expression 
after conjugal transfer 
Waksman and Henrici 
(1943)132 
E. coli EPI300 T1R F ¯ mcrA ∆(mrr-
hsdRMS-
mcrBC)φ80dlacZ∆M15∆ 
lacX74 recA1 endA1 
araD139 ∆(ara, 
leu)7697 galU galK λ¯ 
rpsL nupG trfA tonA dhfr 
Host strain for DNA 
fragments of gene 
library 
Epicentre, Madison, 
WI 53713, USA 
E. coli 
ET12567/pUZ8002 
dam-, dcm-, hsdS-, cat, 
tet, Cmr, Kanr 
Non-methylating 
plasmid donor strain for 
intergeneric conjugation 
Flett et al. (1997)133 
MacNeil et al. 
(1992)124 
E. coli XL1 blue recA1 endA1 gyrA96 thi-
1 hsdR17 supE44 relA1 
lac [F’ proAB 
laclqZ∆M15 Tn10 (Tetr)] 
Host strain for 
subcloning of DNA 
fragments 
Stratagene, La Jolla, 
CA 92037, USA 
 
 
Table 5.10 Plasmids applied in this work 
Vector Biological property Size Reference or source 
Plasmids used in the kanosamine project 
pHGF7604 rifG-N Shuttle vector, ColE1-
origin, Ampr (selection in 
E. coli); SCP2*-origin, 
Thior (selection in 
Streptomyces), genes rifG-
N under actII-orf4 
promoter 
22.3 kb Yu et al. (2001)66 
 
pHGF/pNEB rifK, L, M 
 
Shuttle vector, ColE1-
origin, Ampr (selection in 
E. coli); SCP2*-origin, 
Thior (selection in 
Streptomyces), genes 
rifK,L,M under actII-orf4 
promoter 
19.2 kb Kaulard (2006)85 
pHGF/pNEB rifL, M Shuttle vector, ColE1-
origin, Ampr (selection in 
E. coli); SCP2*-origin, 
Thior (selection in 
17.8 kb Kaulard (2006)85 
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Streptomyces), genes 
rifL,M under actII-orf4 
promoter 
pHGF/pNEB rifK*, L, 
M 
Shuttle vector, ColE1-
origin, Ampr (selection in 
E. coli); SCP2*-origin, 
Thior (selection in 
Streptomyces), genes 
rifL,M under actII-orf4 
promoter, rifK* point 
mutated 
19.2 kb Kaulard (2006)85 
 
pHGF empty plasmid 
(1,48 kb) 
1480 bp fragment of 
promoter region of 
pNEB193C in pHGF7604 
without rif gene cassette 
16 kb Kaulard (2006)85 
 
Plasmids used for the characterisation of the IB-00208 gene cluster 
pAY1 shuttle vector, Aprar, oriT 9.4 kb Li and Piel (2002)83 
pBluescript II SK(+) cloning vector 
Ampr, lacZ 
3 kb Stratagene, La Jolla, CA 
92037, USA 
ET12567/pUZ8002 helper plasmid, Cmr/Kanr  Flett et al. (1997)133 
 
 
Table 5.11 PCR primer 
Primer name DNA- sequence 
(5`- 3`) 
Melting point 
T (°C) 
Number of base 
pairs 
Reference 
Primer pairs for amplification of oxidoreductase gene rifL 
Oxidofw 
(degenerate) 
GCG GTG GTC 
GGG CTC GGS 
TGG G 
 
80,0 22 Boettcher (2003)72 
Oxidorv 
(degenerate) 
 
GGT TSG GGC 
TGA AGC CGA 
AGG TGC 
 
80,0 
 
24 Boettcher (2003)72 
 
RT-PCR-
Oxido_for 
(homologous) 
GCG GTC GTC 
GGG CTC GGC 
TGG G  
 
73,3 22 
 
Yu et al. (2001)66 
NCBI- accession-
no. AAS07754 
 
RT-PCR-
Oxido_rev 
(homologous) 
GGT TGG GGC 
TGA AGC CGA 
AGG TGC 
69,6 24 Yu et al. (2001)66 
NCBI- accession-
no. AAS07754 
Primer pairs for amplification of a PKS fragment in analysis of the cosmid gene library 
KS2F YGS YGC SAR 
TGC GAC TTC G 
51 19 Li and Piel 
(2002)83 GenBank- 
accession no. 
AF509565 
KS2R CCG AYC ATS 
GAC TTG ATG 
GAG C 
53 22 Li and Piel 
(2002)83 GenBank- 
accession no. 
AF509565 
KS4F GAG GCS VTC 
GMS GAC AGC 
GG 
57 20 Li and Piel 
(2002)83 GenBank- 
accession no. 
AF509565 
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KS1R AGT CSA GGT 
CRC AYT CSG 
GGT C 
55 22 Li and Piel 
(2002)83 GenBank- 
accession no. 
AF509565 
BES1 T7 1F 2F 
(homologous) 
TCG ACT TGA 
TGG AGC TGA 
CC 
60.2   20 this work 
BES1 T7 1F 2R 
(homologous) 
GGG CTG GAG 
GAG GAG TAC 
AT 
59.4   20 this work 
Primer pair for spot-sequencing of the positive cosmid clones 
AY1ES1 Forward AGC ACG CCA 
TAG TGA CTG 
GC 
(51) 20 this work 
AY1ES1  
Reverse 
TTT CAC ACA 
GGA AAC AGC 
TA 
(43) 20 this work 
The following letter code was used to indicate base variables in degenerate primer sequences: Y=C,T/ 
S=C,G/ R=A,G/ M=A,C/ V=G,A,C 
 
Primers for rifL studies were supplied by MWG Biotech (Eggenstein) in a lyophilised form, 
and were redissolved in TE buffer yielding a concentration of 20 µM/L.  
 
Primers for PKS studies were supplied by Invitrogen™ (Karlsruhe) in a lyophilised form, and 
were redissolved in TE buffer yielding a concentration of 50 µM/L.  
 
 
5.3 Buffers and solutions 
Table 5.12 Buffers for enzyme purification 
Buffer Composition Ionic strength/ 
concentration (m/v) 
pH- value 
Lysis buffer 
 (Gomori, 1955) 
Potassium phosphate 
buffer 
0,1 M pH 7,5 
FPLC- buffer A Tris- HCl 
EDTA 
DTT 
in Glycerol 
25 mM 
  1 mM 
  2 mM 
  10% 
pH 7,4 
 
FPLC- buffer B Tris- HCl 
EDTA 
DTT 
NaCl 
in Glycerol 
25 mM 
  1 mM 
  2 mM 
     1 M 
10% 
pH 7,4 
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Table 5.13 Buffers and solutions for SDS-PAGE and staining of PA matrix 
Name Composition Comment  
denaturing loading 
buffer (5x) 
Glycerol 87 % 
Mercaptoethanol 
SDS 
Bromophenol blue 1%  
(m/ v) 
Tris-HCl (1,9 M;  
 pH 6,8) 
5,75 g 
2,5 ml 
9,0 g 
0,1 ml 
 
1,65 ml 
Ingredients were mixed 
and heated until 
completely dissolved, 
stored at 4-8 °C, 
warmed up to room 
temperature before use 
APS-solution 20 % Ammonium peroxodisulfate 
H2O 
2,0 g 
ad 10 ml 
Store at –20 °C  
Stacking gel buffer SDS 
Tris-HCl 
0,4 % (m/v) 
0,5 M 
pH 6,8 
Resolving gel buffer SDS 
Tris-HCl 
0,4 % (m/v) 
1,5 M 
pH 8,8 
Electrophoresis buffer 
(5x) 
Glycine 
Tris-HCl 
SDS 
0,96 M 
0,125 M 
0,5 % (m/ v) 
pH 8,5 
Coomassie staining 
solution 
Coomassie Brilliant blue 
G250 
Glacial acetic acid (100%) 
Methanol 
1 g/ l 
 
75 ml/ l 
200 ml/ l 
 
Colour stripping 
solution 
Glacial acetic acid (100%) 
Methanol 
75 ml/ l 
200 ml/ l 
 
Stacking gel matrix 
4 % 
Stacking gel buffer  
Acrylamide solution 40%  
H2O 
APS (20%) 
TEMED 
2,5 ml 
1,0 ml 
6,4 ml 
75 µl 
15 µl 
Components 1-3 were 
mixed and degassed, 
after adding of APS 
and TEMED directly 
poured into glass 
chamber 
Resolving gel matrix 
13,5 % 
Resolving gel buffer 
Acrylamide solution 40% 
H2O 
APS (20%) 
TEMED 
10 ml 
13,4 ml 
16,4 ml 
200 µl 
25 µl 
Prepared as above, 
covered with a layer of 
butanol, polymerised 
over night 
 
Low molecular weight 
marker 
Phosphorylase B (97,4 kDa) 
BSA (66,2 kDa) 
Ovalbumin (42,7 kDa) 
Carbohydrase (31 kDa) 
Soy bean trypsin inhibitor 
(21,5 kDa) 
Lysozyme (14,4 kDa) 
  
 
 
 
Table 5.14 Buffers for MALDI-TOF-MS sample preparation 
Name Composition 
Buffer A TFA 0.1% 
Buffer B Acetonitrile 90%, TFA 0.085% 
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Table 5.15 Buffers for DNA, RNA and plasmid DNA isolation 
Name Composition 
Buffer P1 50 mM Tris-HCl (pH 8) 
10 mM EDTA 
100 µg/ml RNAse A (heated at 99 °C for 1 min 
prior to addition to buffer to remove DNAse 
activity) 
Buffer P2 200 mM NaOH 
1% SDS 
Buffer P3 3 M KOAc (pH 5.5) 
STE buffer 300 mM Sucrose 
25 mM Tris-HCl (pH 8) 
25 mM EDTA (pH 8) 
Lysozyme 5 mg/ml 
TE buffer 10 mM Tris-HCl (pH 8) 
1 mM EDTA (pH 8) 
 
 
Table 5.16  Buffers for native agarose gel electrophoresis 
Name Composition Preparation 
Loading buffer (6x) 
 
Bromophenol 
Blue 
Xylene cyanol 
Orange G 
Glycerol 
0.05% 
 
0.05% 
0.05% 
30% 
 
TAE buffer (50x), pH 8.5 Tris-HCl 
Glacial acetic 
acid 
EDTA (0.5 M)
  
242 g 
57.1 ml 
 
100 ml 
 
TBE buffer (10x), pH 8.0 Tris 
Boric acid 
EDTA (pH 8) 
0.90 M 
0.90 M 
0.02 M 
pH adjustment with HCl 
 
 
Table 5.17 Solutions for preparation of competent cells by chemical method 
Name Composition 
TFB I 
 
 
 
 
TFB II 
 
 
 
Potassium acetate          30 mM 
Calcium chloride           10 mM 
Potassium chloride      100 mM 
Manganese chloride      50 mM 
Glycerol                          15% 
MOPS (Sigma)              10 mM 
Calcium chloride           75 mM 
Potassium chloride        10 mM 
Glycerol                          15% 
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5.4 Microbiological methods 
5.4.1 Culture media and antibiotics 
Table 5.18  Media for cultivation and preservation of bacteria 
Medium Composition Annotation/remark/comment 
R5 medium 
(Thompson et al., 
1980) modified 
K2SO4 
MgCl2 x 6 H2O 
Glucose 
Casaminoacids 
Trace element solution 
Yeast extract 
TES buffer 
KH2PO4 (0,5%) 
CaCl2 x 2 H2O (5 M)1 
L-Proline (20%)2 
NaOH (1 M)3 
  0,25 g 
10,12 g 
10,00 g 
  0,10 g 
     2 ml 
   5,00 g 
   5,73 g 
10,0 ml 
  4,0 ml 
15,0 ml 
  7,0 ml 
 
 
 
 
 
 
 
 
 
1, 2, 3)
 Added after autoclaving 
Trace element 
solution 
 
ZnCl2 
FeCl3 x 6 H2O 
CuCl2 x 2 H2O  
MnCl2 x 4 H2O  
NaB4O7 x 10 H2O 
(NH4)6Mo7O24 x 4 
H2O 
  40 mg 
200 mg 
  10 mg 
  10 mg 
  10 mg 
  10 mg 
 
 
M2 medium (=YMG) Yeast extract 
Malt extract 
Glucose 
Agar 
   4,0 g 
 10,0 g  
   4,0 g 
 16,0 g 
pH 7.8 
Stock culture medium 
for Streptomyces 
 
Glycerol  15% (m/v)  
Stock culture medium 
for E. coli 
Glycerol 30% (m/v)  
Meat extract medium Glucose 
Peptone from meat 
Yeast extract 
Meat extract 
Instant Ocean® 
10 g 
2 g 
1 g 
1 g 
7.5 g 
pH 7.8 
TSB medium Tryptic Soy Broth  30 g  
MS medium 
(Hobbs et al., 1989) 
Mannitol 
Soya flour 
20 g 
20 g 
autoclave twice at 115 °C for 
15 min with gentle shaking 
between the two runs 
2CM medium 
(Yuan, 1983) 
NaCl 
K2HPO4 
Potato starch, water-
soluble 
Salt solution 
Mg2SO4 x 7 H2O 
Tryptone  
CaCO3 
(NH4)2SO4  
Agar 
1 g 
1 g 
10 g 
 
1 ml 
2 g 
2 g 
2 g 
2 g 
22 g 
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Salt solution  FeSO4 x 7 H2O 
MgCl2 x 6 H2O 
ZnSO4 x 7 H2O  
1 g 
1 g 
1 g 
 
 
DSG medium 
(Kieser et al., 2000) 
Yeast extract 
Casaminoacids  
CaCl2 (5M) 
10 g 
10 g 
2 ml 
 
LB medium 
(Bertani, 1951) 
NaCl 
Tryptone 
Yeast extract 
10 g 
10 g 
5 g 
pH 7 
Quantities are listed for the preparation of 1 liter solutions 
 
 
 
Table 5.19 Antibiotics for the counterselection of recombinant strains 
Antibiotic Concentration 
Medium (µg/ ml) 
Concentration 
Stock solution (mg/ 
ml) 
solvent 
Ampicillin 100 100 water 
Apramycin 50 50 water 
Chloramphenicol 25 25 ethanol 
Kanamycin 25 25 water 
Nalidixic acid  - 1 water 
Thiostrepton 20 50 DMSO 
 
 
5.4.2 Cultivation and long term storage of Streptomyces lividans strains 
Streptomyces lividans strains were used for biosynthetic studies of RifL oxidoreductase.  
 
5.4.2.1 Cultivation of Streptomyces lividans on solid medium 
 
For plating on YMG agar (table 5.18), 100 µl of a stock culture (5.4.2.3) were used. The 
selection of recombinant Streptomyces lividans strains was accomplished by the addition of 
thiostrepton in a concentration of 20 µg/ml medium. The petri dish, containing approximately 
30 ml of medium, was incubated at 28 °C for 7 days.  
 
5.4.2.2 Cultivation of Streptomyces lividans in nutrient solution 
 
Bacterial growth in liquid culture was initiated by a slice of agar (1 cm2) obtained in 5.4.2.1. 
A sterile 500 ml baffled flask was filled with 50 ml of R5 medium containing 20 µg/ml 
thiostrepton when required for the recombinant strains. The baffles provided sufficient 
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aeration of the culture broth. The flasks were covered with aluminium foil. The cells were 
harvested for expression studies after shaking at 180 rpm and 28 °C for 5 days (5.4.7).  
 
Alternatively 500 µl of a stock solution from a permanent culture (5.4.2.3) were used to 
inoculate liquid cultures of Streptomyces lividans strains.  
 
5.4.2.3 Long term storage of Streptomyces lividans strains 
 
A liquid culture (5.4.2.2) was incubated for three days. Sedimentation was carried out at 5000 
rpm and 4 °C for 15 minutes. Subsequent washing with 20 ml of a 15% glycerol solution was 
followed by sedimentation at 5000 rpm and 4 °C for 15 minutes and resuspension in a 10 ml 
glycerol solution. Aliquots of 1 ml were transferred to Nalgene® cryo tubes and stored at –80 
°C. All steps were carried out under sterile conditions. 
 
5.4.3 Cultivation of Streptomyces sp. GW2/5831 
Streptomyces sp. GW2/5831 and Streptomyces albus J1074 were employed in polyketide 
studies.  
 
5.4.3.1 Cultivation of Streptomyces sp. GW2/5831 for the production of the red-coloured 
polycyclic xanthone IB-00208  
 
The fermentation protocol was kindly provided by F. Lissy from the work group of Prof. 
Laatsch in Göttingen.  
 
An agar slant of Streptomyces sp. GW2/5831 was used for the inoculation of solid M2 
(=YMG) medium, whereas meat extract medium was employed for the production of the red-
coloured compound in liquid broth. The cultures were incubated for 18 days at 28 °C, and 95 
rpm respectively.  
 
5.4.3.2 Cultivation of Streptomyces sp. GW2/5831 for genomic DNA isolation  
 
The bacterial strain was grown in tryptic soy broth (TSB) at 28 °C and 95 rpm for 18 days. 
For the isolation of genomic DNA the cells were harvested by centrifugation at 5000 rpm 
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under sterile conditions. Approximately 100 mg of pelleted bacterial cells were used for 
genomic DNA isolation (5.5.1). The excess of cell material was stored at –20 °C for later use.  
5.4.4 Preparation of a spore suspension from Streptomyces albus for conjugation 
Streptomyces albus was inoculated on a MS agar plate and incubated at 30 °C for 7 days. The 
mould was then transferred to 2 ml of 20% glycerol using a sterilised Q-tip. The concentration 
of the spore suspension was estimated by means of a dilution series that was obtained by 
plating of different amounts of spores.  
 
5.4.5 Cultivation and long term storage of recombinant Streptomyces albus 
strains 
 
5.4.5.1 Cultivation of conjugated Streptomyces albus strains for the isolation of genomic 
DNA  
Conjugated Streptomyces albus strains were inoculated in 20 ml LB medium including 500 µl 
of a 20% Glycine solution. The flasks were each equipped with a metal coil. After 20-24 
hours of cultivation at 30 °C and 200 rpm, 1 ml of liquid culture was used for genomic DNA 
isolation (5.5.1). The remaining culture broth was harvested by centrifugation at 5000 rpm 
under sterile conditions, and was stored at –20 °C for later use.  
 
5.4.5.2 Cultivation of conjugated Streptomyces albus strains for monitoring of potential 
secondary metabolite producing recombinants  
For the observation of a potential colour change of the liquid medium or agar plate due to 
secondary metabolite production, conjugated strains were inoculated in and on different 
media. Liquid cultures were set up in meat extract and LB nutrient broth, whereas agar plates 
were established using 2CM, MS, M2 and LB medium.  
 
5.4.5.3 Cultivation of conjugated Streptomyces albus strains for selection of incoming 
cosmid 
Conjugated Streptomyces albus strains were spread on LB agar plates containing 50 µg/ml 
apramycin. 
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5.4.5.4 Preservation of conjugated Streptomyces albus strains 
Conjugated Streptomyces albus strains were grown on MS agar plates for 7 days at 30 °C. A 
sterile Q-tip was used to transfer the mould to a tube that contained 15% glycerol solution. 
These stock cultures were stored at –80 °C.  
5.4.6 Cultivation and long term storage of recombinant E. coli strains 
Recombinant E. coli strains were inoculated in 3 ml cultures of LB medium containing the 
appropriate antibiotic in the required concentration. Inoculation was carried out using a 
sterilised tooth pick that remained in the culture broth. These cultures were grown for 16 
hours at 37 °C, and were then utilised for the preparation of plasmid DNA (5.5.2). Stock 
cultures were produced by mixing 750 µl of overnight culture with the same amount of 30% 
glycerol solution. These stock cultures were stored at –80 °C. 
5.4.7 Growth kinetics of Streptomyces lividans  
Cultures for protein expression studies were harvested at the end of the exponential growth 
phase. To determine the specific time of the end of exponential growth phase, a set of ten 
liquid cultures (5.4.2.2), representing different growth phases, was inoculated during ten 
consecutive days. On the eleventh day all cultures were subjected to cell-free extract 
production (5.6.1) and spectrophotometric measurement (5.6.6). Cell free extract production 
was accompanied by weight determination of the cell pellet. Therefore, bacterial growth was 
simultaneously documented by quantity. Measurement of the optical density of a cell 
suspension is not suitable in this case, because Streptomyces tend to aggregate in liquid 
cultures.  
 
5.5 Molecular biological methods 
5.5.1 Isolation of genomic DNA from gram positive bacteria 
A Streptomyces culture consisting of 20 ml LB medium including 500 µl of a 20% glycine 
solution was incubated with shaking at 200 rpm and 37 °C. After 24 hours (for Streptomyces 
sp. GW2/5831 see chapter 5.4.3.2) 1 ml was removed from the flask and centrifugation was 
carried out in a 2 ml Eppendorf tube at 14000 rpm for 30 seconds. The supernatant was 
discarded, and the pellet was resuspended in 500 µl of STE buffer containing 2.5 mg 
lysozyme. This mixture was incubated at 37 °C and 200 rpm for 3 hours. After the addition of 
500 µl of 10% SDS solution and 100 µl of 3 M sodium acetate pH 5.3 and vigorous mixing, 
incubation was continued for 45 minutes. The samples were then extracted three times with a 
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mixture of phenol-chloroform-isoamyl alcohol (25:24:1). The aqueous layer above the protein 
interphase was carefully transferred to 600 µl isopropyl alcohol and was vortexed heavily. 
High molecular weight DNA was recovered after centrifugation at 10000 rpm for 2 minutes. 
The pellet was rinsed with 500 µl of 70% ice cold ethanol, dried at room temperature and 
dissolved in 30 µl TE buffer (pH 8). The DNA quality (size and concentration) was 
determined on an agarose gel (5.5.4.1).  
 
5.5.2 Isolation of plasmid and cosmid DNA   
The isolation of plasmid or cosmid DNA from recombinant E. coli cells was carried out 
according to the method described by Birnboim and Doly with slight modifications.134 The 
modified alkaline lysis procedure of the cells was performed as follows: 
 
A 1.5 ml of E. coli overnight culture (5.4.6) was centrifuged in a 1.5 ml Eppendorf tube at 
10000 rpm for 30 seconds. The harvested cell pellet was resuspended in 200 µl of buffer P1 
(table 5.15). For alkaline lysis 200 µl of buffer P2 were added, and the tube was inverted 
several times. After a maximum of 2 minutes 200 µl of buffer P3 were added to the lysate, 
after which the tube was inverted several times. The resulting precipitate was removed from 
the solution by centrifugation at 13000 rpm for 3 minutes. The supernatant was transferred to 
a 1.5 ml Eppendorf tube filled with 500 µl of chloroform. After vigorous mixing the sample 
was centrifuged at 13000 rpm for 5 minutes. A 300 µl of the aqueous upper layer were 
removed, omitting the protein interphase, and were then intensely mixed with 350 µl of 
isopropyl alcohol. After centrifugation at 13000 rpm for 20 minutes the supernatant was 
discarded. The DNA pellet was rinsed with 500 µl of ice cold 70% ethanol. The supernatant 
was removed and the pellet was vacuum-dried and dissolved in 30 µl of  MilliQ water.  
 
5.5.3 Purification, concentration and quantification of DNA 
 
5.5.3.1 Purification of vector DNA via phenol-chloroform extraction 
The DNA was extracted twice with a mixture of phenol, chloroform and isoamyl alcohol 
(25:24:1, v/v/v), followed by a single chloroform extraction. Between each step, 
centrifugation was carried out for 1 minute at 14000 rpm and room temperature. The 
supernatant was subjected to precipitation (5.5.3.2 to 5.5.3.4). 
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5.5.3.2 Purification and concentration of vector DNA by means of isopropyl alcohol 
precipitation 
The aqueous DNA solution was mixed with 1 volume of isopropyl alcohol and 1/10 volume 
of 3 M sodium acetate (pH 5) that provided the required monovalent cations. After storage at 
–20 °C for 30 minutes, centrifugation was performed at 14000 rpm and 4 °C for 45 minutes. 
The obtained pellet was rinsed two times with ice cold 70% ethanol, and sedimented at 14000 
rpm and 4 °C for 15 minutes. The vacuum-dried pellet was resuspended in 5 µl of purified 
water.  
 
5.5.3.3 Purification and concentration of insert DNA for library production by means of 
ethanol precipitation  
The aqueous DNA solution was gently mixed with 1/10 volume of 3 M sodium acetate (pH 
7), and 2.5 volume of room temperature-equilibrated 100% ethanol was added. After standing 
for 10 minutes, centrifugation was carried out for 40 minutes at 14000 rpm and room 
temperature. A small white pellet was visible, and approximately 95% of the supernatant was 
carefully removed. Approximately 5 ml of ice cold 70% ethanol were slowly added along the 
rim of the vessel. Sedimentation was performed at 4 °C and 11000 rpm for 20 minutes. The 
last three steps were repeated, and at the end most of the supernatant was removed, leaving 50 
µl of remaining liquid. 50 µl of elution buffer (Qiagen) were added to immediately dissolve 
the pellet. Residual ethanol was evaporated under the clean bench.  
 
5.5.3.4 Purification and concentration of blunt ended insert DNA for library production 
by means of isopropyl alcohol  precipitation       
The aqueous DNA solution resulting from blunt ending reaction (5.5.10.1) was gently mixed 
with 1.7 volume of isopropyl alcohol and 1/4 volume of 3 M sodium acetate (pH 5). After a 
30 min incubation at room temperature, the sample was centrifuged at 4 °C and 14000 rpm 
for 45 minutes. 95% of the supernatant was removed, avoiding contact with the inner surface 
of the tube. Approximately 500 µl of ice cold 70% ethanol were slowly added, and 
sedimentation was carried out for 5 minutes at 14000 rpm. The supernatant was discarded, 
leaving approximately 7 µl in the tube. After the addition of 7 µl elution buffer (Qiagen) the 
pellet was resuspended while heating at 50 °C in a water bath.  
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5.5.3.5 Quantification and purity of nucleic acids 
The concentration and purity of DNA and RNA samples was determined by means of a 
spectrophotometer. Assuming a seam of 1 cm in the cuvette, the absorption value of 1.0 at a 
wavelength of 260 nm corresponds to a concentration of 40 µg/ml for single-stranded DNA or 
RNA, and to 50 µg/ml for double-stranded DNA. As proteins exhibit an absorption maximum 
at 280 nm, the scale of purity was obtained by use of the A260 nm to A280 nm ratio. This quotient 
was valid up to an absorption value of 2.0, whereas high quality nucleic acid solution was 
reflected by a quotient between 1.7 and 2.0.135  
 
The DNA concentration was calculated according to the following formula: 
 
[c] = A260 x dilution factor x 50 [mg/ ml] 
 
5.5.4 Agarose gel electrophoresis 
 
5.5.4.1 Native agarose gel electrophoresis 
Due to the negatively charged phosphate groups in DNA molecules, DNA fragments can be 
separated in an electric field. According to their size, smaller DNA fragments migrate longer 
distances in agarose gel matrices than larger DNA molecules.  
 
Agarose gel electrophoresis was carried out to check for the presence of DNA, to separate 
DNA fragments of different sizes and to determine their molecular weight, yield and purity. 
This method was additionally used to isolate particular bands for downstream applications 
(5.5.5.2, 5.5.10.1) and to visualize PCR products. The gels consisted of 1% agarose NEEO 
ultra in either 0.5 x TBE or 1 x TAE buffer. The respective buffer served as an electrophoresis 
buffer as well, and thus covered the gel in horizontal gel chambers during electrophoresis. 
The current inducing the electric field ranged between 80 V and 120 V, depending on the 
required separation. A loading dye was added to each sample in a ratio of 1:10 to visualize 
DNA migration on the gel. This dye contained a mixture of Xylene Cyanol FF (migrates at ~ 
5000 bp), Bromophenol Blue (migrates at ~ 300 bp) and Orange G (migrates at ~ 50 bp). 
Glycerol was included in this loading dye to weight the sample solution down to the gel slots. 
2-5 µl of a commercial size marker were applied to at least one outer lane. Specific size 
markers allowed simultaneous DNA quantification where required (5.5.10.1). The DNA was 
visualised by the addition of ethidium bromide. This binds strongly to DNA by intercalating 
between the bases and when exposed to ultraviolet light, it will fluorescent with an orange 
colour. Ethidium bromide was either directly included in the gel matrix to enable visualisation 
 Materials and methods 
  91 
 
under UV light in the gel documentation system or used for staining of the gel after 
electrophoresis. Therefore it was agitated in ethidium bromide solution (10 µg/ml) for 3-5 
minutes. Non intercalated ethidium bromide was subsequently washed out with purified water 
while shaking for 5 minutes. Analysis was performed using a UV transilluminator and a 
digital camera.  
 
5.5.4.2  DNA extraction from agarose gels 
If required for downstream applications, the designated DNA fragment was excised from the 
agarose matrix after the separation on an agarose gel omitting ethidium bromide (5.5.4.3). For 
DNA recovery the QIAquick Gel Extraction Kit (Qiagen) was used according to the 
manufacturer’s instruction manual.  
 
5.5.4.3  Gel electrophoresis without ethidium bromide 
To avoid DNA damage by exposure to UV light, electrophoresis was also performed without 
including ethidium bromide in the agarose solution. The DNA was loaded in a larger well of 
the agarose gel, with a ladder on each side. After electrophoresis, both sides including the 
ladder were cut off with a sharp scalpel, and were then stained with ethidium bromide 
solution for 15 minutes with shaking. A scalpel was used to mark the positions were the band 
of interest should be situated and then all gel parts were again reassembled. Out of the UV 
range, the desired fragments were excised from the gel according to the markings and then 
subjected to DNA gel extraction (5.5.4.2).  
5.5.5 DNA amplification by the polymerase chain reaction (PCR) 
The polymerase chain reaction is a rapid in vitro technique for the amplification of DNA 
fragments.136 This enzymatic reaction can only be conducted if at least the sequence 
information of the flanked regions of the targeted DNA is known.  
 
The sequence of the target region was taken as a template for deducing complementary 
oligonucleotides, which are referred to as primers in the further course of the study (table 
5.11).  
 
The PCRs were carried out in a thermo cycler T3 or TGradient for optimisation of cycle 
settings respectively. Optimisation of PCR conditions is indispensable for the efficient and 
reliable amplification of DNA fragments. Therefore the reaction mixture and the cycling 
protocol were varied with respect to the usage of DMSO for GC rich templates, MgCl2 
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concentration and primer annealing temperature. The most suitable parameters to obtain a 
distinct product, without unspecific amplification, were used for analysis as listed below.      
 
For each PCR experiment positive and negative controls were carried out. Genomic DNA of  
Streptomyces sp. GW2/5831 was used as template for the positive controls, whereas no DNA 
was included in negative controls.  
 
5.5.5.1  PCR conditions for pre testing of degenerate ketosynthase primer pairs on 
genomic DNA from Streptomyces sp. GW2/5831 
The following degenerate PCR primers were used for pre testing: KS2F, KS2R, KS4F and 
KS1R (table 5.11). The primer pairs were applied in the PCR of genomic DNA from 
Streptomyces sp. GW2/5831 as listed in table 5.20. Conserved motifs of KSα proteins from 
pradimicin-type compound biosynthesis formed the basis of degenerate PCR primer 
construction.83 The obtained PCR product was, subcloned in pBluescript II SK (+), sequenced 
and the sequences were then used for designing specific primers (5.5.5.2) for library 
screening.  
 
Table 5.20 Degenerate primer pairs 
Primer pair Upstream primer Downstream primer Annealing 
temperature 
1 KS2F KS2R 46 °C 
2 KS4F KS1R 50 °C 
3 KS4F KS2R 48 °C 
 
 
Table 5.21 PCR mixture 
Reagent Volume 
GoTaq®  reaction buffer (green)  10.0 µl 
dNTP mix 10 mM    1.0 µl 
DMSO   5.0 µl 
Upstream primer   1.0 µl 
Downstream primer   1.0 µl 
GoTaq® DNA polymerase (5 units/µl)   0.5 µl 
Millipore water 30.5 µl 
Template (genomic DNA of Streptomyces sp. 
GW2/5831) 
  1.0 µl 
The reaction buffer contained magnesium chloride in a final concentration of 1.5 mM in each PCR.  
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Table 5.22 Cycling protocol 
Step Temperature Time 
1. initial denaturation 97 °C 5 minutes 
2. primer annealing 46 °C/ 50 °C/ 48 °C 1.5 minutes 
3. extension 74 °C 1 minute 
4. denaturation 95 °C 0.5 minutes 
5. primer annealing 46 °C/ 50 °C/ 48 °C 1 minute 
6. repeat steps 3-5 - 29 cycles 
7. final extension 74 °C 10 minutes 
8. Cooling 4 °C indefinitely 
 
 
5.5.5.2 Design of specific primers for the screening of the Streptomyces sp. GW2/5831 
library  
The yielded PCR product, amplified with degenerate primers (table 5.20), was visualised on a 
gel and purified via gel extraction by means of QIAquick® Gel Extraction Kit (Qiagen). The 
recovered DNA fragment, having 3’-A overhangs due to terminal transferase activity of Taq 
polymerase, was subcloned into pBluescript II SK(+) vector having 3’-T overhangs (5.5.8). 
Heat shock transformation (5.5.9.2) was carried out using chemical competent E. coli XL-1 
Blue cells (5.5.9.1). Colonies were grown in overnight cultures, consisting of LB medium 
including ampicillin, and plasmid DNA was isolated (5.5.2). After restriction analysis with 
RsaI, samples were subjected to sequence analysis (5.5.12). Sequence data were then used for 
designing specific primers that were required for the PCR screening of the genomic library. 
The primer design was done with OligoPerfect™ software from Invitrogen™.  
 
5.5.5.3 PCR conditions for library screening and monitoring of cosmid integration into 
Streptomyces albus genome 
To optimise PCR conditions, the annealing temperature of the specific primer pair was varied 
between 48.5 and 56.2 °C (in steps of 2 °C, and 1.7 °C respectively), whereas 54.5 °C 
emerged as suitable annealing temperature (table 5.24) resulting in one clear PCR product 
with a size of ~700 bp. The usage of DMSO did not show any improvement of the PCR, 
although generally recommended for GC-rich DNA. PCR was carried out in the presence of 
1.5 mM magnesium chloride (MgCl2). Additional MgCl2 up to 3 and 4 mM showed no effect 
on product amplification. The genomic DNA from Streptomyces sp. GW2/5831 served as a 
positive control for each set of PCR. Negative controls were performed simultaneously 
excluding any template DNA in the corresponding PCR vessel.  
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Usage of the PCR program for GC-rich DNA matrices described in 5.5.6.3 resulted in highly 
unspecific amplification. Therefore the whole cell cycling program listed in table 5.24 was 
used for PCR mixtures (table 5.23). 
For saving time and materials, row superpools were prepared for PCR. For that, aliquots of 20 
µl culture from each of the 12 wells of an entire row of the microtiter plate were pipetted 
together in one eppendorf tube. In this way, one microtiter plate could be screened in a round 
of 8 PCRs instead of 96. Once a positive superpool identified, all the 12 wells of the 
corresponding row were screened separately.  
 
Screening of the library was conducted via whole cell PCR of E. coli. Direct usage of 
Streptomyces cells in PCR is not possible, therefore genomic DNA had to be isolated (5.5.1).  
 
Table 5.23 PCR mixture 
Reagent Volume  
GoTaq®  reaction buffer (green)  1.25       µl 
dNTP mix 10 mM 0.125     µl 
Bovine serum albumin (BSA) 100x 0.0625   µl 
Upstream primer BES1 T7 1F 2F 1.25       µl 
Downstream primer BES1 T7 1F 2R 1.25       µl 
GoTaq® DNA polymerase (5 units/µl) 0.03125 µl 
Millipore water 9.78125 µl 
Template (pooled fractions or single wells of 
library, genomic DNA of Streptomyces sp. 
GW2/5831 or conjugated Streptomyces albus 
strains) 
1.0         µl 
 
 
Table 5.24 Cycling protocol 
Step Temperature  Time 
1. cell lysis 95 °C 5 minutes 
2. initial denaturation 95 °C 0.5 minutes 
3. primer annealing 54.5 °C 1 minute 
4. extension 72 °C 1 minute 
5. repeat steps 2-4 - 34 cycles 
6. final extension 72 °C 5 minutes 
7. Cooling 4 °C indefinitely 
 
 
5.5.6 Reverse transcription polymerase chain reaction (RT-PCR) 
RT-PCR is a very sensitive technique intended for monitoring gene expression. To prove the 
presence of rifL mRNA transcript, total RNA was isolated from Streptomyces lividans 
pHGF7604 using the RNeasy® Mini Kit (Qiagen) according to the manual. First strand 
synthesis was performed by means of reverse transcriptase and random hexamer primer 
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according to the technical manual of First Strand cDNA Synthesis Kit (Fermentas). The 
obtained cDNA product was used as a template for PCR with the specific primer pair RT-
PCR-Oxido_for and RT-PCR-Oxido_rev (table 5.11). The amplified PCR product was 
visualised under UV light after staining with ethidium bromide.  
 
5.5.6.1 Isolation of total RNA from Streptomyces lividans pHGF7604  
RNA was isolated using the method described by Chomczynski and Sacchi.137 All steps were 
carried out under the clean bench in order to avoid contamination with RNA degrading 
enzymes (ribonucleases). Additionally, all instruments (e.g. pipettes, …) were treated with 0.1 
M sodium hydroxide solution if possible and exposed to UV light for 30 minutes. 
 
A 50 ml liquid culture (5.4.2.2) of Streptomyces lividans pHGF7604 was harvested at 11000 
rpm and 4 °C for 5 minutes. Approximately 65 mg of the cell material were subjected to RNA 
isolation, according to the technical manual of the RNeasy® Mini Kit (Qiagen). 
 
5.5.6.2 Protocol for cDNA-synthesis 
The First Strand cDNA Synthesis Kit (Fermentas) was used for synthesis of complementary 
DNA. 
 
Total RNA     6 µl  
Random hexamer primer   1 µl 
Deionised, RNase free water                  ad 11 µl  
 
were carefully mixed in a PCR vessel and centrifuged for 5 seconds. The mixture was heated 
at 70 °C in a thermo cycler for 5 minutes and cooled on ice.  
 
5x reaction buffer               4 µl 
Ribonuclease inhibitor   1 µl 
10 mM dNTP mix    2 µl 
 
were carefully added, centrifuged for 5 seconds and incubated at 25 °C in a thermo cycler for 
5 minutes.  
 
M- MuLV Reverse Transcriptase  2 µl 
 
was included in the reaction mixture. The mixture was first incubated at 25 °C for 10 minutes, 
then at 37 °C for 60 minutes.  
The reaction was stopped while heating at 70 °C for 10 minutes. The sample was cooled 
down on ice, quantified and applied to PCR amplification.  
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5.5.6.3 PCR conditions for RT-PCR 
As a precondition to this experiment, a PCR was carried out using the degenerate primer pair 
“Oxidofw” and “Oxidorv” (table 5.11) and genomic DNA (5.5.1) from Streptomyces lividans 
pHGF7604 as DNA template. The PCR mixture was set up as listed in table 5.24, and the 
cycling protocol shown in 5.26 was applied. For increased specificity, the specific primer pair 
“RT-PCR-Oxido” (table 5.11) was employed in a PCR performed under the same conditions 
as described above. After successful amplification of the rifL fragment, the specific primer 
pair “RT-PCR-Oxido” was used for RT-PCR.  
 
 
Table 5.25 PCR mixture for RT-PCR and corresponding pre test 
Reagent Volume 
GoTaq reaction buffer (green) 10.0 µl 
dNTP mix 10 mM   1.0 µl  
DMSO   5.0 µl 
Upstream primer (20 µM)   1.0 µl 
Downstream primer (20 µM)   1.0 µl 
GoTaq polymerase (5 units/µl)   0.2 µl 
Millipore water (sterilised) 30.8 µl 
DNA template (obtained in 5.5.6.2)   1.0 µl 
           
           
 
Table 5.26  Cycling protocol for GC-rich DNA 
 
Step Temperature Time 
 1. Initial denaturation 97 °C 5 minutes 
 2. Primer annealing 65 °C 1.5 minutes 
 3. Extension 74 °C 1 minute 
 4. Denaturation 95 °C 0.5 minutes 
 5. Repeat steps 3-6   29 cycles 
 6. Primer annealing 65 °C 1 minutes 
 7. Final extension 74 °C 10 minutes 
 8. Cooling 4 °C indefinitely 
 
 
5.5.7 Enzymatic manipulation of DNA 
5.5.7.1 DNA analysis by restriction 
Endonucleases were used together with the supplied buffer from the manufacturer. Sequence 
specific cleavage was carried out utilising restriction endonucleases type II. Incubation of the 
DNA with the enzyme and appropriate buffer, including BSA, was conducted at 37 °C for 2 
hours.  
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Standard protocol for digestion of DNA  
 
Reaction: 
 
DNA   0.5 µl 
Endonuclease  0.5 µl 
Buffer   1.0 µl 
BSA (100x)  0.1 µl 
Purified water  7.9 µl 
 
 
5.5.7.2 Restriction cleavage for subcloning technique   
For the subcloning of cosmid DNA fragments into pBluescript II SK (+) vector, both insert 
and vector DNA were digested with the same restriction enzyme. The reactions were carried 
out as listed below. 
 
Standard protocols for restriction cleavage in subcloning work: 
 
Reaction for insert DNA 
 
Cosmid DNA  50.0 µl 
Endonuclease  10.0  µl 
Buffer   15.0 µl 
BSA (100x)    1.25  µl 
Purified water          23.75 µl 
 
Incubation time at 37 °C was extended to 3 hours to ensure complete digestion. The 
restriction reaction was applied to a gel without ethidium bromide. The DNA fragments were 
excised separately, as far as possible, and were then recovered from the gel (5.5.4.2) for usage 
in ligation reactions (5.5.7.4).  
 
Reaction for vector DNA: 
 
Vector DNA  20.0 µl 
Endonuclease    2.5 µl 
Buffer     5.0 µl 
BSA (10x)    5.0 µl 
Purified water          17.5 µl 
 
After 2 hours of incubation at 37 °C, inactivation of the enzyme was achieved by heating at 
65 °C for 20 minutes. The DNA was then dephosphorylated (5.5.7.3).  
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5.5.7.3 Dephosphorylation of linearised pBluescript vector DNA  
Antarctic phosphatase catalyses the removal of 5´ phosphate groups from DNA. 
Dephosphorylation was carried out incubating 50 µl of the vector restriction solution with 
6.25 µl of antarctic phosphatase in an appropriate buffer at 37 °C. After 30 minutes another 1 
µl of antarctic phosphatase was added, and incubation was continued for further 15 minutes. 
Dephosphorylation of pBluescript vector DNA was followed by purification via gel extraction 
(5.5.4.2). The vector was then used for ligation (5.5.7.4).  
 
5.5.7.4 Ligation by means of T4 DNA ligase 
During ligation, DNA ligase catalyses the formation of covalent phosphodiester bonds 
between adjacent nucleotides in duplex DNA strands. As a precondition, one nucleotide 
requires a 5'-phosphate group and the other a 3'-hydroxyl group. In this work, T4 DNA ligase 
(NEB) was used for all ligation reactions together with the supplied buffer.  
 
Ligation reaction: 
 
Insert DNA  7 µl 
Vector DNA  1 µl 
T4 ligase  1 µl 
Ligase buffer  1 µl 
            10 µl 
 
 
The ligase reaction was incubated in a thermo block at 16 °C over-night. T4 DNA ligase was 
then inactivated by heating at 65 °C for 20 minutes. 
 
Each time, between 2-5 µl of the ligation reaction were transformed either by electroporation 
or by heat shock, depending on the size of the introduced foreign DNA. Electroporation was 
suitable for large inserts like cosmids, whereas smaller plasmids were transferred by heat 
shock transformation.   
  
5.5.8 Cloning of PCR fragments in a T-overhang vector  
This method was performed as described by Marchuk et al.138  
 
5.5.8.1 Preparation of a T-overhang vector  
The vector pBluescript II SK(+) was digested with the endonuclease EcoRV yielding blunt 
ends. Therefore 10 µl of the vector plasmid preparation were incubated with 2.5 µl of the 
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restriction enzyme, including the appropriate buffer, BSA and purified water to a final volume 
of 50 µl. The mixture was incubated for 2 hours at 37 °C, followed by heat inactivation of the 
enzyme at 80 °C for 20 minutes. Addition of 3’ T-overhangs was carried out during two hours 
of incubation at 70 °C with 0.5 µl Taq polymerase and dTTP’s in a final concentration of 2 
mM. The extraction and precipitation of the vector DNA from the reaction mixture was 
achieved as described below: 
 
- 100 µl of chloroform were added and the solution was mixed thoroughly  
 
- centrifugation was carried out at 13000 rpm for 5 minutes 
 
- the upper layer was transferred to 70 µl of isopropyl alcohol, avoiding the protein interlayer 
 
- after vigorous shaking, the solution was centrifuged at 4 °C and 13000 rpm for 20 minutes 
 
- the supernatant was discarded, and the pellet was rinsed with 200 µl of ice cold 70% ethanol 
 
- the pellet was vacuum-dried and dissolved in 10 µl of purified water 
 
 
5.5.8.2 Ligation of unmodified PCR fragments into T-overhang vector  
The TA cloning method benefits from the terminal transferase activity exhibited by Taq 
polymerase. This enzyme adds an A-overhang to each end of a PCR product. Therefore it is 
possible to perform a ligation of a PCR product directly into a vector provided with T-
overhangs. Therefore the PCR product obtained in 5.5.5.1 could be directly cloned into the 
vector pBluescript II SK(+) that was prepared as described in 5.5.8.1.  
 
5.5.9 Preparation of competent cells and their transformation 
5.5.9.1 Preparation of E. coli XL1-Blue competent cells for heat shock transformation 
Approximately 1 ml of an overnight-culture was added to 100 ml of fresh LB medium, and 
grown at 37 °C and 200 rpm to an OD600 between 0.4 and 0.5. Cells were harvested by 
centrifugation in 50 ml falcon tubes at 5000 rpm and 4 °C for 6 minutes. Pellets were 
dissolved in 12.5 ml TFB I solution (table 5.17), sedimented as above and redissolved in 2 ml 
TFB II solution (table 5.17). Aliquots of 100 µl were shock-frozen in liquid nitrogen, and 
stored at –80 °C.  
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5.5.9.2 Heat shock mediated transformation 
Chemically competent cells obtained in 5.5.9.1 were mixed with 10 µl of a ligation reaction 
(5.5.7.4, 5.5.8.2) and stored on ice for 20 minutes. Heat shock was carried out for 1 minute at 
42 °C. Subsequently, the mixture was incubated on ice, and 900 µl of LB medium were 
added. Incubation at 37 °C and 200 rpm for 1 hour was followed by centrifugation at 5000 
rpm at room temperature for 10 seconds. Approximately 750 µl of the cell suspension were 
spread on LB agar plates containing Ampicillin (100 µg/ml) that were impregnated with 20 µl 
of X-gal (50 mg/ml) and 100 µl of IPTG (100 mM) at least 30 minutes prior to use. After 
incubation at 37 °C for 16 hours colonies were visible. Blue and white colonies were 
identified after at least 2 hours of storage at 4-8 °C. White colonies contained the DNA of 
interest ligated into the vector (5.5.9.6), and were therefore subjected to plasmid DNA 
isolation (5.5.2).  
 
5.5.9.3 Preparation of E. coli ET12567/pUZ8002 competent cells for electroporation 
Cells of E. coli ET12567/pUZ8002 were grown overnight at 37 °C for 16 hours in 5 ml LB 
medium containing 25 µg/ml chloramphenicol and 25 µg/ml kanamycin. On the next day, 1 
ml of this pre-culture was used to inoculate 100 ml of fresh LB medium containing 
antibiotics. After reaching the OD600 of approximately 0.4, the cells were recovered by 
centrifugation at 4000 rpm and 4 °C for 5 minutes. After decanting the supernatant, the pellet 
was washed by gentle resuspension in 40 ml of ice-cold 10% glycerol. This was repeated with 
30 ml, as well as 15 ml of ice-cold glycerol. After sedimentation in 15 ml glycerol, the 
supernatant was discarded after centrifugation and the cell pellet was resuspended in the 
residual glycerol. Aliquots of 50 µl were placed in tubes and treated with liquid nitrogen. The 
obtained electrocompetent cells were stored at –80 °C.  
 
 
5.5.9.4  Preparation of E. coli XL-1 Blue competent cells for electroporation 
A 5 ml overnight-culture was used to inoculate 200 ml of fresh LB medium, followed by 
incubation at 37 °C and 200 rpm to an OD600 between 0.4 and 0.6. All subsequent steps were 
carried out either on ice or at 4 °C. For centrifugation at 5000 rpm for 5 minutes, the culture 
broth was portioned into 50 ml falcon tubes. After resuspension in 25 ml of 10% glycerol and 
sedimentation, the cells were washed twice with 10 ml of 10% glycerol. Two tubes were 
combined and diluted with 5 ml of 10% glycerol to a volume of 25 ml. The next 
centrifugation steps were carried out as described above (5.5.9.3). The cell pellet was first 
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resuspended in 5 ml, then finally in 1 ml glycerol solution. The contents of all tubes were 
combined, and aliquots of 70 µl were shock-frozen in liquid nitrogen and stored at –80 °C.  
 
5.5.9.5 Electroporation 
Electroporation was carried out using a Bio-Rad MicroPulser® and electroporation cuvettes (2 
mm). Electrocompetent cell suspensions were mixed with 2 µl of oriT-containing vector, 
including the desired DNA fragment. Electroporation was carried out (program settings: 
bacteria, Ec2), and 1 ml of ice-cold LB medium was immediately added to the shocked cells. 
This mixture was transferred to a tube and incubated with shaking for 1 hour at 37 °C. 
Approximately 500 µl were spread on LB agar plate with appropriate antibiotic selection. 
Subsequent incubation at 37 °C took place for 16 hours. The selection of recombinant clones 
by “blue-white” screening is referred to in chapter 5.5.9.2 and 5.5.9.6.  
 
5.5.9.6 Identification of recombinant clones using “blue-white” screening 
The vector pBluescript II SK(+), employed in primer design and subcloning, contains the lacZ 
gene with an internal multiple cloning site harbouring different restriction sites that can be 
cleaved with the corresponding endonucleases. The foreign DNA is then inserted within the 
lacZ gene in a ligation reaction, preventing the correct expression of ß-galactosidase that 
metabolises the modified galactose sugar X-gal after induction with isopropyl-ß-D-1-
thiogalactopyranoside (IPTG). This reaction was then screened by examining the colour of the 
resulting colonies. The vector without an insert expressed a functional ß -galactosidase 
enzyme that converted its substrate X-gal to a bright blue-coloured product that is visible in 
colony clones. The disruption of the lacZ gene results in white colonies that were utilised for 
further studies. The insertion of a foreign DNA fragment can thus be monitored, but evidence 
for a specific fragment must be obtained otherwise. Therefore plasmid DNA of white clones 
was isolated after transferring to liquid medium, and restriction analysis was performed. The 
samples were then subjected to sequence analysis.   
 
5.5.10 Construction of a gene library from Streptomyces sp. GW2/5831 
5.5.10.1 Genomic DNA isolation and library construction 
Genomic DNA from Streptomyces sp. GW2/5831 was isolated according to the previously 
described procedure (5.5.1). The highly concentrated high molecular weight DNA solution 
obtained in the isolation procedure was dissolved with 1000 µl Millipore® water. 
Approximately 700 µl (~ 2 µg) from this crude DNA solution were loaded onto a 0.9% (w/v) 
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low melting point agarose gel. After electrophoresis,  fragments of approximately 40 kb in 
size were recovered from the gel by gel-digestion with GELase (Epicentre Biotechnologies), 
according to the manufacturer's protocol with following modifications: 1 U of GELase 
enzyme preparation was added to each 300 µl of melted agarose, followed by incubation at 45 
°C for 2 h. After inactivating the enzyme at 70 °C for 10 min and removing any undigested 
agarose by centrifugation at 11.000 rpm for 30 min, the DNA was precipitated at room 
temperature with 2.5 volumes of 100% ethanol (5.5.3.3) and 1/10 volume of sodium acetate 
(pH 7). That was followed by centrifugation at 11.000 rpm for 40 min and two washing steps 
with 70 % Ethanol at 4 °C. The DNA was then dissolved in 50 µl Tris buffer (10 mM, pH 
8.5). This size-selected genomic DNA was first blunt-ended for 45 min at room temperature 
(see below), the reaction being stopped by adding EDTA to a final concentration of 10 mM 
and by a subsequent 10 min inactivation step at 70 °C. The DNA was then precipitated with 
isopropyl alcohol (5.5.3.4) and 3 M sodium acetate (pH 5), and after a 30 min incubation step 
at room temperature, the nucleic acids were recovered after 45 min of centrifugation at 14.000 
rpm and 4 °C. Approximately 50 ng of blunt-ended DNA eluted with 7 µl Tris buffer (10 
mM, pH 8.5) were used in a 2 h ligation step (5.5.10.3) at room temperature with 
approximately 200 ng of pAY1 vector (5.5.10.2), using Fast-Link DNA ligase (Epicentre 
Biotechnologies). The DNA was then packaged in lambda phage and used to infect EPI300™ 
T1R E. coli cells according to the manufacturers protocol (CopyControl Fosmid Library 
Production Kit from Epicentre Biotechnologies). The infected EPI300™ T1R E. coli cells 
were spread on 25 LB agar plates containing apramycin, and incubated for 16 hours over 
night. Approximately 4800 clones were obtained, and the library was established comprising 
2016 random clones (5.5.10.4). The clones were subjected to whole cell PCR screening as 
described in 5.5.10.6 and 5.5.5, using the specific primers “BES1 T7 1F 2F” and “BES1 T7 
1F 2R”.  
 
 
blunt ending reaction 
 
End-repair buffer (10x)    8 µl 
dNTP mix (2.5 mM)     8 µl 
ATP (10 mM)      8 µl 
DNA (~40 kb)              50 µl 
End-repair enzyme mix    4 µl 
(T4 DNA ligase + T4 polynucleotide kinase) 
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5.5.10.2 Preparation of pAY1 cosmid vector DNA  
Cosmid vector DNA was isolated from the E. coli DH5α host strain according to the plasmid 
isolation protocol (5.5.2). For the clean-up procedure, the vector DNA was loaded onto a gel 
and was recovered via gel extraction (5.5.4.2). Approximately 34 µl of the vector DNA were 
then restricted with 2 µl of the endonuclease EcoRV in appropriate buffer including BSA. The 
resulting blunt ended DNA was yielded after 3 hours of incubation at 37 °C. The removal of 
5’phosphate groups was catalysed by antarctic phosphatase. This was performed during 
incubation of 20 µl of vector DNA with 2 µl antarctic phosphatase (see also 5.5.7.3) at 37 °C. 
After 30 minutes another 1 µl antarctic phosphatase was added, and incubation was continued 
for 30 minutes. The previous step was repeated. The enzyme was inactivated by heating at 65 
°C for 5 minutes. The mixture was purified by phenol-chloroform extraction (5.5.3.1) and 
concentrated by precipitation (5.5.3.2). The vector DNA was quantified on an agarose gel by 
comparing with Fosmid Control DNA. 
 
5.5.10.3 Ligation 
The ligation reaction was set up as follows: 
 
8.5 µl insert DNA (approximately 50 ng) 
0.5 µl vector DNA (approximately 200 ng) 
1.2 µl Fast-Link™ Ligation Buffer (10x) 
1.0 µl ATP (10 mM) 
1.0 µl Fast-Link™ DNA Ligase 
12.2 µl 
 
incubated at room temperature for 2 hours, heat-inactivated at 70 °C for 10 minutes. 
 
5.5.10.4 Size of library for genome coverage 
Evaluation of the correct number (N) of clones required for the coverage of the whole genome 
of Streptomyces sp. GW2/5831, for an average insert length of 40 kb, was achieved by the 
following formula:139  
 
N =  ln (1 - P) / ln (1 - f) 
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In this equation P (99.9% = 0.999) represents the probability of a genome fragment to occur 
in the library, whereas f (= 0.005) denominates the quotient of insert length to the genome 
size of 8 Mb for Streptomycetes.5  
 
5.5.10.5 Clone picking and replication  
The construction of the library was performed by inoculating individual clones into the wells 
of 21 microtiter plates, resulting in 2016 preserved clones. Therefore, each well was pre-filled 
with 100 µl of LB broth containing 50 µg/ml apramycin. The cosmid clones were transferred 
to the medium via sterilised tooth picks, and incubated over night at 37 °C. On the next day a 
copy of each microtiter plate was established using a transfer seal to inoculate a fresh pre-
filled microtiter plate as described above. After replication 100 µl of 50% glycerol were 
added to the wells of the original plates by gentle mixing. The yielded 25% glycerol stock 
cultures that harboured one individual cosmid clone each were stored at –80 °C. The replicas 
were used to combine 20 µl aliquots of the wells 1 to 12 in each row, obtaining 8 pooled 
fractions from each microtiter plate consisting of 96 wells. 
 
5.5.10.6 PCR based screening of the library 
To obtain a general survey on the number and rough location of positive clones included in 
the library, whole cell PCR was carried out employing the pooled lines from replicates 
(5.5.10.5). Each microtiter plate was analysed by a set of ten PCRs comprising 8 pooled 
fractions as well as a positive and a negative control. After the detection of a positive pool, 
corresponding wells were screened separately. Hence thirteen PCRs were carried out, 
including twelve single well samples and a positive control. This resulted in the identification 
of the exact coordinates of single positive clones harbouring the DNA fragment of interest. 
 
5.5.11 Intergeneric transfer of cosmid DNA between E. coli and Streptomyces  
This technique was described by Flett et al.133 The cosmid containing oriT was introduced 
into the competent cells of E. coli ET12567/pUZ8002 by electroporation (5.5.9.5). A single 
colony of the transformant was inoculated into 3 ml of LB medium containing 25 µg/ml 
chloramphenicol (for ET12567 selection), 25 µg/ml kanamycin (for pUZ8002 selection) and 
50 µg/ml apramycin (for pAY1 selection). The culture was incubated for 16 hours at 30 °C 
and 200 rpm. On the next day 100 µl of the pre-culture were used to inoculate fresh LB 
medium including appropriate antibiotics. Cultivation was continued until an optical density 
of OD600 0.4-0.6 was obtained. At the same time 100 µl of a Streptomyces albus spore 
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suspension (108) (5.4.4) were mixed with 500 µl of TES buffer (0.05 M TES, pH 8). The 
mixture was heat shocked for 10 minutes at 50 °C, and, after cooling down, 500 µl of DSG 
(double strength germination) medium were added. Incubation was continued for 1.5 hours at 
37 °C.  
 
Approximately 1 ml of E. coli cells was washed three times with fresh LB medium without 
any antibiotic, and mixed with the spores after germination. The mixture was shortly 
centrifuged, the supernatant was decanted, and the cells were plated on 2CM agar plates. 
After incubation at 30 °C for 15-16 hours, the overlay was carried out using 1 ml water 
containing 1 mg nalidixic acid and 1 mg apramycin to inhibit overgrowth of E. coli cells. 
Agar plates were continuously incubated at 30 °C for approximately 5-7 days until potential 
exconjugants matured. Exconjugants were then transferred to different solid and liquid media 
for colour monitoring (5.4.5.2).  
 
5.5.12 DNA sequence analysis 
5.5.12.1 Sequence analysis of large cosmid DNA via spot-sequencing  
For evidence of PKS fragments and coverage of the gene cluster, the positive cosmids were 
end-sequenced with primers designed according to the pAY1 sequence adjacent to EcoRV 
cleavage site (AY1ES1 Forward and AY1ES1 Reverse) deduced as shown in 4.2.6 (figure 
4.26). The end-sequences were analysed by conducting BLAST homology searches with 
Advanced BLAST X data base tool (5.5.12.4).  
 
5.5.12.2 Sequence analysis of large cosmid DNA via subcloning technique 
To obtain more sequence data, the DNA of two selected cosmid clones comprising 
approximately 50 kb was digested into 12-14 smaller fragments by restriction cleavage with 
NotI and SacI endonucleases (5.5.7.2). The cloning vector pBluescript was treated with the 
equivalent endonuclease, and dephosphorylation was carried out using antarctic phosphatase 
(5.5.7.3). After purification of the vector DNA by means of gel extraction (5.5.4.2), each 
fragment was inserted into pBluescript via ligation reaction (5.5.7.4). The inserts were end-
sequenced with T7 and T3 universal primers. Sequences were analyzed by BLAST homology 
searches. 
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5.5.12.3 DNA sequencing 
The Sequence data were obtained from GATC Biotech AG service or 4baseLab. Samples 
were automatically sequenced on an ABI 3730xl DNA Analyzer (Applied Biosystems) using 
the dideoxy mediated chain termination method.140 The employed dideoxy nucleotides were 
linked with four fluorescent dyes, each base type carrying a specific colour. Therefore the 
nucleotide sequences were determined by means of a fluorescence detector subsequent to 
sample separation via capillary electrophoresis in a polyacrylamide matrix.   
 
5.5.12.4 Computer-assisted appraisal of obtained DNA sequences 
The software programs BioEdit and Vector NTI® were used to attend DNA sequences. The 
raw data were subjected to the Advanced BLAST X homology search data base for nucleotide 
sequence alignment (http://www.ch.embnet.org/software/aBLAST.html). Advanced BLAST 
X program searches a protein database using a translated nucleotide query that provides 
information about putative gene products and their functions.141 The computation was 
performed using the BLAST network service that utilises the NCBI (National Centre for 
Biotechnology Information) BLAST 2 software.  
 
 
5.5.12.5 Determination of open reading frames (ORFs) 
After the determination of the nucleotide sequence, the obtained data were analysed to 
identify open reading frames.5 An ORF is a nucleotide sequence of substantial length between 
a start and a stop codon that could potentially code for a protein. Analysis of Streptomyces 
DNA results in a high Guanine and Cytosine content. In all likelihood the positions 1 and 3 of 
each triplet are occupied with a Guanine or Cytosine base (see table 5.27).142  In Streptomyces 
G+C rich DNA it is encountered frequently that all of the six possible reading frames (both 
directions, position 1, 2 or 3 of a triplet possible as ORF start) produce large ORFs. For 
assured prediction of protein coding regions a FRAME analysis was performed using the 
FramePlot 4.0 program.143 This program was developed on the basis of the FRAME program 
in which the G+C distribution across codons is determined, and the corresponding open 
reading frames are calculated with graphical representation.142 Frame shift errors can be 
detected in the graph.  
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Table 5.27: Asymmetric G+C distribution across codons in 64 Streptomyces genes 
 
5.6 Protein biochemical methods 
5.6.1 Preparation of crude cell-free extracts from Streptomyces liquid cultures 
All steps were carried out at 4 °C or on ice to sustain active protein conformation.  
 
Liquid cultures (5.4.2.2) were harvested after five day cultivation (5.4.7) by centrifugation at 
11000 rpm for 20 minutes. For that purpose, the culture broth was transferred to 50 ml falcon 
tubes. The resulting cell pellet was washed with chilled 0.1 M potassium phosphate buffer pH 
7.5 (table 5.12) and centrifuged again. The supernatant was poured off, and the weight of the 
pellet was determined. Potassium phosphate buffer served as a lysis buffer, and was therefore 
added in a ratio of 1.5 ml per gram of cell pellet. To inhibit serine degrading enzymes the 
protease inhibitor PMSF was required in 1 mM final concentration. Cell disruption was 
performed by sonication with a micro tip (ultrasonic disintegrator Sonifier 250, Branson). 
Disintegration was directly stopped after the acoustic sound pattern was changed from a high 
pitched to a lower pitched frequency. At this stage the cells were lysed and thus proteins were 
released into the buffer. After centrifugation at 11000 rpm for 20 minutes the supernatant was 
used as a crude cell-free extract (CFE) for subsequent purification and analysis. The samples 
were stored at –20 °C, and retained activity for the following 7 days.  
5.6.2 Protein purification by means of fractionated ammonium sulfate 
precipitation 
All steps were carried out at 4 °C. 
Ammonium sulfate exhibits high water solubility, even at low temperatures, and it has no 
adverse effect on protein activity. At sufficiently high ionic strength, proteins can be 
completely precipitated from the solution by hydrophobic interaction. This salting out 
procedure is a native precipitation, and thus conserves biological activity of the protein.  
 
The cell-free extracts (5.6.1) were subjected to saturation degrees between 10 and 90% of 
ammonium sulfate. The cell-free extracts were carefully stirred in an ice water bath, while the 
appropriate amount of grinded salt was slowly added to the protein solution in small 
Position in triplet Average G+C content 
Position 1 70% 
Position 2 51% 
Position 3 92% 
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portions.144 Ammonium sulfate was added only after previous portions had been completely 
solved. An extensive foam formation was avoided. The protein solution was stirred for 
another 30 minutes after the salt addition was completed. Sedimentation was then carried out 
for 15 minutes at 11.000 rpm, and the pellet was resuspended in 3.5 ml of phosphate buffer. 
The protein solutions from the different fractions were subjected to the desalting treatment 
(5.6.3) and activity testing (5.6.6).  
 
5.6.3 Removal of low molecular weight components from crude cell-free extracts 
(desalting procedure) 
 
All steps were carried out at 4 °C. 
 
Compounds with low molecular weight are present in crude cell-free extracts. As their  
precipitation can interfere with optical tests like UV-enzyme assays, these compounds were 
eliminated through size exclusion chromatography. Compounds (M < 1000) such as salts 
migrate through small matrix pores thus covering a longer distance through the column than 
large size fragments passing through large pores.  
 
A solid phase extraction column, PD-10 Amersham®, filled with 5 ml Sephadex® G-25, was 
first conditioned with 25 ml potassium phosphate buffer. The enzyme solution was then added 
to the column, and the flow-through was discarded. Elution of the proteins was carried out 
with 3.5 ml of potassium phosphate buffer.  
This desalting procedure was used after ammonium sulfate precipitation if necessary. 
 
The column was flushed with 25 ml of 0.1 M sodium hydroxide for regeneration, as well as 
washed with deionized water to pH 7.  
 
5.6.4 Concentration of pre-purified proteins from column eluents 
Amicon® Ultra-15 centrifugal filter units were used for the concentration of pre-purified 
proteins from column eluents. The filtering membrane is made up of regenerated cellulose 
(Ultracel). The molecular weight cut-off (= MWCO) lies at 10 kD, therefore compounds with 
a molecular weight from 10 kD upwards are retained in the filtering cartridge.  
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5.6.5 Colorimetric quantitative analysis based on Bradford’s method 
The utilized Bradford-reagent contains the synthetic, amphoteric dye Coomassie® Brilliant 
Blue G250, ethanol and phosphoric acid. The assay is based on an absorbance shift in the dye 
when the previously red form of the Coomassie reagent changes into blue by the binding of 
protein. In acidic medium the dye is present in its red, cationic form showing an absorbance 
maximum of 465 nm. The amino acids of the proteins form a complex with the dye resulting 
in a shift of the absorbance maximum to 595 nm. This is accompanied by a blue coloration. 
The increase of the absorbance value at 595 nm correlates with protein quantity. Not all 
amino acids take part in complex formation in the same manner, particularly basic and 
aromatic amino acid residues are favoured. Therefore it is only possible to determine the total 
protein concentration. Since the transient dye-protein complex formation is time-dependent, it 
is important to measure all samples after the same reaction time.  
 
The measurement in a spectral photometer at 595 nm took place five minutes after the 
addition of 900 µl of Bradford’s reagent to 100 µl of sample solution. The sample solution 
contained 10 µl of cell-free extract and 90 µl of purified water. The reference cuvette was 
filled with water instead of the sample solution. A calibration curve was established for each 
measurement series. Therefore Bovine Serum Albumin (BSA), which was used as a standard 
protein was applied in concentrations between 1 and 40 µg per ml.  
 
5.6.6 UV-spectroscopy 
Photometric enzyme assay 
 
Light absorption is often an important indicator for activity measurements of enzymes. Time-
referenced change in light absorption represents the velocity of the catalyzed reaction, 
associated with the activity of the enzyme.  
 
UV data were recorded on a two-beam spectral photometer (Uvikon 860, Kontron). 
 
The intended purpose of this enzyme assay was to determine the oxidoreductase activity of 
the heterologous expressed RifL protein from Amycolatopsis mediterranei by the use of 
recombinant Streptomyces lividans strains.  
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Determination of RifL oxidoreductase activity  
 
The course of the reaction was followed by measuring the consumption of the coenzyme 
nicotinamide adenine dinucleotide (NAD+) over a period of 20 minutes. NAD+ and its 
reduced form NADH deviate in their absorption maxima. The emerging reduced form NADH 
was monitored by the increase of absorption at a wavelength of 340 nm. The temperature of 
the photometric chamber was adjusted to 37 °C.  
 
 
Table 5.28  Assay composition 
constituent amount final concentration 
 sample reference  
UDP-Glucose 50 mM 120 µl -    6   mM 
NAD+ 50 mM   80 µl   80 µl    4   mM 
Glutamine 50 mM *   40 µl   40 µl    2   mM 
Magnesium chloride 1 M**    10 µl    10 µl   10  mM 
Pyridoxal phosphate 5 mM     2 µl     2 µl 0.01  mM 
Cell-free extract 100 µg 100 µg  
Potassium phosphate buffer 0.1 
M; pH 7.5 ** 
ad  
   1000 µl 
ad  
   1000 µl 
 
Solutions were stored at –20 °C, except for * that was stored at 4-8 °C and ** at  
room temperature. 
 
The assay components (as listed in table 5.28) were combined in the sample cuvette except 
for the substrate UDP-Glucose which was added later. At the same time the reference cuvette 
was prepared with the assay components as listed above. For volume adjustment 120 µl of 
additional buffer were filled in the reference mixture. Both solutions were stirred through 
cautious pipetting. The reaction was started after pre incubation at 37 °C for 5 minutes by the 
addition of UDP-glucose, and after 1 minute of stabilizing time the change in absorption at 
340 nm was monitored.  
 
A negative control reaction was set up in the same manner with the exception that the applied 
cell-free extract was obtained from an unaltered Streptomyces lividans strain.  
5.6.7 Protein separation via polyacrylamide gel electrophoresis (PAGE) 
All buffers and solutions are referred to in table 5.13 . 
 
SDS disrupts the secondary, tertiary and quaternary structure of the analysed proteins in order 
to produce a linear polypeptide chain that is coated with negatively charged SDS molecules. 
Mercaptoethanol assists the protein denaturation by reducing disulfide bonds. After a uniform 
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charge had been applied to the proteins using the anionic detergent SDS, electrophoretic 
mobility depends primarily on size. Each SDS molecule has one negative charge. Under these 
conditions proteins migrate at a rate that reflects their molecular weight. In polyacrylamide 
gels larger molecules are restrained from migrating as fast as smaller molecules. The gel has 
the function of a molecular sieve.  
 
The discontinuous gel system consisted of two types of matrix compositions that differed in 
polyacrylamide concentration as well as in pH value. The resolving gel solution was poured 
into the glass apparatus, and was covered by a layer of butanol in order to obtain a straight 
edge of the matrix. The organic solvent also prevents the polyacrylamide from oxygenation, 
and thus it speeds up the polymerisation that was completed after one hour at room 
temperature. The upper organic layer was discarded and the stacking gel solution was added. 
The sample-well forming comb was placed in the stacking gel phase and allowed to dry for 30 
minutes. Application of a stacking gel is useful to obtain a high resolution due to 
isotachophoresis. 
 
The protein samples were mixed with 0.2 parts per volume of the denaturing loading buffer 
and were then heated to 100 °C for 10 minutes. Due to the annealing of the SDS molecules to 
the protein surface, the derived poly anions mediate the migration through the polyacrylamide 
porous matrix when an electrical field is applied. After cooling on ice 20 µl of the sample 
solution were filled in the gel slot. The low molecular weight marker was solved in 100 µl of 
loading buffer, and was treated in the same manner as the sample solution. 5 µl of the marker 
were applied to the matrix in order to estimate the size of the sample proteins. Gels were 
developed until the sample reached the lower border of the matrix. This was indicated by the 
tracking dye Bromophenol Blue included in the loading buffer. Migration through the 
stacking gel takes place at a currency of 20 mA, whereas the resolving gel is passed through 
at 60 mA. For staining of the separated proteins, the resolving gel was gently mixed in 
Coomassie solution for at least one hour. The stacking gel was discarded. Visualization of the 
protein bands was possible after shaking in colour stripping solution over night, and thus 
removing unspecific staining of the gel matrix.  
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5.7 Analytical methods 
5.7.1 Thin layer chromatography (TLC) 
Thin layer chromatography was used to detect the amino sugar kanosamine. Aluminium 
sheets coated with silica gel 60 F254 were applied as the stationary phase. Chromatograms 
were developed with acetonitrile, ethyl acetate, water and glacial acetic acid in a ratio of 
5:5:3:1 at room temperature.145 Visualisation was accomplished using ninhydrine spraying 
reagent (1 g ninhydrine, 50 ml ethanol 96%, 10 ml glacial acetic acid) followed by heating at 
100 °C for 5 minutes. Kanosamine caused red-coloured spots on a white plate. Alternatively 
an orcinol spraying reagent (0.2% orcinol, 20% sulfuric acid) was used indicating gray-blue 
spots of the amino sugar.  
 
For optimization of chromatography conditions, other eluents such as propanol or pyridine 
were tested instead of acetonitrile. Every mobile phase mixture was also applied to cellulose-
covered TLC sheets.  
 
For the detection of 2-oxoglutaramate on silica gel plates the mobile phase consisted of 
methanol, chloroform and liquid ammonia (20%) in a ratio of 2:2:1.146 The detection was also 
carried out using ninhydrine spraying reagent.  
 
5.7.2 High performance liquid chromatography (HPLC) 
HPLC was performed on a Dionex system consisting of a GP-40 pump and an ED-40 
electrochemical detector. The anion exchange column Carbopac® PA-10 was used with an 
adequate pre column, and 18 mM sodium hydroxide represented the mobile phase. The 
resulting data were processed with Dionex PeakNet ® software. The high-pH anion-exchange 
(HPAE) chromatography coupled with pulsed amperometric detection (PAD) was described 
by Hardy and Townsend147 and complemented by Dionex Technical Note 21148 for the 
application presented here.  
5.7.3 Fast Protein Liquid Chromatography (FPLC) 
This method was used on the basis of a protein purification strategy described by Amersham 
Biosciences (2000, application note 18-1142-32 AA). Fast Protein Liquid Chromatography 
was carried out using the medium pressure system Äkta® FPLC for the purification of protein 
solutions. The chromatography column was filled with 20 ml of the anion exchange matrix 
 Materials and methods 
  113 
 
DEAE- Sepharose® FF.  The chloride anion from the Tris-HCl-buffer solution represents the 
counter ion. The previously fractionated (5.6.2) and desalted (5.6.3) cell-free extracts were 
applied to the column, and separation was carried out according to the protocol given below 
(table 5.29). Buffer composition is listed in table 5.12. Fractions of 10 ml were collected by 
means of a fraction collector. Amicon® ultracentrifugation tubes were used to concentrate the 
protein fractions up to a volume of 1 ml each (5.6.4).  
 
Quantitative analysis was conducted (5.6.5), and the purified protein fractions were applied to 
the enzyme assay (5.6.6).  
 
 
 
Table 5.29 Purification protocol , DEAE- Sepharose® FF  
Chromatography steps Buffer A Buffer B Volume (ml) 
1. Equilibration 100% 0% 40 
2. Sample application    
3. Wash step 1 100% 0% 80 
4. Gradient elution 100-50% 
50% 
0-50% 
50% 
400 
20 
5. Wash step 2 0% 100% 40 
 
 
 
5.7.4 Mass spectroscopy 
5.7.4.1  LC-MS analysis 
HPLC-MS measurements were performed using an Agilent 1100 Series HPLC with an diode 
array detector (DAD). Sample separation was accomplished by means of a Nucleodur 100 
column (RP18, Macherey-Nagel) and gradient elution (from MeOH/H2O 10/90 to 
MeOH/H2O 100/0 in 20 minutes, MeOH 100% for 10 minutes, with added NH4OAc, 2 mM 
as external standard). This system was coupled to an API 2000, Triple Quadrupole, MS/MS, 
Applied Biosystems/MDS Sciex with electro spray ionisation (ESI).  
 
5.7.4.2 GC-MS analysis 
GC-MS analysis was kindly carried out by Dr. Marc Lamshöft (INFU, Dortmund) on a 
Surveyor MSQ (Thermo Finnigan).  
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5.7.4.3  MALDI-TOF-MS analysis 
MALDI-TOF-MS (Matrix assisted laser desorption ionisation time of flight mass 
spectrometry) can be used for molecular weight determination of large sized molecules like 
proteins. This application was described by Karas and Hillenkamp.149 Fragmentation of the 
analyte was avoided by embedding in the organic matrix sinapic acid. Measurements were 
performed on a Voyager-DE STR 4337 (Applied Biosystems), which used an acceleration 
voltage of 25 kV. The recorded spectrum was set between 2000 and 100 000 Dalton.  
 
This procedure was applied to cell-free extracts in order to detect the enzymes RifK, RifL and 
RifM. Sample preparation was therefore accomplished using an Amprep octadecyl mini 
column. That cartridge was first wetted with 5 ml isopropyl alcohol and then equilibrated with 
5 ml of buffer A. The sample was diluted with 500 µl of buffer A before it was filled in the 
column. Elution of the proteins took place using a 5 ml mixture of buffer A and buffer B 
(1:1). Regeneration of the Amprep matrix was possible with 5 ml of a mixture of buffer A and 
B in a ratio of 1:9.  
 
5.7.5 1 H-NMR experiments 
NMR spectra in biosynthetic studies were measured by Dr. Gerald Dräger (Institut für 
Organische Chemie, Hannover) on a Bruker DPX 500.   
NMR experiments for the verification of 2-oxoglutaramate were recorded on a Bruker Avance 
300 DPX (Institut für Pharmazeutische Biologie, Bonn).  
 
5.8 Synthesis of 2-oxoglutaramate  
The substance 2-oxoglutaramate was employed as a nitrogen acceptor in an enzyme assay 
(5.6.6), and could not be purchased. Therefore it was synthesized according to the method 
described by Nissim et al.150 The synthesis is based on the conversion of the L-amino acid L-
glutamine by the L-amino acid oxidase from the eastern diamond rattle snake Crotalus 
adamanteus. The reaction took place for 10 h at 37 °C in 20 mM Tris-HCl buffer pH 8. As a 
side effect, the amino acid oxidase irreversibly transferred hydrogen to oxygen yielding 
hydrogen peroxide. Added catalase prevented the accumulation of hydrogen peroxide through 
its rapid degradation. The enzymes were removed from the solution using an Amicon® Ultra-
15 centrifugal filter device (5.6.4), and the flow-through was applied to a PD-10 column 
(5.6.3) for buffer exchange.  
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The cyclization from 2-oxoglutaramate to 5-hydroxypyroglutamate occurs spontaneously in 
aqueous solutions. The formation of 5-hydroxypyroglutamate was verified via LC-MS 
analysis (5.7.4.1) and 1H- NMR experiments (5.7.5). 
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6 Appendix 
6.1 FPLC (DEAE-Sepharose®) of a cell-free extract from Streptomyces 
lividans pHGF7604 that was precipitated using 60% ammonium sulfate 
prior to FPLC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RifL assay runs 1-6 the following FPLC fractions were pooled:  
 
1) tested protein solution consisted of fraction 14 and 15 
2) tested protein solution consisted of fraction 16 and 17 
3) tested protein solution consisted of fraction 19 and 20 
4) tested protein solution consisted of fraction 21-24 
5) tested protein solution consisted of fraction 27-29 
6) tested protein solution consisted of fraction 31-33 
 
RifL activity was only detected in assay run 2) comprising protein fractions 16 and 17. 
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6.2 Total ion current (TIC) of a GC-MS run using kanosamine reference 
RT: 0,00 - 58,47
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6.3 Mass spectrum of a GC-MS run (see 6.2, TIC) using kanosamine 
reference- displayed retention time between 28,54 and 28,59 min 
 
 
 
 
KANOSAMINE2 #1352-1355 RT: 28,54-28,59 AV: 4 SB: 6 28,40-28,49 NL: 1,63E4
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